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Health plays an important role in the economic growth process and increasing productivity 
concurrently creates better health outcomes. The stock of an individual’s health increases as 
income rises as well as investment in health augmenting consumption. The increasing attention 
paid to the health-income nexus motivates this thesis to use macroeconomic theory, tools and 
methods to examine the link. This study first replicates a highly cited empirical work by 
Hartwig (2008) on Baumol’s Cost Disease (BCD) to explain the rising trends of healthcare 
expenditure. The gaps identified during the replication prompt the designing of testable 
theoretical models of BCD in Chapter 3. The formulated BCD hypotheses are tested using two 
sets of panel data estimators that assume slope homogeneity and heterogeneity. In Chapter 4, 
a Monte Carlo simulation experiment is conducted to investigate the performance of recently 
developed “mean group type” panel estimators that are robust to cross-sectional dependence, 
slope heterogeneity, non-stationarity and endogeneity. The simulation experiment results 
inform the choice of the panel estimators used to examine the income elasticity of healthcare 
expenditure for selected African countries in Chapter 5.  Overall, I find that Hartwig’s (2008) 
study suffers from methodological flaws and the tested hypotheses revealno significant 
relationship to support the BCD predictions using an OECD dataset. From the simulation 
experiments, I find the Common Correlated Effect Mean Group (CCEMG) estimator to be the 
“best” on the dimensions of bias, efficiency, and coverage rates. Lastly, the empirical analysis 
using the dataset for 47 African countries and estimating with CCEMG provides no significant 
outcomes to support whether total, public and private health expenditures are either income 
inelastic or elastic i.e., health care is a necessity or luxury good. 
Key words: Health expenditure, income, panel data, cross-sectional dependence, slope 
heterogeneity, factor models, endogeneity, OECD, Africa 
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Improvements in human welfare and productivity are dependent on the individual’s 
health status. Ill health and sickness have detrimental consequences for the capacity of humans 
to engage in economic activities (Bloom & Canning, 2003; Bloom, Canning, & Sevilla, 2004). 
Health is one of the main determinants of economic growth (Barro, 1996; Well, 2007).  As a 
component of human capital development, it defines and enhances the productive capacity of 
the workforce in an economy. Similarly, economic growth provides an opportunity for 
technological advancement to further improve the health status of individuals. Thus, health 
plays an essential role in the economic growth process via human capital development, while 
increasing productivity simultaneously feeds back into better health outcomes. 
Over the last four decades, following on seminal contributions by Grossman (1972a) 
and Newhouse and Phelps (1974), there has been increasing attention paid to the health-income 
nexus. Micro-level interest has focussed on the impact of health on human well-being, while 
macro-level analyses have focused on the growth consequences of health status. Health 
production has also received considerable attention and cost-effectiveness studies of various 
medical or lifestyle interventions abound. Of particular interest to policy makers and health 
economists is the cost of providing medical care services. These can either be financed by the 
public sector (i.e. government health care expenditure) or the private sector (i.e. out-of-pocket 
spending, private health insurance).  
This thesis analyses the macro-level inter-relationships between healthcare expenditure 
and economic growth. In the relevant literature, research has evolved along different strands. 
One category of research focuses on the causes and consequences of rising medical spending. 
A second category analyses the effect of health status on economic growth. A third category is 
concerned with the growth effect of health care expenditure. Another research line investigates 
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health-labour productivity (in terms of labour participation and numbers of hours worked). Yet 
another strand examines the consequences of demographic changes such as population aging 
and/or ethnic composition.  Finally, more recently, empirical research has started to focus on 
the time-series properties (stationarity, cross-sectional dependence and cointegration) of health 
care expenditures (e.g. Baltagi & Moscone, 2010; De Mello-Sampayo & De Sousa-Vale, 2014; 
Moscone & Tosetti, 2010; Murthy & Okunade, 2016). The first and last categories combined 
are the main focus of this thesis. In particular, I study the causes of rising medical expenditures 
while carefully addressing their time-series properties.    
 
1.2 Statement of the Problem and Rationale for this Study 
Health contributes to the growth of a country through human capital development 
(Barro, 1996; Bloom et al., 2010; Bloom et al., 2004; Knowles & Owen, 1995, 1997; Narayan, 
Narayan, & Mishra, 2010; D. N. Weil, 2014; Well, 2007)1. This indicates that health is an input 
into a productive workforce. According to Grossman (1972b) , health is a durable capital stock 
that can be improved via investment in medical care and income. The effectiveness of medical 
care is determined not only by activities of skilled health professionals like physicians, but also 
through financing mechanisms and governance structures (see Newhouse, 1970; Pauly, 1987).  
A key concern at the heart of public health policy is whether health production is 
efficiently organized and operated.  Economic costs include wastage, misallocation and the 
draining of resources from more productive activities.  Health care expenditures as a share of 
national output have more than doubled over recent decades in the OECD (Organisation for 
Economic Co-operation and Development).  As a result, the cost side of the industry has 
become a focus of policy debate across the OECD countries (Baltagi & Moscone, 2010; 
                                                          
1 There is a contradictory view that health proxied by life expectancy has a smaller effect on economic growth 
but a larger impact on population growth (Acemoglu & Johnson, 2007).  
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Baltagi, Moscone, & Tosetti, 2012; Hartwig, 2008b). In 1960, the OECD average of GDP spent 
on health care was 3.83%.  By 2010, it had increased to 9.13%, a 138% rate of growth. While 
this upward trend was suspended during the global financial crisis of 2007/2008, health care 
spending has once again started to rise, especially in Europe (OECD, 2015) .  
In an attempt to look for explanations of the rising health care spending, there has been 
a revival of interest in Baumol’s Cost Disease (Baltagi et al., 2012; Baumol, 1967, 1993; 
Hartwig, 2008b, 2011a; Nixon & Ulmann, 2006; Oliveira Martins & De la Maisonneuve, 
2006). However, the existing literature has been hampered by a fairly loose application of 
theory to empirical specification.  This suggests the need for a theoretically-appropriate test of 
Baumol’s Cost Disease hypothesis. Chapter 2 of this thesis replicates a highly cited empirical 
work in the area of BCD in order to better understand the concept, framework and existing 
gaps. Chapter 3 then attempts to fill these gaps by designing a testable theoretical model of 
Baumol’s Cost Disease.   
Another common hypothesis in the literature is that rising income is a major 
determinant of increasing health expenditures (see Gerdtham & Jönsson, 2000b; V. N. Murthy 
& A. A. Okunade, 2009; Prieto & Lago-Peñas, 2012). However, previous studies provide a 
wide range of estimates of the income elasticity of health care spending, and the appropriate 
model specification and estimation procedures are disputed.  In Chapter 4, following Bond and 
Eberhardt (2013a), I conduct a replication of a Monte Carlo simulation experiment to 
investigate the performance of the recently developed “mean group type” panel estimators 
compared with the “pooled type” estimators. The outcomes of the simulation experiment 
inform the choice of the estimators used in Chapter 5 (discussed below). 
In Chapter 5, I investigate the relationship between health care expenditures and income 
for African countries. In particular, I adopt a robust analytical framework from the previous 
simulation in order to appropriately control for technological spill-overs, endogeneity, cross-
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sectional dependence, interdependence of health policies across countries, and heterogeneity 
of unobserved effects. In addition to income, I include non-income determinants of health care 
spending which have so far received only little attention in the literature. Among those 
variables that have been identified are budget deficits or government fiscal capacity  (Jönsson, 
1996; Jönsson & Musgrove, 1997; Ke, Saksena, & Holly, 2011), institutional factors (see D. 
N. Weil, 2014), and official development assistance (Gbesemete & Gerdtham, 1992; Okunade, 
2005). Chapter 5 investigates these determinants, paying particular attention to issues of 
measurement and conceptual design that have been noted elsewhere (see Cutler, McClellan, 
Newhouse, & Remler, 1998). 
Chapter 6 summarises and concludes the entire thesis as well as identifies areas of 
further research. Finally, Chapter 7 describes and presents the estimation codes used in this 
thesis.  
 
1.3 Research Questions 
Emanating from the empirical, theoretical and analytical issues discussed above, the 
following research questions form the focus of this thesis:  
I. Is the most cited research in the area of “Baumol Cost Disease” replicable and robust? 
(Chapter 2) 
II. Is the health sector infected by a “cost and price disease”? (Chapter 3) 
III. What is the comparative performance of the “mean group type” and “pooled type” panel 
data estimators under different set-ups? (Chapter 4) 















Chapter 2: Replication of “What drives health care expenditure? 
--- Baumol’s model of ‘unbalanced growth’ revisited” (Journal of 



















2.1 Overview of Hartwig (2008) 
This chapter of the thesis replicates and assesses the robustness of the study by Hartwig 
(2008b, henceforth HW) on the determinants of health care expenditure (HCE) in OECD2 
countries. HW was motivated by the fact that rapidly rising health expenditure relative to gross 
domestic product (GDP) of developed nations, inclusive of OECD countries, has raised 
concerns among policy makers and analysts. The concerns stemmed from the unclear 
determinants of rising HCE. In particular, HW picks up on three main methodological 
concerns: First, for over three decades, most empirical studies have focused on national 
income/GDP as a determinant of health care expenditure. Several attempts have been made to 
identify other factors such as proximity to death and ageing as composite drivers of health 
expenditure.  However, these have been largely unsuccessful, controversial and/or 
inconclusive. 
Second, the most commonly employed theory (cf. Grossman (1972a) is only concerned 
with an individual’s demand for health, rather than aggregate demand. This calls for a 
theoretical foundation for analysing the determinants of national health care expenditure. This 
theoretical gap motivated HW to revisit Baumol (1967) model of “unbalanced growth” in 
explaining the rapid rise in health care expenditure. HW empirically verified Baumol’s model 
to examine non-income determinants that drive HCE. 
Lastly, the unknown order of integration of health expenditure variables constitutes the 
third rationale for the HW study. Hartwig posited that to achieve robust and non-spurious 
results using health expenditure time series variables, it is better to employ variables in their 
stationary form when specifying a regression model. Thus, HW leveraged on the contribution 
of Gerdtham and Jönsson (2000b) that advocate the need to study growth rates of health 
                                                          
2Organisation for Economic Co-operation and Development (OECD) 
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expenditure instead of levels. This approach helps resolve the controversial issue of the degree 
of integration of the HCE panel time series. On this basis, HW employed a set of panel unit 
root tests to precisely determine the stationary form of HCE series and also incorporated the 
growth rate of health expenditure series in the adopted modelling approach. 
The findings of HW have often been cited, especially his conclusion that wage increases 
in excess of labour productivity growth are a significant determinant of HCE. Specifically, HW 
hypothesized and showed that the value of the coefficient on the ‘Baumol variable’3 is (i) 
statistically different from zero; and (ii) close to one. Indeed, HW’s empirical evidence 
indicated strong support for Baumol’s model of ‘unbalanced growth’ and further established 
that the coefficients were in fact equal to one using Wald parameter restriction tests on all 
specifications as reported in Table 1 and 2 in his study (see Hartwig, 2008b, p. 610). HW 
concluded that the parameter estimate of ‘Baumol’s variable’ being equal to one emanates from 
a prediction of Baumol’s theory and his model can therefore serve as a theoretical foundation 
for investigating the determinants of health care expenditure.  
HW’s empirical contribution has been seen as significant as it provides another non-
income factor that drives HCE from a theoretical perspective with an elasticity coefficient near 
unity. The study likewise suggested that labour prices (i.e. wages) play a significant role in 
explaining the continuous rise in HCE. The work has been cited 184 times as reported on 
Google Scholar (as of 24th February, 2017).  
The relevance of HW in the macroeconomic field of health expenditure analysis 
motivates its selection for replication. This chapter re-analyses the data underlying HW for 
consistency and performs robustness checks.  
  
                                                          
3 Defined as the difference between the growth rates of nominal wages and productivity per employee. 
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2.2 Replication Methods 
2.2.1 HW Model and Data Description 
HW investigated the impact of wage increases in excess of labour productivity on 
current health expenditure using a linear growth regression similar to Barros (1998) of the 
form: 
ititit eXy          (2.1) 
where ity  is the log difference (growth rate) of HCE per capita in country i in year t . X
denotes a vector of exogenous determinants including the “Baumol variable” defined as the log 



















dBaumol loglog       (2.2) 
    PRODdWSPEdBaumol loglog       (2.3) 
where WAGE is nominal wages; GDPR  is Real Gross Domestic Product; EMP  is total 
employment; PROD  is productivity per employee; and WSPE is the nominal wage per 
employee. The expression (2.3) represents an ‘unsplit Baumol variable’, while HW also 
considered a split (/disaggregated) Baumol variable from (2.2) as: 
      EMPdGDPRdWSPEdBaumol logloglog     (2.4) 













   (2.5) 
20 
 
ititit eBaumolHCEd   log 10        (2.6) 
where  ite  is an error term and taken as white noise.  
2.2.2 HW Estimation Techniques and Sample Description 
HW estimated equations (2.5) and (2.6) using Pooled Ordinary Least Squares (POLS), 
Cross-section Random Effects (CRE), and Time period Random Effects (TRE).  The latter two 
procedures allow the unobserved, “fixed component” of the error term to be associated either 
with a specific country or a specific year, respectively.  The panel models were estimated for a 
sample of 19 OECD countries comprised of Australia, Austria, Canada, Denmark, Finland, 
France, Germany, Iceland, Ireland, Italy, the Netherlands, Norway, Portugal, South Korea, 
Spain, Sweden, Switzerland, the United Kingdom and the United States of America. The 
unbalanced panel time series cover the period 1960 to 2005 and were sourced from OECD 
Health Data 2005 CD-ROM. 
2.3 Sample Description and Summary Statistics 
HW graciously provided the original data employed in his study on request. Using the 
data, this thesis was able to replicate HW’s Table 1 and 2 for specified models (2.5) and (2.6). 
It is essential to describe the panel time series characteristics of the data employed in the 
estimation of the panel regression models (2.5) and (2.6). However, HW does not report the 
sample characteristics. A closer look at my Table 2.1 indicates that the pooled average annual 
growth rate values of current health expenditure per capita (DLHCEP), nominal wages per 
employee (DLWSPE), real gross domestic product (DLGDPR), total employment (DLEMP), 
productivity per employee (DLPROD), and the wage-productivity gap (BAUMOL) in the 
OECD between 1960 and 2005 stood at 9.88%, 8.28%, 2.56%, 2.07%, 3.04%, 1.07%, 1.89%, 
and 6.72% respectively. This reflects the high growth rate of current health expenditure per 
capita, low labour productivity growth and a large wage-productivity gap in OECD countries. 
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Table 2.1: Descriptive Statistics for Hartwig’s (2008) Pooled Original Data 
 




DLHCEP 589 9.9% 7.2% -9.2% 63.0% 
DLWSPE 623 8.6% 7.3% -15.6% 44.3% 
DLGDPR 646 3.0% 2.6% -7.6% 11.7% 
DLEMP 761 1.1% 2.1% -7.3% 24.3% 
DLPROD 624 1.9% 2.3% -19.3% 11.5% 
BAUMOL 623 6.7% 7.0% -4.5% 47.4% 
  
The average values for individual countries are reported in Table 2.2. The mean values 
reveal that countries with high growth in the wage-productivity gap (such as Finland, South 
Korea, Netherland, Norway, U.K, France, and Germany) recorded the highest average annual 
growth rate of current health expenditure per capita (see Figure 2.1)4. 
Table 2.2: Descriptive Statistics for Hartwig’s (2008) Original Data: By Country 
 
Sample DLHCEP DLWSPE DLGDPR DLEMP DLPROD BAUMOL 
Australia 9.9% 7.3% 3.6% 1.9% 1.6% 5.7% 
Austria 7.9% 5.6% 2.6% 0.6% 1.9% 3.8% 
Canada 8.2% 5.6% 3.1% 2.2% 1.1% 4.5% 
Denmark 4.2% 7.3% 2.4% 0.5% 1.9% 5.4% 
Finland 18.4% 21.2% 3.7% 1.9% 1.7% 19.5% 
France 10.9% 10.2% 5.0% 1.2% 3.5% 6.8% 
Germany 10.5% 8.3% 2.8% 0.3% 2.5% 5.9% 
Iceland 6.6% 3.0% 2.6% 1.9% 0.5% 2.5% 
Ireland 6.3% 10.3% 2.3% 0.1% 2.0% 8.3% 
Italy 10.7% 7.2% 3.4% 0.9% 2.4% 4.9% 
Netherland 12.5% 15.0% 6.8% 2.7% 4.3% 10.7% 
                                                          
4 This implies that there is a high correlation between current health expenditure per capita growth rates and 
labour prices (see Figure A2.1 in the Appendix) as well as with growth in the wage-productivity gap (see 
Figures A2.2 in the Appendix) 
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Sample DLHCEP DLWSPE DLGDPR DLEMP DLPROD BAUMOL 
Norway 15.1% 11.0% 3.0% 0.8% 2.2% 8.8% 
Portugal 5.9% 7.6% 2.0% 0.4% 1.7% 5.9% 
South Korea 18.1% 13.6% 3.2% 0.9% 1.9% 11.7% 
Spain 6.3% 4.5% 2.3% 0.7% 1.4% 3.0% 
Sweden 6.8% 4.4% 1.4% 1.0% 0.5% 3.9% 
Switzerland 5.4% 7.0% 2.1% 0.4% 1.4% 5.6% 
UK 10.7% 8.6% 2.3% 0.3% 1.8% 6.8% 
USA 8.6% 5.5% 3.1% 1.7% 1.5% 4.1% 
 
The descriptive analysis of HW’s data highlights two econometric issues. First, it 
identifies a concern that the individual country series are characterized by cross-sectional 
correlation or dependence. Figure 2.1 indicates a high degree of correlation between country-
level explanatory variables. This is to be expected as these variables are linked by a country’s 
history, climate, geography, labour mobility, economic relations, and health status. One would 
expect that countries that share these common factors would likewise have systematic error 
correlations.   
Second, as seen in Figure 2.2, while many countries align along a linear relationship 
between HCE per capita growth and wage-productivity gap growth, there are a disproportionate 
number of countries that lie outside the 95% confidence interval for this linear relationship. 




Figure 2.1: Scatter Correlation Matrix Plot of BCD Variables
 
These two econometric issues have potential implications for model specification and 
efficiency of standard panel data estimators, but were not addressed in HW’s econometric 
analysis. In subsequent sections, the procedures adopted in addressing the aforementioned 
issues are discussed in detail. 




2.4 Pure Replication Results  
The original dataset provided by HW was in EViews workfile format.  The results 
reported in HW’s Tables 1 and 2 (see Hartwig, 2008b, p. 610) are replicated in Tables 2.3 and 
2.4. I was able to exactly reproduce HW’s results using EViews 8.1, while obtaining somewhat 
different results using Stata (version 14.1).  The reported t-ratios in HW’s Tables 1 & 2 were 
based on EViews White cross-section standard errors and covariance method that Arellano 
(2003, p. 18) termed fixed T and large N robust standard errors.  They correct bias for 
heteroskedasticity and ‘within group’ cross-section/ serial correlation.  The Stata estimates use 
cluster robust standard errors.  As noted by Reed & Ye (2011, p. 5), EViews and Stata use 
different degrees of freedom in calculating clustered standard errors. 
The replication output using Stata revealed substantial differences from HW’s main 
results in reported standard errors and t-statistics.  The differences are highlighted in yellow. 
This is no doubt due to the different degree of freedom calculations employed by Stata and 
Eviews. 
2.5 Robustness Checks 
2.5.1 Robustness Check #1: Test of Cross-section Independence 
Most of the recent theoretical and applied panel data econometric studies have 
emphasised the need to address the methodological issue related to cross-section or “between 
groups” dependence in error terms when dealing with panel data models.  
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Table 2.3: Results for Growth Rate Equations -- 'Baumol Variable' Split 
Dep. Variable: Log difference of health care expenditure per capita [dlog(HCEP)] 
Variables 




Replicated Results HW Results 
(Eviews 
Output) 
















5(I) 5(II) 5(III) 5(IV) 5(V) 5(VI) 5(VII) 5(VIII) 5(IX) 
  
dlog(WSPE) 
1.066*** 1.066*** 1.066*** 1.064*** 1.064*** 1.064*** 1.059*** 1.059*** 1.035*** 
(28.557) (28.557) (48.50) (27.561) (27.561) (48.22) (27.155) (27.155) (28.73) 
dlog(GDPR) 
-0.339*** -0.339*** -0.339*** -0.351*** -0.351*** -0.351*** -0.308*** -0.308*** -0.233*** 
(-3.951) (-3.951) (-4.85) (-4.049) (-4.049) (-4.78) (-3.571) (-3.571) (-2.80) 
dlog(EMP) 
0.601*** 0.601*** 0.601*** 0.599*** 0.599*** 0.599*** 0.588*** 0.588*** 0.574*** 
(7.377) (7.377) (7.32) (7.331) (7.331) (7.49) (7.511) (7.511) (6.97) 
  
Obs. 507 507 507 507 507 507 507 507 507 
 
NOTE: Original results are taken from Table 1 in HW. The replicated results are identical. The explanatory variables are: dlog(WSPE) = log difference of wages 
and salaries per employee in the overall economy, dlog(GDPR)= log difference of real Gross Domestic Product (GDP), and dlog(EMP)= log difference of overall 
employment. The values shown in parentheses are t-ratios, based on White’s Cross-section robust standard error and covariance. The Swamy-Arora GLS 
estimator was used to estimate the random effects models. The highlighted values indicated the areas of difference between the original and replicated 
results. *** denotes significance at 1% significance level  
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Table 2.4: Results for Growth Rate Equations -- 'Baumol Variable' Unsplit 
 
Dep. Variable: Log difference of health care expenditure per capita [dlog(HCEP)] 
Variables 






























1.033*** 1.033*** 1.033*** 1.016*** 1.016*** 1.016*** 1.029*** 1.029*** 0.982*** 
(34.763) (34.763) (37.31) (32.763) (32.763) (31.58) (34.204) (34.204) (19.12) 
 
Obs. 507 507 507 507 507 507 507 507 507 
 
NOTE: BAUMOL is the wage-productivity gap growth derived from the difference between dlog(WSPE) and dlog(PROD). dlog(WSPE) = log difference of wages 
and salaries per employee in the overall economy, and dlog(PROD) = log difference of labour productivity (real GDP per employee) in the overall economy. 
The values shown in parentheses are t-ratios, based on White’s Cross-section robust standard error and covariance. The Swamy-Arora GLS estimator was 
used to estimate the random effects models. The highlighted values indicated the areas of difference between the original and replicated results. *** denotes 
significance at 1% significance level.   
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Cross-sectional correlation often emanates from unobserved common “shocks” and 
unobserved, time-invariant heterogeneous error components (Anselin, 2001; Baltagi, 2005; De 
Hoyos & Sarafidis, 2006; Eberhardt & Teal, 2011, 2014; Pesaran, 2004, 2006; Pesaran & 
Tosetti, 2011; Phillips & Sul, 2003; Robertson & Symons, 2000; Sarafidis & Wansbeek, 2012). 
This error component is a sub-component of the error term, incorporating spatial dependence 
and idiosyncratic pairwise dependence in the disturbance (De Hoyos & Sarafidis, 2006). 
Although the notion of cross-sectional dependence has been in existence since the 1930s, as 
noted in the works of Stephan (1934), Neprash (1934), and Fisher (1935), it is often ignored 
by researchers in panel model estimation. 
The existence of cross-sectional correlation between error terms can have severe 
implications for the estimation of both coefficients and standard errors using standard panel 
data estimators (e.g., pooled ordinary Least Squares (POLS), fixed effects (FE) and random 
effects (RE) estimators). This can lead to poor policy decisions based on biased parameter 
estimates. The impact of cross-sectional dependence on estimation varies according to 
circumstances (Coakley, Fuertes, & Smith, 2006) but depends on two major factors: (i) the size 
of the average pairwise cross-sectional correlation; and (ii) the nature or source of the cross-
sectional correlation (De Hoyos & Sarafidis, 2006).  
For instance, in a case where the cross correlation of errors emanates from omission of 
common effects or unobserved spatial effects but is uncorrelated with the incorporated 
explanatory variables (i.e.   0, Xucorr i ), conventional panel estimators such as POLS, FE, 
and RE can produce misleading policy inference, inefficient estimators, and biased standard 
errors (Chudik & Pesaran, 2013; De Hoyos & Sarafidis, 2006; Phillips & Sul, 2003; Reed & 
Ye, 2011; Sarafidis & Robertson, 2009; Sarafidis & Wansbeek, 2012; Sarafidis, Yamagata, & 
Robertson, 2009). Accordingly, I test for cross-sectional independence in the data used by HW 
to estimate models (2.5) and (2.6) as reported in Tables 2.3 and 2.4 above.  
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For this purpose, the three most often used cross-sectional dependence test procedures 
- Pesaran (2004), Friedman (1937), and Frees (2004) cross-sectional dependence (CD) tests5 - 
were employed to examine the between-group correlation in error terms (as a post-estimation 
diagnostic test) and panel time series variables (as a pre-estimation diagnostic test). De Hoyos 
and Sarafidis (2006, p. 490) indicated that the CD test is only valid as a post-estimation test 
after estimating a FE or RE model using the xtcsd [ , pesaran friedman frees 
abs show] Stata command. Baltagi and Moscone (2010, p. 807) emphasized the need to 
determine the size of cross-sectional dependence in underlying panel data using the Pesaran 
(2004) procedure (based on the Stata command xtcd varnames) by regressing the series 
on their individual specific intercepts. 
The test hypothesis of interest for this replication study emanates from model (2.1). 
Under the null hypothesis, ite  is assumed to be white noise (i.e. independent and identically 
distributed (iid)), and the alternative hypothesis is that ite  is cross-sectionally correlated, with 
no serial correlation. It should be noted that Frees and Friedman’s tests were originally 
designed for static models, unlike Pesaran’s CD test for static and dynamic models. Also, all 
the cross-sectional dependence tests are more suitable for cases where T is small and N
(De Hoyos & Sarafidis, 2006) as well as where both are large (Chudik & Pesaran, 2013). Also, 
Pesaran’s cross-sectional dependence test is more applicable for pre- and post-estimation 
testing, unlike other tests that are more appropriate as post-estimation tests (De Hoyos & 
Sarafidis, 2006). 
Test Results 
Table 2.5 presents the test results for cross-sectional correlation. It shows the average, 
country-specific correlation coefficients for the panel series full matrix and off-diagonal matrix 
                                                          
5 Full description of all the cross-sectional dependence tests are presented at the appendix 
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elements, as well as Pesaran’s cross-sectional dependence test statistics. The results indicate 
high positive, pairwise cross-sectional correlation of panel time series for current health 
expenditure per capita growth, wages and salaries per employee growth (as a proxy for labour 
prices), real GDP growth, and wage-labour productivity gap growth. The results further reveal 
the presence of cross-sectional dependence based on Pesaran’s CD test statistics for each 
variable. The null hypothesis of cross-sectional independence is rejected at the 1% significance 
level.  
Table 2.5: Panel Time Series Cross-Sectional Dependence Test Results 
 
Variables ̂  ̂  PESCD  
dlog(HCEP) 0.442 0.445 26.53*** 
dlog(WSPE) 0.509 0.554 32.45*** 
dlog(GDPR) 0.332 0.36 19.77*** 
dlog(EMP) 0.227 0.298 13.06*** 
dlog(PROD) 0.146 0.241 8.63*** 
Baumol 0.528 0.556 32.99*** 
Note:  ̂ , ̂ , and PESCD  are respective average of the full elements of the cross-sectional 
correlation matrix of the series; average absolute value of the off-diagonal elements of the cross-
sectional correlation matrix of the series; and Pesaran (2004) CD test statistic. 
 
*** denotes significance at 1% significance level 
 
As a result of the statistics and tests above, I conclude that the individual country, panel data 
series employed in HW’s study are correlated, likely due to similar patterns of health care 
reforms and common macroeconomic shocks.  
In Table 2.6, I investigate the presence of “between groups” correlation in country-
specific residuals using parametric and non-parametric correlation techniques as well as 
Pesaran’s cross-sectional dependence test. The standard (or parametric) average absolute 
correlation indicates positive pairwise correlation coefficients of all the estimated residuals 
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from replicated models 2.5 (VI & IX) and 2.6 (VI & IX). Also, the pairwise average Spearman 
rank correlation estimates from the models are found to be positive and high above 0.5. This 
indicates that the upper-diagonal has high positive and negative elements of country-specific 
pairwise correlations coefficients, which cancel each other out during averaging. This problem 
invalidates Friedman’s cross-sectional dependence (CD) test.  As a result, I do not place much 
weight on the finding that Friedman’s CD test does not reject the null of cross-sectional 
independence.  In contrast, Frees’ CD test, based on the average sum of squares of the rank of 
pairwise correlations, rejects the null hypothesis of cross-sectional independence at the 1% 
significance level. Similar results are obtained using Pesaran’s CD test. As a result, I conclude 
that the models’ error terms are characterised by significant cross-sectional dependence.  







PESCD  FRICD  FRECD  
2.5(VI) Cross-section RE 0.180 0.510 2.911*** 8.716 5.106*** 
2.5(IX) Time Period RE 0.196 0.503 -3.080*** 8.211 4.892*** 
2.6(VI) Cross-section RE 0.175 0.545 1.874* 16.547 5.208*** 
2.6(IX) Time Period RE 0.192 0.507 -3.052*** 3.663 4.732*** 
Note: 
PW
̂  and 
RK
̂ are average absolute value of the off-diagonal elements of the cross-
sectional pairwise and Spearman rank correlation matrix of residuals respectively. 
PESCD , FRICD , and  FRECD are Pesaran (2004), Friedman (1937), and Frees (1995, 2004) cross-
sectional dependence test statistics with the null hypothesis of cross-sectional independence. 
 
*; **; and *** denote significance at 10%, 5%, and 1% significance levels, respectively.  
 
The findings above potentially causes a problem for HW’s analysis, because the 
standard panel estimators (POLS and RE) used in HW do not correct for the cross-sectional 
dependence of residuals. As a result, the POLS and RE estimators are, at best, at risk of being 
inefficient with biased standard errors. The next section investigates alternative estimators that 




2.5.2 Robustness Check #2: Non-stationarity, Cross-Sectional Dependence and 
Heterogeneous Slope Estimators 
 
The preceding exploratory data analysis has determined that the relationship between 
HCE per capita growth and wage-labour productivity growth in OECD countries is likely 
heterogeneous, which I speculate is due to differential health policies, labour forces, and prices 
across countries. To account for heterogeneous effects, and to control for cross-sectional 
dependence and non-stationarity of unobservable factors, I next consider some recent panel 
data estimators that are designed to address these econometric issues (for detailed assumptions 
and properties see Banerjee, Eberhardt, and Reade (2010); (Beck & Katz, 2007; Bond & 
Eberhardt, 2009; Chudik & Pesaran, 2013; Eberhardt & Teal, 2010, 2011, 2014; Pesaran, 2006; 
Pesaran & Smith, 1995; Poi, 2003; Reed & Ye, 2011; Swamy, 1970).  These estimators include 
Swamy (1970) Generalised Least Squares (GLS) estimator for the Random Coefficients Model 
(RCM); Pesaran and Smith (1995) Mean Group (MG) estimator; Pesaran (2006) Common 
Correlated Effects Mean Group (CCEMG) estimator;  and the Augmented Mean Group (AMG) 
estimator by Bond and Eberhardt (2009) and Eberhardt and Teal (2010)6. 
These panel data estimators can accommodate at least one of the three main identified 
econometric issues to precisely estimate the determinants of HCE per capita growth across 
OECD countries. The replicated results for split and un-split Baumol’s models using the 
estimators robust to heteroskedasticity, and serial correlation are shown in Tables 2.7 and 2.8, 
respectively. All the coefficients were found to have the same signs and significances as 
reported by HW, though coefficient sizes were different7. The non-stochastic heterogeneous 
slope models (MG, CCEMG and AMG) are augmented with a common country trend to 
enhance their performance and accuracy as suggested in a Monte Carlo simulation by Bond 
                                                          
6 Brief description of the considered estimators is presented in Table A2.1 in the appendix.  
7 The scatter plots of the estimated country specific coefficients for each considered estimator are shown in 
the appendix (Figure A2.3, A2.4, A2.5, and A2.6) 
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and Eberhardt (2013b). As shown in Tables 2.7 and 2.8 below, under the RCM, the null 
hypothesis of a homogeneous slopes is rejected, which implies that the slopes are 
heterogeneous across cross-section units. The replicated average cross-section coefficients for 
the Baumol variable (0.964) in Table 2.8 under the RCM and MG without trend is less than 
HW’s Baumol coefficient of 1.016 using a robust cross-sectional RE estimator. When the MG 
specification is augmented with heterogeneous country trends, a lower Baumol’s coefficient of 




Table 2.7: Estimator Sensitivity Analysis of 'Baumol Variable' Split Model [2.5] 
 
Dep. Variable: Log difference of health care expenditure per capita [dlog(HCEP)] 
Replicated Results 
Variables 
RCM MG CCEMG AMG 









2.5(X) 2.5(XI) 2.5(XII) 2.5(XIII) 2.5(XIV) 2.5(XV) 2.5(XVI) 
dlog(WSPE) 
1.012*** 1.058*** 1.049*** 0.839*** 0.842*** 0.905*** 0.884*** 
(17.25) (38.55) (15.79) (8.07) (7.98) (23.15) (14.95) 
dlog(GDPR) 
-0.398*** -0.420*** -0.437*** -0.270*** -0.272*** -0.349*** -0.381*** 
(-3.39) (-4.34) (-5.69) (-2.67) (-2.67) (-4.26) (-5.29) 
dlog(EMP) 
0.573*** 0.556*** 0.527*** 0.591*** 0.595*** 0.517*** 0.494*** 
(4.29) (4.85) (4.35) (4.89) (4.61) (5.52) (5.41) 
Country Trend 
  0.00004  0.0002  0.00007 
  (0.12)  (0.81)  (0.27) 
PH   ...: 10  163.68*** - - - - - - 
RMSE  - 0.0286 0.0279 0.0243 0.0240 0.0264 0.0258 
̂  - 0.183 0.188 0.204 0.205 0.191 0.198 
PESCD  - 1.66* 1.37 -2.84*** -2.62*** -2.85*** -2.61*** 
NOTE: dlog(WSPE) = log difference of wages and salaries per employee in the overall economy, dlog(GDPR)= log 
difference of real Gross Domestic Product (GDP), and dlog(EMP)= log difference of overall employment. The values 
shown in parentheses are t-ratios, based on conventional robust standard error and covariance matrix estimates. 
The Swamy (1970) GLS estimator was used to estimate the random coefficients Model (RCM); the Pesaran and 
Smith (1995) Mean Group (MG) estimator was employed to estimate the MG labelled panel model; the Pesaran 
(2006) Common Correlated Effects Mean Group (CCEMG) Estimator was used to estimate the CCEMG labelled panel 
model;  the Augmented Mean Group (AMG) Estimator by Bond and Eberhardt (2009); Eberhardt and Teal (2010) 
was employed for estimate the AMG labelled panel model; The null hypothesis in the lower panel is a test of 
parameter consistency; RMSE = Root Mean Squared Error; ̂  and PESCD are respective average absolute value 
of the off-diagonal elements of the cross-sectional correlation matrix of the series; and Pesaran (2004) CD test 
statistic. 
 






Table 2.8: Estimator Sensitivity Analysis of 'Baumol Variable' Unsplit Model [2.6] 
 
Dep. Variable: Log difference of health care expenditure per capita [dlog(HCEP)] 
Replicated Results 
Variables 














2.6(X) 2.6(XI) 2.6(XII) 2.6(XIII) 2.6(XIV) 2.6(XV) 2.6(XVI) 
Baumol=dlog(WSPE)-
dlog(PROD) 
0.964*** 0.964*** 0.886*** 0.789*** 0.759*** 0.762*** 0.761*** 
(19.18) (25.50) (23.34) (10.77) (10.72) (16.00) (15.51) 
Country Trend 
  -0.001  0.0003  0.0002 
- - (-2.16) - (0.74) - (0.58) 
PH   ...: 10  118.44*** - - - - - - 
RMSE  - 0.0319 0.0308 0.0285 0.0277 0.0293 0.0282 
̂  - 0.178 0.188 0.200 0.197 0.192 0.190 
PESCD  - 2.52** 2.48** -2.79*** -2.85*** -3.05*** -3.16*** 
NOTE: BAUMOL is the wage-productivity gap growth derived from the difference between dlog(WSPE) and 
dlog(PROD). dlog(WSPE) = log difference of wages and salaries per employee in the overall economy, and 
dlog(PROD) = log difference of labour productivity (real GDP per employee) in the overall economy. The values 
shown in parentheses are t-ratios, based on conventional robust standard error and covariance matrix estimates. 
The Swamy (1970) GLS estimator was used to estimate the random coefficients Model (RCM); the Pesaran and 
Smith (1995) Mean Group (MG) estimator was employed to estimate the MG labelled panel model; the Pesaran 
(2006) Common Correlated Effects Mean Group (CCEMG) Estimator was used to estimate the CCEMG labelled 
panel model;  the Augmented Mean Group (AMG) Estimator by Bond and Eberhardt (2009); Eberhardt and Teal 
(2010) was employed for estimate the AMG labelled panel model; The null hypothesis in the lower panel is a test 
of parameter consistency; RMSE = Root Mean Squared Error; ̂  and PESCD are respective average absolute 
value of the off-diagonal elements of the cross-sectional correlation matrix of the series; and Pesaran (2004) CD 
test statistic. 
 





Similarly, the estimators that have the potential to account for non-stationarity of 
observable and unobservable variables, slope heterogeneity and endogeneity created by the 
common factor shock (Eberhardt & Teal, 2010, p. 5), namely, CCEMG and AMG, produce 
estimates of Baumol’s coefficient between 0.789 and 0.759 as reported in Table 2.8.  These 
compare to HW’s Baumol estimates between 1.016 and 1.033 (cf. Table 2.4).  Figure 2.3 
compares the estimated Baumol coefficients across the different estimators. 
It is evident from Tables 2.7 and 2.8 that the performance of the estimators improves 
based on the RMSE values, especially for MG with trend, CCEMG and AMG. Also, the 
average absolute value of the off-diagonal cross-sectional correlation coefficients of these 
estimators is less than 0.21, compared to an average value of 0.51 reported in Table 2.6 for 
HW’s estimators. Pesaran’s cross-sectional dependence test results in Tables 2.7 and 2.8 
indicate rejection of the null hypothesis of cross-section independence of residuals with the 
exception of the split Baumol’s model under the MG with trend.   
 




A comparison of the off-diagonal cross-sectional correlations of residuals and CD test statistics 
between HW’s panel estimators (CRE and TRE) and the more robust MG, CCEMG and AMG 
estimators indicates that, while “between group” residual correlation continues to exist with 
the latter estimators, it is of generally smaller magnitude. 
2.5.3 Robustness Check #3: Analysis of HW’s Main Finding 
My final check is also my most important.  It consists of a closer investigation of HW’s 
finding of a unit coefficient for the Baumol variable.  This is HW’s main empirical contribution. 
This result is based on two parts.  First, HW tests whether the split Baumol model can be 
reduced to the unsplit model.  After determining that it can be, HW then tests whether the 
coefficient on the resulting Baumol variable is equal to 1.   
Recall that the Baumol variable is defined by equation (2.4): 
𝐵𝑎𝑢𝑚𝑜𝑙𝑖𝑡 = 𝑑𝑙𝑜𝑔(𝑊𝑆𝑃𝐸)𝑖𝑡 − 𝑑𝑙𝑜𝑔(𝐺𝐷𝑃𝑅)𝑖𝑡 + 𝑑𝑙𝑜𝑔(𝐸𝑀𝑃)𝑖𝑡. 
A sufficient condition for the three explanatory variables to be combined into a single, Baumol 
variable is that the coefficients on the three component variables sum to 1 in equation (2.5) (see 
below). 
𝑑𝑙𝑜𝑔(𝐻𝐶𝐸)𝑖𝑡 = 𝛼0 + 𝛼1𝑑𝑙𝑜𝑔(𝑊𝑆𝑃𝐸)𝑖𝑡 + 𝛼2𝑑𝑙𝑜𝑔(𝐺𝐷𝑃𝑅)𝑖𝑡 + 𝛼3𝑑𝑙𝑜𝑔(𝐸𝑀𝑃)𝑖𝑡 + 𝑒𝑖𝑡. 
Specifically, this implies that 𝛼1 + 𝛼2 + 𝛼3 = 1.  Inexplicably, HW does not test this 
restriction.  Rather, he tests the (incorrect) restriction 𝛼1 + 𝛼2 − 𝛼3 = 0.
8  He fails to reject 
this hypothesis, and (falsely) concludes that this allows him to combine the variables into a 
single Baumol variable. It is correct to point out that HW’s restriction is not appropriate. 
Unfortunately, the restriction 𝛼1 + 𝛼2 + 𝛼3 = 1 is also not correct. In order to be able to 
combine the three separate variables on the RHS (right hand side) of equation (2.5) to get a 
single regressor variable defined in Eequation (2.4) the appropriate restrictions are: 𝛼1 = −𝛼2 
and 𝛼1 = 𝛼3 (the third restriction 𝛼3 = −𝛼2  is implied by the first two, so there are two 
                                                          
8 See next to last paragraph on page 610 of Hartwig (2008b). 
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independent restrictions). This gives a common coefficient 𝛽1 on each component as the 
Baumol variable. 
 The top panel of Table 2.9 mostly confirms HW’s results for the (incorrect) hypothesis 
test.  Of the 10 different models/estimators used to estimate the split Baumol specification of 
equation (2.5), only the Time Period Random Effects (TRE) model produces a significant test 
result, albeit at the 10 percent significance level.  It is interesting to note that this contrasts with 
HW’s finding of an insignificant test result for the TRE model.  The reason for the discrepancy 
is due to the previously noted fact that Stata and Eviews produce different estimates for the 
TRE model (cf. Tables 2.3 and 2.4 above).   
 When I turn to testing the correct restriction, I obtained clearresults. Interestingly, had 
HW tested the correct hypothesis, he would have concluded that it was not appropriate to 
combine these components into a single Baumol variable.  The test results for the POLS, CRE, 
and TRE models all soundly reject the null hypothesis at the 1 percent level of significance. 
Also, the RCM and various mean group estimators all return significant test results excluding 
CCEMG in the two cases for second restriction tes, which can be interpreted as not strongly 
supporting the aggregation of the separate components into a single Baumol variable. 
 The bottom panel of Table 2.9 tests the unsplit Baumol model.  Of particular interest is 
the test of 𝛽1 = 1, which HW takes as consistent with Baumol’s model of “unbalanced 
growth.”  Using the same three models/estimators as HW, I likewise fail to reject the null that 
𝛽1 = 1, and thus confirm HW’s finding in support of Baumol’s model.  However, when I use 
alternative models/estimators, the majority of these models strongly reject this hypothesis. As 
the CCEMG and AMG models are particularly well-suited to handle cross-sectional 
dependence in the errors, and as I have uncovered strong evidence of the same in HW’s data, I 




This study replicates Hartwig (2008b) and performs a variety of robustness checks. 
Using the same statistical package that HW used (Eviews), I am able to successfully replicate 
his findings for the split and unsplit Baumol panel models. However, when I re-estimated the 
models using Stata Version 14.1, I found discrepancies with the estimates reported by HW.  
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Table 2.9: Wald Coefficient Restriction Test Results 
 
Model 
Incorrect Restriction Correct Restriction 
STATA  STATA 
0: 3210  H  210 :  H  310 :  H  
(2.5) 
POLS [F-statistic] 1.11 111.53*** 26.31*** 
Cross-section R.E [Chi-square] 0.90 100.26*** 26.66*** 
Time Period R.E [Chi-square] 3.51* 95.64*** 20.78*** 
RCM [Chi-square] 0.03 19.21*** 6.97*** 
MG [Chi-square] 0.27 39.91*** 17.96*** 
MG + Trend [Chi-square] 0.29 36.27*** 14.28*** 
CCEMG [Chi-square] 0.01 15.41*** 2.43 
CCEMG + Trend [Chi-square] 0.02 15.12*** 2.18 
AMG [Chi-square] 0.09 37.43*** 14.64*** 
AMG + Trend [Chi-square] 0.00 29.00*** 12.87*** 
 0: 10 H  1: 10 H  
(2.6) 
POLS [F-statistic] 1391.75*** 1.4 
Cross-section R.E [Chi-square] 997.57*** 0.26 
Time Period R.E [Chi-square] 365.38*** 0.12 
RCM [Chi-square] 367.8*** 0.51 
MG [Chi-square] 650.50*** 0.93 
MG + Trend [Chi-square] 544.60*** 9.04*** 
CCEMG [Chi-square] 115.96*** 8.32*** 
CCEMG + Trend [Chi-square] 114.86*** 11.60*** 
AMG [Chi-square] 255.88*** 25.00*** 
AMG + Trend [Chi-square] 240.58*** 23.85*** 
NOTE: The restrictions come from testing the coefficients in the split Baumol model (cf. equation 2.5).  The 
estimators are given by POLS = Pooled Ordinary Least Squares; R.E = Random Effect; RCM = Random 
Coefficients Model; MG = Mean Group; CCEMG = Common Correlated Mean Group; AMG = Augmented 
Mean Group. 
 
*, **, and *** denotes rejection of the null hypothesis at 10%, 5% and 1% significance level respectively. 
 
HW’s findings support Baumol’s theoretical prediction that the effect of wage-labour 
productivity gap growth on HCE per capita growth is equal to one. My replication of HW’s 
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models produces mixed results.  The “best” models, in the sense that they are most appropriate 
for data characterised by cross-sectional dependence (i.e., the CCEMG and AMG models), 
produce substantially different results from HW and challenge his conclusion in favour of 
Baumol’s “unbalanced growth” model.  
To summarise, this chapter contributes to the body of knowledge by identifying and 
addressing some of the estimation and theoretical issues in HW’s empirical analysis. In 
particular, five econometric issues were addressed: (1) cross-sectional correlation of 
observable and unobservable series, (2) non-stationarity of unobservable common factors, (3) 
homogeneity of slope coefficients across countries, (4) non-correlation between explanatory 
variables and the unobservable error term, and (5) correct specification of a test of the Baumol 
model.  
Robustness checks presented in this chapter accounted for the aforementioned issues in 
three ways: I first examined the presence of cross-sectional correlation of observable and 
unobservable series in the model and found the presence of ‘between group’ correlation in the 
panel time series variables employed by HW. I then estimated residuals from the naïve 
estimators used by HW and found them to be cross-sectionally dependent with an average off-
diagonal correlation coefficient of 0.5. Second, I used robust and less restrictive panel data 
estimators that account for slope heterogeneity, cross-sectional dependence, non-stationarity 
of unobservable factors, and endogeneity emanating from common, unobservable shocks. 
These estimators produced estimates of the effect of wage-labour productivity gap growth on 
HCE per capita growth that were smaller in magnitude than those found by HW.  
Third, I undertook further investigation of HW’s test of the Baumol hypothesis.  I found 
that HW tested the wrong restriction pursuant to combining the component variables into a 
single Baumol variable.  A test of the correct restriction produced clear results that the variables 
in the split model can not be combined to derive a single Baumol variable.  Likewise, a re-
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analysis of HW’s test of Baumol’s unit coefficient resulted in mixed results, with the more 
robust panel data estimators producing estimates that disconfirmed HW’s findings. 
In conclusion, it should be noted that while there is some evidence that labour prices 
are a significant determinant of HCE per capita growth rate,  estimates suggest a smaller effect 
than the value of 1.02 reported by Hartwig (2008b). For example, recent studies such as Bates 
and Santerre (2013) report much lower estimates (less than 0.04) using labour prices in the 
health sector rather than aggregated, economy-wide labour prices as used by HW. This further 
supports our finding that it might not be legitimate to sum all the variables in HW’s split model 
into one variable to directly measure “Baumol’s effect”.  On a related note, the theoretical basis 
relating HW’s empirical tests to Baumol’s model is tenuous and not well developed.  There is 
no mathematical model that directly derives the unitary coefficient on the Baumol variable as 
a necessary consequence of Baumol’s model.  Also, no robust model framework in the 
literature that accounts for endogeneity of Baumol’s variable. Bates and Santerre (2013) 
suggested that output shock can affect Baumol’s variable in the health sector through its impact 
on wages and productivity. However, the lack of a strong theoretical basis to HW’s empirical 

















Chapter 3: Is health care infected by Baumol’s Cost Disease? Test 





















3.1  Introduction 
Health is essential to the productivity of human capital and overall economic growth. 
The increasing cost9 of health care services has received much attention from health managers, 
health economists and public policy makers. For instance, health care spending has been rising 
across developed countries. OECD countries with high average per capita income growth have 
recorded high growth of health care expenditure per capita between 1960 and 2014 as shown 
in Figure 3.1.  
 
Figure 3.1: Scatter Plot of Real HCE Per Capita vs. Real GDP Per Capita (1960-2013)  
 
 
The strong relationship between rising income and health spending is a common finding 
in the literature (Costa‐Font, Gemmill, & Rubert, 2011; Gerdtham & Jönsson, 2000b; V. N. 
                                                          
9 The focus of BCD is the price component of health expenditure (Q*Ph). Cost and expenditure are used 
interchangeably as synonyms in this analysis. 
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Murthy & A. A. Okunade, 2009; Prieto & Lago-Peñas, 2012). However, there are still 
controversies in the literature about the size of the income elasticity of health expenditure 
(Gerdtham & Jönsson, 2000b) and studies in this area are confronted with specification and 
estimation issues (Costa‐Font et al., 2011). Also, there is a paucity of theoretical foundation for 
most documented studies on determinants of health spending.  The field of health economics 
lacks sound macroeconomic theory (Gerdtham & Jönsson, 2000b) and analyses of significant 
non-income factors (Baltagi & Moscone, 2010; Baltagi et al., 2012; Hartwig, 2008b) to provide 
an explanation for the rising cost of health care. 
In an attempt to explore other non-income determinants and provide a strong theoretical 
explanation of rising health care spending, there has been a revival of interest in Baumol’s Cost 
Disease (Baltagi et al., 2012; Baumol, 1967, 1993; Hartwig, 2008b, 2011a; Nixon & Ulmann, 
2006; Oliveira Martins & De la Maisonneuve, 2006). William Baumol in his 1993 paper, 
"Health care, education and the cost disease: A looming crisis for public choice" made the 
pioneering empirical attempt to use his 1967 theoretical study on “Cost Disease” hypothesis 
for health care spending analysis.  Prior to that, the theory was first discussed in Baumol and 
Bowen (1965) in the context of the performing arts industry. Baumol and Bowen (1965, p. 499) 
theoretical explanation of cost development relative to productivity growth was based on a 
two-sector model in which one sector, by virtue of its production technology, enjoys regular 
productivity increases, while the other sector, by nature of its production technology, does not.   
Baumol (1967) used the same theory to explain rising costs in the health care industry 
- considered as a non-progressive sector whose productivity is stable and cost increases are 
unavoidable. The central theoretical idea of the Baumol Cost Disease (BCD) model according 
to Baumol (1967, p. 51) is to explain the behaviour of labour-intensive industries such as health 
care whose demand continually increases, without corresponding increases in output per man-
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hour.  Because of stagnant productivity growth and little substitutability of capital for labour, 
real costs inexorably climb over time. 
However, a key challenge in investigating BCD is the development of a theoretically-
appropriate empirical test. This thesis fills this gap by building a new theoretical model that is: 
(i) strictly based on Baumol’s axioms; and (ii) directly testable empirically. Previous attempts 
(Bates & Santerre, 2013; Baumol, 1993; Colombier, 2012, 2017; Hartwig, 2005, 2008a, 2008b, 
2010, 2011a, 2011b; Martins & de la Maisonneuve, 2006; Nixon & Ulmann, 2006; Nordhaus, 
2008) to provide a testable hypothesis of BCD using different approaches have not explicitly 
and comprehensively linked the model specification to the full set of key axioms of the theory. 
This issue is further discussed in section 3.3 below.  
3.2 Baumol’s Cost Disease: Characteristics and Propositions 
According to Baumol (1967), the non-technologically progressive sector (such as the 
health care industry) with constant output per man-hour (i.e. productivity) does not benefit 
from productivity-induced cost savings. This distinguishes the non-technologically progressive 
sector from the progressive sector, where technology promotes innovation, research and 
development and increasing economies of scale. In the technologically progressive sector (such 
as manufacturing) output per man-hour grows rapidly, offsetting, and more than offsetting, 
accompanying increases in the nominal wage.  
In an attempt to explain the factors responsible for increasing costs in the non-
progressive sector, Baumol (1967) model was based on five fundamental premises. The first 
premise is that economic activities can be grouped into technologically progressive and non-
progressive sectors (henceforth, PS and NPS respectively) in terms of different productivity 
growth rates. Second, the only input is labour.  Third, nominal wages in the two sectors are the 
same and grow at the same rate. The fourth essential axiom is that there is mobility of labour 
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between the two sectors. Lastly, nominal wages will rise with productivity growth in the 
progressive sector. 
Baumol (1967) employs a single factor production function for the goods and services 
sectors, with labour as the only input.  The productivity of labour in the PS is assumed to grow 
exponentially over time.  Productivity growth of labour in the NPS is assumed to be slow or 
non-existent.  
On the basis of the defined axioms, Baumol (1967) derives two theoretical results 
within the framework of his model.  The first is that “the cost per unit of output of the NPS will 
rise without limit over time, while the unit cost of the PS will remain constant” (Baumol, 1967, 
p. 418) This result is derived from the combination of rising wages with stagnant productivity 
in the NPS and from the fact that productivity and wage increases exactly balance each other 
out so that the unit cost of output in the PS remains constant over time. 
A second theoretical result from Baumol’s model is that “the labour share of the NPS 
will increase over time” (Baumol, 1967, p. 418).  In the limit, all labour in the economy is 
employed in the NPS.  The result is derived from the assumption that the relative share of 
outputs in the two sectors remains constant over time.  Increased productivity in the PS causes 
that sector to release labour resources.  The equivalence of wages in the two sectors, along with 
the assumption of perfect labour mobility, implies the result.  
In summary, the BCD hypothesises that the health care sector will consume an 
increasing share of the economy’s resources i.e. GDP.  Further, it suggests that the increases in 
costs over time are unavoidable because they are driven by productivity increases outside the 
health sector (see Baumol, 1967, 1993; Hartwig, 2008b; Towse, 1997). In the words of Baumol 
(1967), the entire analysis is summarized as “if productivity per man hour rises cumulatively 
in one sector relative to its rate of growth elsewhere in the economy, while wages rise 
47 
 
commensurately in all areas, then relative costs in the non-progressive sectors must inevitably 
rise, and these costs will rise cumulatively and without limit” (Baumol, 1967, p. 419). 
The different presentations of the “Cost Disease” model by Baumol (1967, 1993, 2012) 
provide a theoretical framework for understanding the increasing size of the health care 
industry, but are not formulated in such a way as to produce testable hypotheses.  Efforts made 
by other studies to revive and empirically test the hypotheses are reviewed in Section 3.3 
However, this thesis argues that these previous attempts (such as Bates & Santerre, 2013; 
Hartwig, 2008a, 2008b, 2011a, 2011b), suffer from several shortcomings.  This motivates my 
attempt to develop an empirically testable formulation of the BCD model.  The model is 
presented in Section 3.4 below.  
3.3 Tests of Baumol’s Cost Disease for the Health Sector: Empirical Review 
The first application of BCD in the health sector is in the work of Baumol (1993) titled 
‘Health care, education and the cost disease: A looming crisis for public choice’. Baumol 
(1993) descriptively analyses the trend of productivity and total spending in the goods and 
services sectors in the U.S. He establishes the price implications of the model and concludes 
that prices in the service sector will continue to rise inevitably due to rising costs and declining 
labour productivity in the sector. Nixon and Ulmann (2006) expand on this work by studying 
health expenditures and health outcomes for 15 European Union countries from 1980 to 1995.  
The first attempt to empirically test BCD using an estimable model was made by 
Martins and de la Maisonneuve (2006).  They employ a fixed effect panel model for 30 OECD 
countries from 1981 to 2002. They test the BCD hypothesis by regressing the growth of long-
term health expenditures on the growth of labour costs (other explanatory variables such as 
income and a set of demographic factors).  This approach is known as “labour cost” or “wage 
growth” approach to capture the “Baumol’s effect”. They report evidence of upward shifts in 
per capita long-term health expenditures due to a “cost-disease” effect.   
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Later, Hartwig (2008b) introduces the “wage-productivity growth gap” approach that 
has been widely cited. This approach uses the difference between economy-wide wage and 
productivity growth rates to measure “Baumol’s effect” to explain rising health spending in 
OECD countries. In the spirit of Baumol’s framework, Hartwig (2008b) approach is based on 
the logic that if wage increases in the PS reflect productivity increases but wage increases in 
the NPS are only driven by equalization of wages across sectors (due to a mobile, competitive 
labour market), then wages in the overall economy will grow faster than overall labour 
productivity. He employs a simple econometric model to test BCD in the health sector by 
estimating a Barros (1998) growth model that expresses the health care expenditure (HCE) 
growth rate as a function of growth in wages and salaries, national output and employment. 
Hartwig (2008b)  finds supporting evidence for BCD in a panel of 19 OECD countries.  A 
similar approach was adopted by later studies10 such as Colombier (2012, 2017) and Bates and 
Santerre (2013) for 20 OECD countries and 50 U.S. states, respectively.  
However, when replicating Hartwig (2008b) in Chapter 2 of this thesis, key issues 
relating to theoretical modelling, measurement and hypotheses testing were found and 
discussed in detail. For instance, Hartwig (2008b) tests the parameter restriction11 that the 
coefficient on the “wage-productivity gap” variable is equal to one.  He claims that this is a 
direct test of the “Baumol effect.”  But the restriction that the coefficient of the wage-
productivity growth variable should equal one is nowhere derived from theory.  This further 
supports the point initially made by Colombier (2012, p. 12) that no special attention should be 
given to the coefficient value of the wage-productivity growth variable and that the BCD 
hypothesis cannot be confirmed on that basis.  
                                                          
10 See Table A3.1 in the Appendix for a summary of previous studies examining BCD in the context of the 
health industry. 
11 Through the replication experiment, I discovered that the parameter restriction tested by Hartwig (2008b, p. 
610) does not match the baseline specification algebraically.  
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Another approach taken by Hartwig for testing BCD in the health sector uses the 
“output-expenditure growth nexus” (Hartwig (2008a). He reports that increases in health care 
spending reduce future output growth.  This is consistent with the BCD proposition because 
increases in costs (i.e. health expenditures) mean that resources have shifted to a non-
progressive sector with lower productivity growth and, as a consequence, subsequent periods 
should experience reduced output growth.  
Other investigations of the BCD using industry level data include Nordhaus (2008). He 
provides a comprehensive analysis of “Baumol’s effect” using U.S. industry-level data from 
1948-2001. Nordhaus (2008) uses multiple model specifications where a set of dependent 
variables (such as price, nominal output, real output, wages, employment, and profits) are 
expressed as a function of industry-level productivity. From his approach, the spirit of BCD is 
immediately apparent as industry-level trends are driven by exogenous technological change. 
Consistent with BCD, Nordhaus finds that sectors that are relatively technologically stagnant 
experience rising relative prices and falling relative real outputs and employment.  Hartwig 
(2010, 2011b) extends Nordhaus’ approach using Swiss and EU data, respectively. 
It is stated in Section 3.2 that Baumol’s framework implies that the relative price of 
services like health care will rise over time with productivity increases in other sectors.  
Hartwig (2011a) uses this proposition to motivate his study but then focuses on the 
consequences, rather than the determinants, of relative price changes.  In particular, Hartwig 
(2011a) employs a “relative medical price” approach and finds that the relative price of health 
care (used as an explanatory variable) is a significant positive determinant of health care 
expenditures in the OECD.  This is consistent with BCD proposition that rising prices are 
responsible for the observed rapid health expenditure growth. 
It is important to note that while each of the above studies links its empirical 
specification to the spirit of the BCD framework, in no case have I found an empirical 
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specification, based on a formal theoretical model that is strictly derived from the full set of 
Baumol’s axioms.  For example, the “wage-productivity growth gap” approach introduced by 
Hartwig (2008b) focuses on economy-wide wage growth, productivity growth, and 
employment growth as exogenous explanatory variables, sometimes combined into a single 
“Baumol variable”. This set up does not directly relate labour migration into the health sector 
as a response to productivity (and hence wage) increases.  Yet, labour migration into health 
care is one of the key predictions of Baumol’s framework.   
Similarly, the “relative medical price” approach in Hartwig (2011a) models changes in 
productivity as a function of exogenous relative health care prices – again ignoring how BCD 
implies that the relative price of health care is endogenous to productivity. Nordhaus (2008) 
and Hartwig (2010, 2011a) do not suffer from these endogeneity problems. However, their 
empirical analysis is again based on the spirit of BCD rather than strictly following Baumol’s 
main propositions. For example, Nordhaus (2008, p. 9) studies six diseases that might be 
associated with Baumol’s analyses, but these are not directly derived from Baumol’s 
propositions. To the best of my knowledge, this thesis is the first to develop a directly-testable 
theoretical model that is closely related to Baumol (1967) framework. The next section presents 
this theoretical model. 
3.4 A Theoretical Model for Testing Baumol’s Cost Disease 
On the basis of the above-discussed theoretical gap, my study develops Baumol (1967) 
model to allow direct empirical testing.  Like Baumol, I start with a two-sector economy 
consisting of a technologically progressive sector (representing the non-health sector) and a 
stagnant sector (representing the health industry). For the purposes of this analysis, the two 
sectors are respectively referred to as the health (H) and non-health (NH) sectors. Also like 
Baumol, I assume that the only input to production is labour.  The production functions for the 
two sectors are given by:  
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NHNH LY           (3.1) 
HH LY            (3.2) 
where   is labour productivity in the non-health sector; LNH and LH  are the amounts of labour 
employed in the non-health and health sectors; and YNH and YH are the associated real outputs. 
Also, 𝜙 represents relative labour productivities in the NH and H sectors, with 𝜙 > 1 indicating 
greater productivity in the NH sector.  
 A key assumption is that output in both sectors is a constant share of total output in the 
economy, Y (Baumol, 1967, p. 419).  Define k as the share of total economy output accounted 
for by the non-health sector: 
kYYNH            (3.3) 
Demand equals supply in the NH sector implies that: 
NHLkY            (3.4)  











                        (3.5) 
Total labour supply is given by L, so that 
LLL NHH   .          (3.6) 



















          (3.7) 
Equations (3.6) and (3.7) constitute two equations in two unknowns, LH and LNH, as functions 
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         (3.15) 
Equation (3.15) implies that the health sector share of the labour force is positively related to 














        (3.16) 
from (3.15) and (3.16), it can be confirmed that (i)  when k = 1, 1
L
LNH  and 0
L
LH ; and (ii) 
when k = 0, 0
L
LNH  and 1
L










































































From Equation (3.15): 
 
 


































       (3.17) 
It is easily determined that both terms on the right hand side of Equation (3.17) are positive, 












          (3.18) 
Let NHw   and PNH  be the market wage and price level in the NH sector. The marginal product 










MPL          (3.19) 














MPL ,        
 (3.20) 
where PNH is the price of the non-health sector good. So that: 
NHNHNHNH PPMPLw           (3.21) 
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Equilibrium in the labour market requires workers in the H and NH sectors to be paid the same:  
NHNHH Pww            (3.22)  
 Given the constant returns-to-scale production in the non-health sector, profits in this 











     (3.23) 
Profits in the health sector are given by 
  HHHHHHHHHHHH LwPLwLPLwYP      (3.24)  
If the condition that a competitive equilibrium in the health sector drives profits to zero12 is 
imposed, then it follows that  𝑃𝐻 = 𝑤𝐻 , and, from Equation (3.22), 
NHH PP             (3.25)13 
In terms of relative prices, (3.25) can be expressed as a function of productivity in the non-






          (3.26) 







         (3.27) 
The preceding analysis has given two key implications of BCD: 
                                                          
12 This is also consistent with the view of Newhouse (1970) that the health sector is dominated by not-for-profit 
firms whose administrators or managers maximise quality and quantity subject to a break-even constraint. Pauly 
(1987), on the other hand, argues that non-profit institutions like hospitals still de facto make profit which is 
then paid out in form of dividends to decision makers such as the administrator and physicians. In this latter 
view, non-profit firms seek to maximize the money income of decision making agents.  
13 This expresses a simplified health care price model dependent on labour productivity in the progressive sector 
or the equilibrium wage rate and general price of other goods in the economy. In relative prices as shown in (3.26), 
the expression captures the Baumol’s effect. This is similar to Hartwig (2008b, 2011a) and Colombier (2012, 
2017) argument that the essence of testing for the Baumol’s effect is to examine the impact of health price 
increases on health expenditure. Considering the measurement shortcomings of constructing a reliable medical 
price index as emphasized by Cutler et al. (1998), Baumol’s variable is seen as a proximate measure to capture 


















 (from Equation 3.27)      
The economic intuition underlying these hypotheses is as follows: Productivity 
increases in the non-health sector cause fewer workers to be needed in this sector.  As a result, 
workers are released to the heath sector and the health sector share of the labour force increases.  
At the same time, higher productivity in the non-health sector raises wages there.  Equilibrium 
in the labour market causes these wage increases to spill over to the health sector.  The resulting 
higher costs of production in the health sector drive up prices, so that the ratio of prices in the 
health and non-health sectors also rises. 
If the parameter,   , which measures productivity in the non-health sector, were 
observable, then the inequalities above would provide testable hypotheses of BCD, as both 
 LLH  -- the share of labour employed in the health sector -- and  NHH PP -- the relative price 
indices of output in the health and non-health sectors – are not difficult to obtain. However,   
is frequently unobserved, or non-comparable, especially when working with cross-country 
data.  Therefore, the two consequences of the BCD model are reformulated in terms of 
economy-wide productivity, PROD, which is observable. 
 Define economy-wide productivity as 
L
Y
PROD            (3.28) 





















PROD HNH ,        (3.29) 
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 are functions of   (from Equations 3.15 and 3.16).  Thus 
 fPROD   and  
 PRODf 1          (3.30) 
It is feasible to demonstrate that:  
(i) 















       
  
(ii) 
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To prove the above, it is sufficient to show that 
PROD

































































































NH 1        (3.33) 





















































































































       (3.34) 
It is easily determined that both terms on the right hand side of Equation (3.34) are positive, 
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PP NHH         (3.38) 
 In words, Equations (3.37) and (3.38) state that (i) the share of labour employed in the 
health sector (LH / L) and (ii) the price index of goods produced in the health sector relative to 
the price index of goods produces in the non-health sector (PH / PNH) should both be increasing 
functions of economy-wide productivity. 
The above model incorporates all the five properties that characterise Baumol (1967) 
cost disease framework in that: (i) the economy consists of two sectors: a technologically 
progressive sector, and a technologically stagnant sector; (ii) labour is the only input into 
production; (iii) wages in the two sectors grow at the same rate; (iv) labour is perfectly mobile 
between the two sectors; and (iv) nominal wages rise with productivity growth in the 
progressive sector. The BCD characteristics are used to generate hypotheses that are testable 
with observable data.   
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Further, the hypotheses given by expressions (3.37) and (3.38) are sufficiently specific, 
and not obviously consistent with alternative theories, that they are strong candidates for testing 
whether BCD can explain rising health care costs across countries. 
3.5 Methods 
3.5.1 Data Description, Sources and Sample 
 The variables required for this study are: the health price index, overall consumer price 
index, GDP in current prices, total number of hours worked, health sector employment, and 
total labour force. Other explanatory variables that are commonly considered in explaining 
rising health spending in previous studies are also used. These include the age and gender 
composition of the population, health outcomes (life expectancy at birth and infant mortality), 
health-related behaviour (tobacco and alcohol consumption per capita), and economic growth.  
Also, using a precise measure of non-health prices is an improvement over previous 
studies which rely on the GDP deflator instead (e.g., Hartwig, 2008a; Hartwig, 2008b, 2011a).  
Productivity is measured as the ratio of real GDP to the number of hours worked.  
It is difficult to obtain a comprehensive and consistent data set with health care prices 
for all OECD countries.  Fortunately, the EUROSTAT 2014 Online Database contains data for 
many OECD countries.  All other variables are sourced from OECD Health Statistics, 2014.  
The final sample covers the years 1995 to 2013 and includes data for 27 out of 34 OECD 
countries: Australia, Austria, Belgium, Canada, Czech Republic, Denmark, Estonia, Finland, 
France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Netherlands, New 
Zealand, Norway, Portugal, Slovenia, Spain, Sweden, Switzerland, Turkey, United Kingdom, 
and the U.S.   
3.5.2 Trend and Descriptive Analyses 
To visualise our data, Figure 3.2 shows time series plots for productivity and the share 





LH . Generally, the plots show increasing trends of health sector labour 
shares as predicted by BCD. However, there is considerable variation across countries. 





, is shown in Figure 3.3. Again, there is substantial variation across countries. In some 
countries, relative health care prices increased (Austria, France, Norway, Spain, Switzerland 
and Turkey), in others they fluctuated (Denmark, Germany, Greece, Iceland, Netherlands, 
Portugal, Sweden, and United Kingdom), and in some countries they even declined (Finland, 
and Italy). 
 












Overall, the plots of productivity measured by the ratio of GDP to the number of hours 
worked show increasing trends over time excluding the period of the global financial crisis (see 
Figures 3.2 and 3.3). The trend analysis indicates the need to incorporate country fixed effects 
and a time trend. 
The trend analysis seems to support the BCD but it is an unreliable and insufficient 
method of testing the formulated hypotheses. The next sub-sections discuss the methods 
employed to formally test the BCD hypotheses. 
The summary statistics of the variables used in testing the BCD hypotheses are reported 
in Table 3.1. The demographic and health variables display much variation across countries.  
For example, the share of the population older than 64 years ranges from 5.4% (Turkey) to 
21.1% (Germany).  The minimum life expectancy at birth in our sample is 67.9 (Estonia), and 
the maximum is 83.2 (Spain), with a mean of 78.5.    
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Table 3.1: Descriptive Statistics 
 
Variable Obs Mean Std Dev Min Max 
Ratio of prices in the health and non-health sectors (PHN)  383 99.66 14.15 55.58 142.6 
Health sector share of the labour force (LHSL) 392 9.94 4.09 2.15 20.13 
Productivity (PROD) 506 38.31 14.30 10.76 86.85 
Population < 15 years (% of total) 513 18.0 3.1 12.9 32.1 
Population > 64 years (% of total) 513 15.0 2.7 5.4 21.1 
Male population (% total) 513 49.0 0.8 46.1 51.1 
Life expectancy at birth (in years) 511 78.5 2.8 67.9 83.2 
Infant mortality (per 1,000 live births) 507 5.2 4.2 0.9 40.9 
Tobacco consumption (grams per capita ≥ 15 years) 328 1758 603 557 3741 
Alcohol consumption (litres per capita ≥ 15 years) 491 9.9 2.7 1.2 15.1 
GDP growth rate (%) 509 2.4 3.0 -14.7 11.7 
 
NOTE: The sample consists of annual data for years 1995-2013 from 27 OECD countries: Australia, Austria, Belgium, Canada, Czech Republic, Denmark, 
Estonia, Finland, France, Germany, Greece, Hungary, Iceland, Ireland, Italy, Luxembourg, Netherlands, New Zealand, Norway, Portugal, Slovenia, Spain, 
Sweden, Switzerland, Turkey, United Kingdom, and U.S.  PHN is calculated using the health price index and the overall consumer price index. LHSL is the 




Table 3.2: Pre-Estimation Diagnostics Test Results 
 
 Variable 
Pesaran (2004)  
CD Test 
Maddala & Wu (1999) PURT Pesaran (2007) CIPS PURT 
Level FD Level FD 
PESCD  ̂  No Trend Trend No Trend Trend No Trend Trend No Trend Trend 
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) 
ln(LHSL) 27.77*** 0.649 1 1 0*** 0*** 1 1 0** 1 
PHN 4.35*** 0.431 1 1 0*** 0*** 1 1 0*** 1 
PROD 48.85*** 0.980 1 1 0*** 0*** 1 1 0*** 1 
Age < 15  63.18*** 0.808 0*** 0*** 1 1 1 1 1 1 
Age > 64  57.58*** 0.741 1 0*** 0*** 0*** 1 1 1 1 
Male  21.26*** 0.626 1 0*** 0*** 0*** 0* 0** 0*** 1 
ln(Life expectancy) 76.54*** 0.980 1 1 0*** 0*** 1 1 0*** 0*** 
ln(Infant mortality)  66.64*** 0.853 1 0** 0*** 0*** 1 1 0*** 0*** 
ln(Tobacco consumption)  - - - - 0*** 0*** - - 0*** 1 
ln(Alcohol consumption) 4.46*** 0.527 1 1 0*** 0*** 1 1 0*** 0*** 
GDP growth rate 52.35*** 0.646 0*** 0*** 0*** 0*** 0** 1 0*** 0*** 
NOTE: CD = Cross-sectional dependence; PURT = Panel Unit Root Test; CIPS = Cross-sectional augmented Im, Pesaran, and Shin (2003); FD = First Difference; 
̂  = average absolute value of the off-diagonal elements of the cross-sectional correlation matrix of the series; PESCD  = Pesaran (2004) CD test; Null hypothesis 
for Maddala and Wu (1999)  and Pesaran (2007) CIPS tests is “no stationarity” i.e. series is I(1); MW test assumes cross-section independence; CIPS test assumes 
cross-sectional dependence in form of a single unobserved common factor; "-" = Insufficient observation [Spain has only 2 observations]. * 10%, ** 5%, and *** 
1% significance level respectively; 1 = No stationary i.e.  the series is I(1); 0 = Stationary i.e. the series is I(0). Lag 1 is used for all the PURTs. The results for 
logged and unlogged forms of PROD, PHN, Age < 15, Age > 64 and Male are identical qualitatively. *, **, and *** indicate statistical significance at the 10%, 
5%, and 1% level, respectively. 
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Infant mortality ranges from 0.9 per 1,000 live births (Iceland) to 40.9 (Turkey).  There 
are also wide differences in lifestyle behaviours that can impact health outcomes.  The 
minimum tobacco consumption in our sample is 557 grams per person (Finland), with a 
maximum value of 3,741 grams per person (Greece).  Alcohol consumption ranges from 1.2 
litres per person (Turkey), to a maximum of 15.1 litres per person (France). 
3.5.3 Pre-Estimation Diagnostic Tests 
 The estimation strategy and robustness checks adopted in this chapter prompt the need 
to investigate the existence and size of cross-sectional correlation of considered variables prior 
to estimation. The cross-sectional correlation of panel series across countries might emanate 
from unobservable common macroeconomic shocks (De Hoyos & Sarafidis, 2006). If each of 
the series is cross-sectionally dependent, standard panel data estimators (such as pooled 
ordinary least squares (POLS), cross-section fixed effect (CFE), time fixed effect (TFE), and 
two-way fixed effect (2WFE)) might produce misleading inference and inefficient estimates 
(Chudik & Pesaran, 2013; Sarafidis & Wansbeek, 2012). 
Pesaran (2004) cross-sectional dependence test is used to investigate the correlation of 
the variables across countries. The method is chosen for its robustness and application to 
unbalanced panel data that is used in this chapter. The method tests the null hypothesis of “no 
cross-sectional dependence”.  
 Also, the stationarity properties of the time series variables are examined using the first 
(Maddala and Wu (1999); henceforth MW) and second (Pesaran (2007); cross-sectional 
augmented Im et al. (2003); henceforth CIPS) generation of panel unit-root tests (PURT) (see 






3.5.4 Estimation Methods 
 This study starts estimating the theoretical BCD predictions of Equation (3.37) and 
(3.38) using standard panel data estimators. This includes POLS, 2WFE, and FE with country-
specific linear time trends. 
 For the diagnostic checks, the cross-sectional correlation and stationarity of the 
residuals from the standard panel data estimators are examined. The methods considered for 
the pre-estimation diagnostic tests are similarly used for the post-estimation tests. To account 
for estimation issues such as serial correlation, cross-sectional dependence and non-stationarity 
when identified, robust panel estimators are employed. The estimators include: Panel-
Corrected Standard Error (PCSE); Mean Group (MG); Common Correlated Effects Mean 
Group (CCEMG); and the Augmented Mean Group (AMG) estimators. 
3.6 Results and Discussion 
 As discussed above, the cross-sectional dependence test and panel unit root test are used 
to evaluate the properties of the variables for examining the BCD predictions expressed in 
Equations (3.37) and (3.38). Table 3.2 reports the results of the Pesaran (2004) CD test 
(Columns 1 and 2), Maddala and Wu (1999) PURT (Columns 3 to 6), and Pesaran (2007) 
PURT (Columns 7 to 10). The null hypothesis of “cross-sectional independence” is rejected at 
the 1% significance level for all the variables used for testing the BCD hypothesis. Most of the 
panel variables excluding the ratio of prices in the health and non-health sectors (PHN) show 
high levels of cross-sectional correlation with coefficients ranging from 0.528 (log of alcohol 
consumption) to 0.982 (log of life expectancy).  
The PURT diagnostic results in Table 3.2 indicate slight differences between the PURT 
methods for trend and no trend specifications when level and first difference series are 
considered. The consistent I(0) results are highlighted in yellow. At level, it is clear that 
population aged less than 15 and GDP growth rate are the only stationary variables using 
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Maddala and Wu (1999) PURT, while the proportion of male population is found stationary 
using Pesaran (2007) PURT. Using CIPS to test account for cross-sectional dependence issue, 
only life expectancy, infant mortality, alcohol consumption and GDP growth rate are found to 
be stationary at first difference. Similarly, Maddala and Wu (1999) PURT (Columns 5 and 6 
of Table 3.2) also confirms the non-stationarity of those series at level, i.e. for all the panel 
units, the variables are integrated of order one. 
Table 3.3 reports the effect of productivity on the health sector share of the labour force 
(LHSL) as a first test of the BCD hypothesis. The POLS, 2WFE, and FE with country specific 
linear time trends are the baseline estimation methods employed to estimate three different 
specifications of Equation (3.37). The first specification controls for age and gender 
demographic factors with productivity. Tobacco and alcohol consumption as lifestyle measures 
are incorporated in the second specification.  Economic growth (GDP growth rate) is included 
as an additional control variable in the last specification to control for possible omitted variable 
bias that may arise from the effect economic growth may have on the economy’s prices and 
input allocations.  
 The results of the diagnostic tests after estimating each of the specifications are reported 
in the bottom rows of Table 3.3.  One of the tests is a test of joint significance of country and 
time effects in specifications estimated by 2WFE and FE with individual country time trends. 
For instance, the F statistic value in column (4), 209.21, is significant at the 1% critical level.  
This indicates that the country and time effects significantly drive variation in the health sector 
share of the labour force (LHSL). The Bayesian Information Criterion (BIC) is another 
diagnostic measure used to evaluate country and time effects.  BIC allows specification 
comparison across regressions, with lower values indicating “better” specifications according 
to this diagnostic.  For example, the regression results in Columns (3) and (6) have identical 
specifications except that Column (6) includes fixed effects for country and year.  The BIC 
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value in Column (3) is 14.54, compared to a value of -668.3 in Column (6).  This indicates that 
country and year fixed effects add valuable explanatory power to the specification. Also, the 
Ramsey Regression Equation Specification Error Test (RESET) is included to test if the 
respective estimated equation is correctly specified. The test procedure involves regression of 
the endogenous variables on a non-linear combination of its predicted values and the original 
regressors. The joint significance of the predicted value estimates is evaluated using an F-test 
with the null hypothesis of “no specification error”.  Rejection indicates misspecification.  
 The reported results in Columns (1) to (6) for specifications estimated using POLS and 
2WFE reveal a positive relationship between productivity (PROD) and LHSL. The coefficient 
on the productivity variable is generally highly significant, with p-values less than 0.01 in all 
but one of the regressions. This result provides support for the BCD hypothesis. However, 
superior analyses based on diagnostics tests (BIC and RESET) support inclusion of country-
specific linear time trends and indicate no support for the BCD hypothesis. The results for the 
FE with country specific time trend indicate a negative and insignificant effect of PROD on 
LHSL. This indicates no support for the BCD hypothesis.  
The justification for the inclusion of country-specific time trends is to control for 
common trending behaviour as reported in section 3.5.2. The country and time effects included 
in the specification (Columns 7 to 9) are jointly significant with reported p-values less than 
0.001. The BIC results also show stronger support for the FE with country-specific time trends 
compared with POLS and 2WFE. For example, Column (9) has a BIC value of -806.0 
compared to -668.3 in Column (6), indicating that country fixed effects with country-specific 
time trends provide a better fit than country and year fixed effects, even after penalizing for the 
inclusion of additional variables.  Lastly, the RESET fails to reject the null hypothesis of “no 
specification error” in two of the three models including country-specific time trends (Columns 
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7 and 9).  In contrast, specification error was found in all the reported results for POLS and 
2WFE (Columns 1 through 6). 
 The results reported in Table 3.3 also reveal robustness of the specifications to the 
inclusion of control variables (age and demographic factors; lifestyle variables; and economic 
growth). The control variables are found significant in some specifications but have little effect 
on the relationship between PROD and LHSL, even in the preferred specifications (Columns 
7 to 9) where negative and insignificant estimates are reported. This provides sufficient 
evidence to conclude that the BCD prediction of Equation (3.37) is not supported by my 
analysis. 
 The reported results for testing the BCD prediction of Equation (3.38) in Table 3.4 are 
similar qualitatively to the findings from Table 3.3. The results provide estimates of the 
relationship between productivity and the ratio of prices in the health and non-health sectors 
(PHN).14 As earlier reported in Table 3.3, productivity estimates from POLS and 2WFE in 
Table 3.4 also indicate a positive and significant effect and provide evidence in support of BCD 
hypothesis. However, the coefficient on the productivity variable turns from positive and 
generally significant in Columns (1) through (6), to negative and statistically insignificant in 
Columns (7) through (9). Similarly, post-estimation diagnostic tests (such as the joint 
significance of country and time effects, BIC and RESET) indicate the robustness of the FE 
with country-specific time trends specification (Columns 7 to 9, Table 3.4). The robustness 
specifications are preferred and the results provide no evidence to support the BCD hypothesis 
when the prediction of Equation (3.38) is tested. 
The preceding results that provide no support for BCD hypothesis could potentially be 
biased due to econometric issues such as cross-sectional dependence, non-stationarity, serial  
                                                          
14 Unlike the specifications in Table 3.3, none of the variables in Table 3.4 are logged.  This time the RESET 
results preferred the unlogged versions of the respective variables.  However, the conclusions regarding the 
significance of the productivity variables were qualitatively identical between the two tables. 
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Table 3.3: First Test of the BCD Hypothesis: Health Sector Share of the Labour Force (LHSL) 
 
Variable 
POLS 2WFE FE with Country-Specific Time Trends 


























































































































































Obs. 384 258 256 384 258 256 384 258 256 
N 27 19 19 27 19 19 27 19 19 
Adj. R2 0.534 0.749 0.749 0.981 0.991 0.991 0.988 0.995 0.995 




POLS 2WFE FE with Country-Specific Time Trends 
(1) (2) (3) (4) (5) (6) (7) (8) (9) 




















Serial Correlation ---- ---- ---- ---- ---- ---- F=50.49*** F=28.89*** F=26.14*** 
Pesaran’s CD test ---- ---- ---- ---- ---- ---- z=11.447*** ---- ---- 
CIPS PURT (Error term) I(1) ---- ---- I(1) ---- ---- I(1) ---- ---- 
 
 
NOTE:  The dependent variable is ln(LHSL).  "POLS",  "2WFE" and "FE with Country-Specific Time Trends" stand for OLS regression without fixed effects, 
OLS regression with fixed effects for country and year, and OLS regression with fixed effects for country and country-specific linear time trends.   Cross-
sectionally augmented Im et al. (2003) panel unit root test (PURT) at lag 1 is used as a residual based cointegration test. Unless otherwise indicated, numbers 
in parentheses report cluster-robust standard errors, with clustering by country.  *, **, and *** indicate statistical significance at the 10%, 5%, and 1% level, 
respectively.   
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Table 3.4: Second Test of the BCD Hypothesis: Ratio of Prices in the Health and Non-Health Sectors (PHN) 
 
Variable 
POLS 2WFE FE with Country-Specific Time Trends 


























































































































































Obs. 382 215 213 382 215 213 382 215 213 
N 21 14 14 21 14 14 21 14 14 
Adj. R2 0.452 0.426 0.442 0.799 0.796 0.795 0.856 0.879 0.880 
Country and time 
effects 




POLS 2WFE FE with Country-Specific Time Trends 
(1) (2) (3) (4) (5) (6) (7) (8) (9) 




















Serial Correlation ---- ---- ---- ---- ---- ---- F=179.54*** F=39.28*** F=41.19*** 
Pesaran’s CD test ---- ---- ---- ---- ---- ---- z=3.646*** ---- ---- 
CIPS PURT (Error 
term) 
I(1) ---- ---- I(1) ---- ---- I(1) ---- ---- 
 
NOTE:  The dependent variable is PHN.  "POLS",  "2WFE" and "FE with Country-Specific Time Trends" stand for OLS regression without fixed effects, OLS 
regression with fixed effects for country and year, and OLS regression with fixed effects for country and country-specific linear time trends.   Cross-sectionally 
augmented Im et al. (2003) panel unit root test (PURT) at lag 1 is used as a residual based cointegration test. Unless otherwise indicated, numbers in parentheses 
report cluster-robust standard errors, with clustering by country.  *, **, and *** indicate statistical significance at the 10%, 5%, and 1% level, respectively. 
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correlation, and endogeneity. For instance, the panel data are likely to be characterised by serial 
correlation because LHSL and PHN series are expected to be persistent over time. Cross-
sectional dependence is also likely to be a problem because factors driving the variables in one 
country are likely to be present in other countries.  Serial correlation and cross-sectional 
dependence cause inefficient estimates and biased standard errors (Chudik & Pesaran, 2013; 
De Hoyos & Sarafidis, 2006; Phillips & Sul, 2003; Reed & Ye, 2011; Sarafidis & Robertson, 
2009; Sarafidis & Wansbeek, 2012; Sarafidis et al., 2009). 
As reported in the last two rows of Tables 3.3 and 3.4 for FE with country-specific time 
trends, Wooldridge (2010) serial correlation test and Pesaran (2004) cross-sectional 
dependence test statistics are significant at the 1% significancel level. This indicates that the 
residuals generated from the models are serially15 and cross-sectionally correlated using 
standard panel data estimators. Also, the residual series are not stationary at level.16  
Endogeneity constitutes another issue that could arise if there are factors that are 
common to both economy-wide productivity and the respective dependent variables. Such 
common factors might be technology shocks in the health sector or unobservable risk factors 
associated with the health sector17.  Lastly, non-stationarity may be an issue as Table 3.2 shows 
that most of the variables are not stationary at level using the heterogeneous PURT that 
accounts for CD.  Also, the results for the residual based coinetgration technique using 
Pesaran’s (2007) CIPS18 test indicated that the estimated residuals are non-stationary. This 
                                                          
15 The static model used in fitting the BCD data instead of estimating an autoregressive or dynamic model might 
be the source of serial-correlation (Durlauf & Blume, 2016, pp. 230-231; Keele & Kelly, 2005). Even though the 
mean grouped type estimators introduced for robustness checks can also be used to estimate dynamic models 
(Chudik & Pesaran, 2015) but the sample size for this study is too small to introduce extra lag variables and have 
sufficient degree of freedom. 
16 This indicates that the examined relationships are not cointegrated. 
17 Baltagi and Moscone (2010) adopt a similar multi-factor error structure to analyse the heterogeneous 
relationship between health and income for OECD countries. 
18 The appropriate critical values for CIPS procedures in testing for cointegration is not available as at the time 
of this research. My approach here is ad hoc and might be less robust but other earlier empirical studies (Baltagi 




implies that there is no long-run relationship in the BCD models. But, evidence from the 
Pedroni (1999, 2004) coinetgration tests provided conflicting results as shown in Table 3.7. 
The conflicting coinetgrtaion outcomes might be due to differences in the underlying 
assumptions used in developing the tests. The next section checks the robustness of the 
preceding results by addressing these respective issues.  
3.7 Robustness Checks 
 I address the econometric concerns identified in section 3.6 by using a set of new panel 
data estimators. The Panel-Corrected Standard Error (PCSE) procedure of Beck and Katz 
(1995) is first considered to treat serial correlation through a Prais-Winsten transformation of 
the variables. PCSE is a quasi-FGLS procedure that parametrically adjusts the standard errors 
to address cross-sectional correlation. Also, more robust panel data estimators that account for 
heterogeneous slope coefficients, non-stationarity, cross-sectional dependence and 
endogeneity in varying degree are used to investigate the robustness of the preceding results. 
The estimators are: Mean Group (MG) estimator by Pesaran and Smith (1995); Common 
Correlated Effects Mean Group (CCEMG) estimator by Pesaran (2006); and the Augmented 
Mean Group (AMG) Estimator by Bond and Eberhardt (2009); Eberhardt and Teal (2010).19 
  Using the alternative estimation procedures, the results for the effect of productivity 
on LHSL and PHN are reported in Tables 3.5 and 3.6, respectively. The productivity estimates 
from PCSE estimation are negative and insignificant. In most cases, estimates from the 
heterogeneous slopes estimators (MG and CCEMG) indicate a positive and insignificant effect 
of PROD on health share of labour force and relative health care prices. The AMG estimates 
of the effects of productivity on LSHL and PHN are negative and positive, respectively. 
However, in both cases, the effects are again insignificant, with none of the p-values close to 
the 10% significance level.  
                                                          
19 The comparative characteristics of all the estimators are shown in Table A2.1 in the Appendix to Chapter 2. 
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The lower parts of Tables 3.5 and 3.6 generally confirm cross-sectional independence, 
especially for the CCEMG and AMG estimators. Also, the corresponding absolute cross-
sectional correlation coefficients are very small and less than 0.37. This indicates that using the 
robust panel estimators addressing various econometric issues does not change the main 
conclusion from above: I find no support for the BCD hypotheses that productivity is related 
to either the share of labour in the health sector, or the ratio of prices in the health and non-
health sectors.  
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PCSE MG CCEMG AMG 










































































































































































Obs. 384 384 231 207 384 231 207 384 209 195 




PCSE MG CCEMG AMG 
(7) (7) (8) (9) (7) (8) (9) (7) (8) (9) 
RMSE 0.0452 0.0214 0.0157 0.0154 0.0061 0.000 0.000 0.0149 0.0112 0.0099 
̂  ---- 0.269 0.235 0.253 0.306 0.363 0.278 0.287 0.217 0.249 
PESCD  ---- 3.59*** -0.27 2.43 -0.51 1.39 -0.73 1.09 -0.27 -1.18 
CIPS PURT 
(Error term) 
---- I(0) I(0) I(0) I(1) I(1) I(1) I(0) I(0) I(0) 
 
NOTE:  The dependent variable is LHSL.  MG, CCEMG and AMG models are estimated with country specific linear time trends. Pesaran (2004) cross-
sectional dependence (CD) procedure is used as a post-estimation test. Cross-sectionally augmented Im et al. (2003) panel unit root test (PURT) at lag 1 is 
used as a residual based cointegration test. RMSE is root mean square error. ̂  = average absolute value of the off-diagonal elements of the cross-sectional 
correlation matrix of the series. PESCD  = Pesaran (2004) CD test. Cross-sectionally augmented Im et al. (2003) panel unit root test (PURT) at lag 1 is used 
as a residual based cointegration test. Unless otherwise noted, numbers in parentheses are z-statistics corresponding to coefficient estimates.  *, **, and *** 







Table 3.6: Robustness Analysis of the BCD Hypothesis: Ratio of Prices in the Health and Non-Health Sectors (PHN) 
 
Variable 
PCSE MG CCEMG AMG 










































































































































































Obs. 382 382 203 201 382 203 201 382 203 201 




PCSE MG CCEMG AMG 
(7) (7) (8) (9) (7) (8) (9) (7) (8) (9) 
RMSE 4.4700 2.8747 2.2838 2.0046 1.1665 0.000 0.000 2.2307 1.3124 1.1452 
̂  ---- 0.277 0.282 0.267 0.320 0.317 0.322 0.261 0.317 0.253 
PESCD  ---- 2.95*** 0.81 2.25** -1.22 2.50** 0.20 -2.30** -1.99** -0.66 
CIPS PURT 
(Error term) 
---- I(0) I(0) I(0) I(0) I(1) I(1) I(0) I(0) I(0) 
 
NOTE:  The dependent variable is LHSL.  MG, CCEMG and AMG models are estimated with country specific linear time trends. Pesaran (2004) cross-
sectional dependence (CD) procedure is used as a post-estimation test. Cross-sectionally augmented Im et al. (2003) panel unit root test (PURT) at lag 1 is 
used as a residual based cointegration test. RMSE is root mean square error. ̂  = average absolute value of the off-diagonal elements of the cross-sectional 
correlation matrix of the series. PESCD  = Pesaran (2004) CD test. Cross-sectionally augmented Im et al. (2003) panel unit root test (PURT) at lag 1 is used 
as a residual based cointegration test. Unless otherwise noted, numbers in parentheses are z-statistics corresponding to coefficient estimates.  *, **, and *** 




Table 3.7: Pedroni’s (2004) Cointegration Results 
Statistic 
Pedroni’s (2004) Cointegration Tests 
Ln(LHSL) PHN 














N 27 21 
T (average per unit) 14 18 
Number of Regressors 6 6 
Standardised Critical 
Values (one-tail): 
1% 5% 10% 
 2.326 1.645 1.282 
Null Hypothesis: “No 
Cointegration” 
Reject Reject 
NOTE:  Dependent variables: LHL (Health Sector Share of the Labour Force); and 
PHN (Ratio of Prices in the Health and Non-Health Sectors); and OPE (Real out-
of-pocket health expenditure per capita). All the regressors in Model (1) as listed on 
Table 3.3-3.6 are used for this test. *, **, and *** indicate statistical significance at the 




This chapter makes a number of contributions to the literature on Baumol’s Cost 
Disease theory. I have developed a theoretical model of BCD that provides an explicit link 
between the theory underlying BCD and estimated models.  In particular, I have derived two 
testable hypotheses that directly capture the predictions and main characteristics of the BCD 
framework.  I then test these hypotheses on a sample of 27 OECD countries over the period 
1995-2013, using a wide variety of model specifications and panel data estimators.  One key 
feature of this theoretical model set-up for testing BCD hypotheses is that it utilises a precise 
measure of the non-health price index, as opposed to the GDP deflator employed in other 
studies. 
 The empirical hypotheses developed in this chapter predict a relationship between the 
economy’s productivity (proxied by GDP per number of hours worked) and (i) the share of the 
economy’s labour force employed in the health sector, and (ii) the ratio of prices in the health 
and non-health sectors.  BCD implies positive correlations for both sets of relationships.  In a 
range of model specifications and estimation procedures, I do not find a significant relationship 
to support the BCD predictions for OECD countries.  This may be due to the failure of the 
BCD model for “non-progressive” sectors like health care to account for technology 
improvements and the resulting substitutability of capital for labour inputs.  Recently, the 
health care industry has experienced innovative growth in medical devices, software, and 
healthcare administration, such as robotic surgery, robotic nurse assistant, and remote patient 
monitoring systems. These innovations are likely to lead to further departures from the original 
BCD framework.  As a result, it may no longer be appropriate to think of the health sector as 
technologically “non-progressive” -- if it ever was.  In any case, the findings of this study 
indicate that health care does not seem to be “trapped” in a dismal world of stagnant 














Chapter 4: Accounting for Heterogeneous and Non-stationary 



















In the last three decades, there have been significant developments and advancements 
in the understanding of how to estimate economic relationships from time series, cross-
sectional and panel data. The availability of open-source datasets characterized by large N 
(groups of cross-sectional units) and T (number of time periods) from major repositories such 
as the OECD20, World Bank, IMF21, WHO22, and Penn-World Table have spurred this 
development.  Pesaran, Shin, and Smith (1999, pp. 621-622) call datasets with N = 24 and T = 
32 as “quite large”, and N = 10 and T = 17 as “quite small”. Pedroni (2008) classifies “macro 
panels” as having N less than 100 and T greater than 20; with “micro panels” consisting of T 
less than 5 or 10 and N very large, having hundreds or even thousands of cross-sectional units. 
The different types of datasets have motivated the development for customized estimators that 
are most appropriate for a given research application.  
The use of macro panels in modelling raises a number of challenges, while opening up 
new possibilities.  With large macro panels, pooling data to estimate long-run coefficients may 
not be necessary. As noted by Pesaran and Smith (1995, p. 80)23 “when T is large enough it is 
sensible to run separate regressions for each group” to estimate the average effects. This is 
advantageous because it allows one to avoid the widely adopted assumption of slope 
homogeneity across cross-sectional units, such as countries. Second, most of the macro panels 
used by applied econometricians are believed to be characterized by non-stationarity (with 
suspected slope heterogeneity) that violate the assumptions of conventional panel data 
                                                          
20 Organisation for Economic Co-operation and Development (OECD) 
21 International Monetary Fund (IMF) 
22 World Health Organisation (WHO) 
23Pesaran and Smith (1995) provide extensive description and implications of the procedures to estimate the 
average effect across groups when T is large. Among the procedures is the mean group estimator that estimates 
the average coefficient explicitly and is found to be more consistent for static and dynamic panel models.  
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estimators. Lastly, thinking about economic relationships in macro panels has developed to 
where modellers now frequently presume that unobserved, common factors underlie many of 
the observed relationships among economic variables.  
With respect to the latter, recent applied and theoretical panel data econometric studies 
have emphasized the existence of cross-sectional or “between groups” dependence among the 
disturbances (i.e.   0, jtit eecor ).  This has been attributed to unobserved “common shocks” 
and unobserved time-variant heterogeneous error components (Anselin, 2001; Baltagi, 2005; 
De Hoyos & Sarafidis, 2006; Eberhardt & Teal, 2011, 2014; Pesaran, 2004, 2006; Pesaran & 
Tosetti, 2011; Phillips & Sul, 2003; Robertson & Symons, 2000; Sarafidis & Wansbeek, 2012).  
Although the existence of cross-sectional dependence has been recognized since the 
1930s as noted in the works of Stephan (1934), Neprash (1934), and Fisher (1935), but it has 
often been ignored by researchers in panel model estimation. Cross-sectional dependence can 
have severe implications for the efficiency and consistency properties of standard panel 
estimators such as pooled ordinary least squares (POLS), fixed effects (FE) and random effects 
(RE).  The impact of cross-sectional dependence in estimation varies (Coakley et al., 2006) but 
is dependent on two major factors: (i) the size of the average pairwise cross-sectional 
correlation; and (ii) the nature or source of the cross-sectional correlation (De Hoyos & 
Sarafidis, 2006).  
For instance, in a case where the cross correlation of errors emanates from the omission 
of common effects or unobserved spatial effects, but where the errors are uncorrelated with the 
explanatory variables (i.e.   0, Xecor i ), the conventional panel estimators (POLS, RE, and 
FE) can result in inefficient estimates and biased standard errors (Chudik & Pesaran, 2013; De 
Hoyos & Sarafidis, 2006; Phillips & Sul, 2003; Reed & Ye, 2011; Sarafidis & Robertson, 2009; 
Sarafidis & Wansbeek, 2012; Sarafidis et al., 2009). Where the unobserved common factors 
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induce correlation between the disturbance and regressors (i.e.   0, Xecor i ), it creates an 
endogeneity problem.  
In recognition of the implications of slope heterogeneity, cross-sectional dependence, 
non-stationarity, and endogeneity induced by the presence of unobserved common factors, new 
panel data estimators have been developed to accommodate one or more of these econometric 
issues. Among these recent estimators24 are Pesaran and Smith (1995) Mean Group (MG) 
estimator, Pesaran (2006) Common Correlated Effects Mean Group (CCEMG) estimator,  and 
the Augmented Mean Group (AMG) estimator by Bond and Eberhardt (2009) and Eberhardt 
and Teal (2010).  
This chapter is concerned with investigating the performances of these mean group type 
estimators relative to the pooled type methods under different panel model set-ups.  It will do 
so through the use of Monte Carlo simulation experiments. Bond and Eberhardt (2013a, 
henceforth B&E) perform similar experiments by extending the Data Generating Processes 
(DGP) of Coakley et al. (2006), and Kapetanios, Pesaran, and Yamagata (2011). This study 
first replicates the simulation experiments in B&E (2013) using the same Monte Carlo DGP 
(i.e. simulated dataset) set-ups. It then extends the analysis to incorporate additional 
performance metrics for comparing the respective estimators.  
The last experiment specifically replicates the first simulation for three sets of panel 
data dimensions (N = 28 and T = 21; N = 23 and T = 21; and N = 51 and T = 21). These are 
chosen to match typical panel data dimensions available in World Development Indicators 
                                                          
24 A brief description and comparison between the standard (i.e. pooled type) estimator and the recent (i.e. mean 
group type) estimators are shown at appendix 4.5 (TABLE A4.1). The assumptions and properties of the 
estimators are extensively discussed in the literature (see Banerjee et al., 2010; Beck & Katz, 2007; Bond & 
Eberhardt, 2009; Chudik & Pesaran, 2013; Eberhardt & Teal, 2010, 2011, 2014; Pesaran, 2006; Pesaran & Smith, 
1995; Poi, 2003; Swamy, 1970). 
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(WDI) in order to provide guidance for my subsequent analysis in chapter five of the income 
elasticity of health spending for selected African countries. 
4.2 Panel Data Model and Estimation Procedure 
This chapter considers the following general empirical cross-section time series model 
set-up25 for Ni ,...,1 (number of cross-section groups), Tt ,...,1 (time periods), Kk ,...,1
(explanatory variables), and Mm ,...,1 (number of factors): 
ititkiktiit uxdy  ,,         (4.1) 
itmtmiit fu   ,,          (4.2) 
itktmimktmimktikitk vfpgdx ,,,,,,,,,         (4.3) 
The slope of k  observed explanatory variables in Eq. (4.1) is heterogeneous and follows a 
random coefficient process with common slope vector (  ): 
ii             (4.4) 
The factor loadings that represent the effect of the unobserved common factors,  and , (cf. 
Eq. (4.2)  and Eq. (4.3)) are heterogeneous of the form: 
ii             (4.5) 
ii             (4.6) 
ii pp            (4.7) 
                                                          




The m  factors are time-variant but cross-sectionally invariant and they are specified to model 
cross-sectional dependence. The errors ( i  and i ) are independent and identically distributed 
across groups, i . Similarly, the idiosyncratic terms ( it  and itv ) in Eq. (4.2) and Eq. (4.3) have 
fixed mean and finite variance. The model set-up also incorporates a vector of observed 
common effects ( td ) in the form of seasonal dummies or deterministic country-specific effects 
(cf. Eq. (4.1) and (4.3)). The effects are differential for each individual group ( i and ik , ). To 
further enrich the set-up, the observables ( ity , itx ) and unobservables ( tf , tmg , )  have the 
potential to be non-stationary ( 1  and 1 ): 
         (4.8) 
         (4.9) 
Another key aspect of the model is the unobserved common factors overlap in Eq. (4.2) and 
Eq. (4.3). This creates an identification problem for the estimation of the heterogeneous slopes, 
i .
26 
The model set-up above can be used to express different types of panel data models by 
the imposition of appropriate restrictions. Examples include Pooled Ordinary Least Squares (
, i  ,1td   i , 0},,{ iii p ), the Fixed and Random Effects models (  
 i , 0},,{ iii p ), Two-way Fixed Effects (2WFE) ( , ), the 
Swamy (1970) Random Coefficients Model (RCM) ( ) and the Pesaran & 
Smith (1995) Mean Group (MG) model ( ).  The pooled type estimators (POLS, 
                                                          
26 Substituting (4.3) and (4.2) into (4.1): 
      ititkitmiimkitmiimktiikiit vfpgdy    ,,1,,,,,,  
ttt ff   1
ttt gg   1
,1td
 i 0},,{ iii p




FE, RE, and 2WFE) assume stationarity of the observable variables, cross-sectional 
independence among disturbances, and slope homogeneity. The RCM model differs from the 
MG estimator in that the latter is based on the simple average of group-specific OLS estimates 
(see Hsiao & Pesaran, 2004 for extensive comparison between the models). Coakley et al. 
(2006), similarly provide detailed comparison between the pooled and mean group type 
models.  
 Pesaran (2006) developed the CCEMG estimator to estimate N, group-specific 
regressions by augmenting the model set-up (cf. Eq. (4.1)) with cross-sectional averages of the 
dependent variable and regressors. For each cross-section unit, the following model is 
estimated: 
ittkiktiitkiktiit uxyxdy  ,,21,,        (4.10)
27 
The augmented covariates ty (T x 1) and tkx ,  (T x k) are proxies for the unobserved common 
factors, tf , causing correlation among error disturbances and between error disturbances and 
regressors. A simple or weighted average of the estimated slope coefficients across group is 





iCMG N  ˆˆ
1
         (4.11) 
From Eq. (4.10), the Pesaran (2006) Pooled Common Correlated Effect (CCEP) estimator 
model can be derived with a few restrictions (  i ) as: 
                                                          







1,,        (4.12)
28 
where Nq ,...,1 ; tt yy 
*
; tt xx 
*
;   is  NN  ; ty and tx are  1T  cross-section 
averages over time; and the Kronecker product gives an  NNT   matrix. The   in Eq. (4.12) 
is estimated using pooled OLS.  
In the same spirit, Bond and Eberhardt (2009) and Eberhardt and Teal (2010) developed 
the Augmented Mean Group (AMG) estimator to estimate the average effect using a different 
approach to account for the unobserved common shocks. The AMG implementation is based 
on a three step procedure (Bond & Eberhardt, 2013a). The first step involves estimating the 
“common dynamic process” (
 ttc ̂ˆ ) from the estimated first difference pooled OLS (FD-




ttitiit uDcxy  
2
        (4.13) 
The extracted estimated slope of tD  ( tĉ ) is designed to explicitly capture the unobserved 
common factor. The common dynamic process can either be subtracted from the dependent 
variable (cf. Eq. (4.14), denoted subsequently as AMG(i)) or incorporated as an additional 
covariate (cf. Eq. (4.15), denoted subsequently as AMG(ii)): 
itiitiitit utxy 
 ̂        (4.14) 
ittiitiiit udxy 
 ˆ         (4.15) 
                                                          
28 The number of parameters to be estimated for the CCEP estimator if ,1td and 1k is   kN 3  with 
the degrees of freedom of   kNNT  3 . 
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N, group-specific regressions of either Equation (4.14) or (4.15) are estimated and the average 
of the coefficients are taken as shown in Equation (4.11).  
The major difference between the CCEMG and the AMG is the approach of accounting 
for the unobserved common factors. Both estimators maintain the same underlying 
assumptions (Bond & Eberhardt, 2013a) for estimating a static panel model when the 
regressors are strictly exogenous as noted in Chudik and Pesaran (2015)29.  B&E also consider 
two other “infeasible” estimators: a FE(inf) and a MG(inf) that append the FE and MG 
estimators with the unobserved common factors as additional regressors.  These are included 
for comparison purposes only since the unobserved common factors are, by definition, 
unobserved, thus rendering these estimators “infeasible.” 
4.3 Simulation I: Replication and Extension of Bond and Eberhardt (2013a)  
This section of the study presents the data generating process (DGP) and Monte Carlo 
simulation set-ups for comparing the performances and checking robustness of the estimators 
of interest in the presence of the previously described econometric issues. The highlighted 
issues include error cross-sectional dependence, slope heterogeneity, non-stationarity of the 
observable and unobservable series, and endogeneity. The experiment involves 1000 
simulations with 50N , 30T  and 0TT 
30 dimension sets, where  50,...,10 T . The first 50 
observations for each cross-section units were ignored (burned off) for estimation purposes. 
The N and T sizes considered for the simulation are typical of macroeconomic panel datasets 
in monthly, quarterly or annual frequency.   
4.3.1 Data Generating Process (DGP) Set-Up 
                                                          
29 Chudik and Pesaran (2015) extend the CCEMG method to accommodate dynamic panel models when the 
regressors are strictly and/or weakly exogenous.  
30 The 50 observations are imposed and added to each dimension of T to have a balanced dataset after differencing 
each series. Other previous simulation experiments (Bond & Eberhardt, 2013a; Coakley et al., 2006; Kapetanios 
et al., 2011) adopted similar approach. 
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The DGP for Ni ,...,1 ; Tt ,...,1 ; 1K ; and 3,2,1m  follows: 
ititkikit uxy  ,,      ittitiiit ffu   ,2,2,1,1  ittiiit   1,  (4.16) 
ittitiiit vffx  ,3,2,2,1    ittiiit evv  1,    (4.17) 
tmtmmmtm ff ,1,,                 tmtmmtm ,1,,       (4.18) 
I use the same parameter settings as Bond and Eberhardt (2013a) for replicating the baseline 
simulation and subsequent extensions. The intercepts in the y , x  and f  models are generated 
as: 
 5.2,5.1~ Uiidi   where   2 iE   
 6,4~ Uiidi   where   5 iE   
 01.0,012.0,015.0m   for 3,2,1m  
The stationarity and autocorrelation specifications for the error disturbances in the y , x  and 
f equations as well as the lag of the unobservable common factors coefficients are generated 
as follows: 
Error disturbance in y : 0i  (Stationary, I(0); No autocorrelation; Cointegration; No 
simultaneity/ feedback effects) 
Error disturbance in x : 25.0  i (Homogeneous serial correlation across groups) 
Error disturbance in mf : 0m (No autocorrelation) 
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Lag of unobservable common factors ( 1, tmf ) coefficients:  1m  (Non-stationary factors, 
I(I)) 
The set-up for the error terms in the data generation process are derived as: 
 2,0~  Niidit   where 00125.02   
 2,,0~ ieit Niide    where  003.0,001.0~2, Uie   
 2,, ,0~ mtm Niid    where 00125.02, m   
The heterogeneous parameters in the y  and x  models are defined as: 
Regressor: 
ii    where 1 ;  25.0,25.0~ Ui ; and  25.1,75.0~ Ui  
Factor Loading: y  equation 
for ii ,11,1    ;  where 1 5.0 ;  5.0,5.0~ Ui , then i,1  1,0~ U ; 
for ii ,22,2   ; where 2 75.0 ;  5.0,5.0~ Ui , then i,2  25.1,25.0~ U  
Factor Loading: x  equation 
for ii ,11,1    ;  where 1 5.0 ;  5.0,5.0~ Ui , then i,1  1,0~ U ; 
for ii ,22,2   ; where 2 75.0 ;  5.0,5.0~ Ui , then i,2  25.1,25.0~ U  

















  (4.19) 











































1   (4.20) 
The DGPs of itx  and ity  in equation (4.19) and (4.20) are generated to correct for serial 
correlation induced by the first order autoregressive (AR(1)) process of errors ( itv ) in itx  (see 
equation (4.17)). The AR(1) error is further transmitted to ity  through itx . 
Case I: Baseline Model 
The key features of the baseline model as described above are nonstationarity in the 
unobserved common factors, tmf , ,  and heterogeneity in the slope coefficients, i . The first 
experiment consists of replicating Bond and Eberhardt (2013a) baseline Monte Carlo 
simulation with N =50 and T = 30. My subsequent experiments follow Bond and Eberhardt 
(2013a) in extending their baseline set-up by incorporating heterogeneous linear trends; a 
feedback effect where shocks to y affect x with a one-period lag; and the individual cross-
sectional units i are divided into two groups (“clubs”) with each group characterized by a 





Case II: Heterogeneous Linear Trends ( ti ) 
Case I is augmented with heterogeneous linear time trends  ti  for the DGP for y  (cf. 
Eq. (4.16)) as follows:  
ititkikit uxy  ,,                itititiiit tffu   ,2,2,1,1           (4.21) 
itititiiitkikit tffxy   ,2,2,1,1,,           (4.22) 
ii    where 005.0 ;  025.0,025.0~ Ui ; and  03.0,02.0~ Ui  
Case III: Feedback Effect 
From Case I, 0i , 25.0i , and 1, ti  (where  2,0~  Niidit  , and 
00125.02  ) is included in the x  equation to create feedback effects. Bond and Eberhardt 
(2013a) describe the feedback effect as an idiosyncratic shock from y  to x , with a one period 
lag. The disturbance term in y  is non-stationary (I(1)) and not cointegrated. Incorporating these 
changes into the DGP for y  yields 
  ittitiitiiitkikit ffxy    ,2,2,1,11,,,           (4.23) 

















































Case IV: Beta Clubs  
In this case, the restriction that the regressor slope coefficient consists of a common 
component,  , across all cross-sectional units is relaxed to allow two different common 
components, 1  and 2 .  This is done to capture the notion of “clubs.” 80% of the cross-
sectional units have 75.0 .  20% have 2 .  These values are chosen so that across all 
cross-sectional units, the common vector of the regressor slope coefficient has an average of 
one.  Each cross-sectional unit’s slope coefficient continues to also have a random component.   
4.3.2 Measures of Estimator Performance 
For performance measures, B&E use the mean, median, standard deviation, and mean 
of the standard errors of the estimated slope coefficients for x , i̂ . This study extends B&E’s 
analysis by also including measures of efficiency and coverage rates. Both measures are 
calculated over the estimates produced from 1000 simulations. Efficiency is defined by root 






1 )(,   r i
r
ESTIMATORi 
     (4.25) 
The coverage rate is defined as the percentage of 95% confidence intervals around i̂ that 
include the true value, i . If the coverage rate is less than 95%, it means the null-hypothesis 
  iri  ˆ  is over-rejected.  
I use a colour code system to identify “relatively good,” “relatively neutral,” and 
“relatively bad” performance.  The thresholds for each category were determined through a 
combination of natural sorting of the data and objective standards.  For example, for RMSE, 
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the respective values were observed to group themselves into three categories: (i) RMSE < 
0.0050, (ii) 0.0050 ≤ RMSE ≤ 0.0100, and (iii) RMSE > 0.0100.  Accordingly, these three 
categories were classified as “relatively good,” “relatively neutral,” and “relatively bad,” 
respectively.  Alternatively, coverage rates between 0.90 and 0.99 were classified as “relatively 
good” as these were reasonably close to the target, 95% confidence level.  Coverage rates less 
than 0.85 and equal to 1.00 were considered “relatively bad” because these values implied that 
hypothesis tests would be substantially impaired.  Values within these two ranges were 
classified as “relatively neutral.” The respective classification criteria are given in Table 4.1 
below. 
Table 4.1: Performance Criteria 
 
 RMSE COVERAGE RATE (= CVR) 
Relatively Good 
(Green) 
RMSE < 0.0050 0.90 ≤ CVR ≤ 0.99 
Relatively Neutral 
(White) 
0.0050 ≤ RMSE ≤ 0.0100 
(i) 0.85 ≤ CVR < 0.90 
(ii) 0.99 < CVR < 1.00 
Relatively Bad 
(Red) 
RMSE > 0.0100 
(i) CVR < 0.85 
(ii) CVR = 1.00 
 
4.3.3 Monte Carlo Results 
Replication of B&E’s simulation experiments for the four different DGP set-ups was 
carried out using two versions of GAUSS, Versions 9 and 16. Version 9 was the version used 
by B&E. Version 16 was the most recent version of GAUSS at the time this research was 
undertaken. The packages differ in their random number generators and produce somewhat 
different results. This section presents the descriptive statistics, efficiencies and coverage rates 
for each of the replicated experiments. The study replicated 100 experiments covering four 
model set-ups according to specific panel dimensions (N and T). Results for  30,50  TN  
are presented in Tables 4.2 to 4.5.  These dimensions were chosen because they are 
representative of many studies that appear in the literature.  
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For the results shown in Table 4.2-4.5, differences in the mean between the original and 
replicated coefficient estimates that were larger than 0.0005 are yellow-highlighted.  Note that 
B&E did not report performance measures for efficiency and coverage rates, so no comparison 
with respect to these measures is possible.  Results for the baseline (Table 4.2), feedback (Table 
4.4), and beta-club (Table 4.5) replications were generally very close to B&E’s reported results. 
In contrast, the results for the heterogeneous trend case (Table 4.3) are substantially different.  
The latter result is likely due to differences in the code used by B&E and myself.  While I 
received B&E’s code for replicating Tables 4.2, 4.4, and 4.5, I had to write my own code for 
Table 4.3.  When I could not replicate B&E’s results for this case, I contacted B&E and sent 
them my results and code.  However, they were unable to resolve the discrepancy for me.  
The results for the baseline experiments are reported in Table 4.2.  To facilitate reading 
of the table, the respective estimators are described again in the note below the table.  The first 
five estimators (POLS, 2WFE, CCEP, FD-OLS, and FE(inf)) are the “pooled” estimators.  The 
next five estimators (CCEMG, AMG(i), AMG(ii), MG, and MG(inf)) are the “mean group” 
estimators.  It must be noted again that FE(inf) and MG(inf) are included for comparison 
purposes only.  They are “infeasible” for actual data analysis because they include the common 
factors as variables in the estimation, and thus presume that they are observed.  In evaluating 
the different estimators, I considered all the three performance measures (MEAN, RMSE, and 
COVERAGE RATE).  Good performance for MEAN consists of a value close to 1.0000.  
(Relatively) good performance for the RMSE and COVERAGE RATE measures is indicated 
by a green colour-coding. 
Among the feasible pooled estimators, only the Common Correlated Effect Pooled 
Estimator (CCEP) does well across all three performance measures. Both B&E and my 
replications using the two versions of GAUSS produce a mean estimate of   close to 1.000.  
Efficiency is comparable to the two infeasible estimators (0.0007 versus 0.0003), as are 
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coverage rates (91.3% and 91.6%).  The First Difference Ordinary Least Squares (FD-OLS) 
estimator just misses out on being “relatively good” across the board because its coverage rate 
for the GAUSS (Version 16) experiments was just shy of 90%. 
Noteworthy is the poor performance of the two pooled estimators, Pooled Ordinary 
Least Squares (POLS) and Two-Way Fixed Effects (2WFE).  These two estimators are 
workhorse estimators for many empirical analyses using panel data.  However, the baseline 
Monte Carlo environment of nonstationarity in the unobserved common factors and 
heterogeneity in the slope coefficient brings out poor performance.  Both estimators 
demonstrate substantial bias, with the mean estimate approximately 3 percent off its true value.  
Both estimators are relatively inefficient, with the POLS estimator being particularly so.  And 
both estimators produce coverage rates far off the mark.  Substantially more than half of the 
respective 95% confidence intervals do not include the true value of  .  This renders 
hypothesis testing with these two estimators virtually useless.  
Among the mean group estimators, the Common Correlated Effect Mean Group 
estimator (CCEMG) and the two Augmented Mean Group estimators (AMG(i) and AMG(ii)) 
perform well – about as well as the CCEP estimator.  Interestingly, the simple Mean Group 
estimator (MG) has bad performance that rivals the worst of the pooled estimators. 
Table 4.3 extends the analysis by adding heterogeneous time trends to the DGPs 
generating the y’s.  Among the pooled estimators, the CCEP and FD-OLS estimators trade 
places with respect to performance.  FD-OLS performs well across all performance measures, 
with CCEP slipping slightly with respect to coverage rates.  Among the mean group estimators, 
the CCEMG, AMG(i) and AMG(ii) estimators generally perform well.  Once again, the POLS, 
2WFE, and MG estimators perform poorly across all three performance measures.  All three 
estimators show dismal coverage rates.  In addition, the MG estimator demonstrates substantial 
bias (approximately 13%). 
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Table 4.2: Performance Comparison (Case I – Baseline) 
 
ESTIMATOR 
MEAN RMSE COVERAGE RATE 
B&E (2013) 
Replication (GAUSS) Replication (GAUSS) Replication (GAUSS) 
Version 9 Version 16 Version 9 Version 16 Version 9 Version 16 
POLS 0.9754 0.9754 0.9758 0.0457 0.0443 29.1 29.7 
2WFE 1.0324 1.0324 1.0321 0.0083 0.0083 45.8 45.7 
CCEP 0.9995 0.9995 1.0004 0.0007 0.0007 91.3 91.6 
FD-OLS 1.0021 1.0021 1.0016 0.0007 0.0008 91.3 89.7 
FE(inf) 1.0000 1.0000 1.0006 0.0003 0.0003 92 91.5 
CCEMG 0.9992 0.9992 0.9994 0.0007 0.0007 98.9 97.8 
AMG(i) 1.0026 1.0026 1.0026 0.0006 0.0007 98.4 97.8 
AMG(ii) 1.0018 1.0018 1.0018 0.0006 0.0006 97.7 97.4 
MG 1.1259 1.1259 1.1261 0.0492 0.0492 26.4 27.2 
MG(inf) 0.9999 0.9999 0.9999 0.0003 0.0003 99.5 99.5 
 
NOTE: POLS = Pooled Ordinary Least Squares; 2WFE = Two-Way Fixed Effects; CCEP = Common Correlated Effect Pooled Estimator; FD-OLS = First 
Difference Ordinary Least Squares; FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG = Common Correlated 
Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with 
common unobservable factors); N =50, T= 30; 1000 iteration;  Average β = 1.000; RMSE = Root Mean Square Error. 
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Table 4.3: Performance Comparison (Case II – Heterogeneous Trends) 
 
ESTIMATOR 
MEAN RMSE COVERAGE RATE 
B&E 
(2013) 
Replication (GAUSS) Replication (GAUSS) Replication (GAUSS) 
Version 9 Version 16 Version 9 Version 16 Version 9 Version 16 
POLS 0.9731 0.9764 0.9741 0.0940 0.0928 29.1 29.4 
2WFE 1.0277 1.0323 1.0332 0.0420 0.0422 40.7 39.5 
CCEP 0.9991 0.9978 0.9997 0.0015 0.0016 90.2 87.5 
FD-OLS 1.0025 1.0022 1.0016 0.0008 0.0008 92.4 91.5 
FE(inf) 0.9998 0.9976 0.9984 0.0018 0.0018 77.6 77 
CCEMG 0.9997 0.9976 0.9985 0.0016 0.0017 96.9 96.2 
AMG(i) 1.0049 1.0026 1.0027 0.0006 0.0007 98.5 97.9 
AMG(ii) 1.0090 1.0015 1.0019 0.0010 0.0010 99.1 98.6 
MG 1.1269 1.1259 1.1261 0.0492 0.0492 26.4 27.2 
MG(inf) 1.0017 0.9982 0.9986 0.0018 0.0018 97.1 97.1 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = Common Correlated Effect Pooled Estimator; FD-OLS = First 
Difference Ordinary Least Squares; FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG = Common Correlated 
Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with 






Table 4.4: Performance Comparisons (Case III – Feedback) 
 
ESTIMATOR 
MEAN RMSE COVERAGE RATE 
B&E (2013) 
Replication (GAUSS) Replication (GAUSS) Replication (GAUSS) 
Version 9 Version 16 Version 9 Version 16 Version 9 Version 16 
POLS 0.9754 0.9754 0.9758 0.0457 0.0443 29.2 29.7 
2WFE 1.0299 1.0299 1.0293 0.0079 0.0079 46.9 46.8 
CCEP 0.9867 0.9867 0.9874 0.0008 0.0008 86.5 86.7 
FD-OLS 0.9149 0.9149 0.9143 0.0079 0.0081 6.9 6.7 
FE(inf) 0.9924 0.9924 0.9929 0.0004 0.0004 87.9 88.9 
CCEMG 0.9828 0.9828 0.9829 0.0009 0.0009 96.4 96.4 
AMG(i) 0.9552 0.9552 0.9552 0.0027 0.0028 73.4 72.3 
AMG(ii) 0.9511 0.9511 0.9511 0.0031 0.0031 64.7 65.3 
MG 1.1157 1.1157 1.1158 0.0458 0.0456 27.7 28.4 
MG(inf) 0.9888 0.9888 0.9889 0.0004 0.0004 99.2 99.1 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = Common Correlated Effect Pooled Estimator; FD-OLS = First 
Difference Ordinary Least Squares; FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG = Common Correlated 
Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with 




Table 4.5: Performance Comparisons (Case IV – Beta-Clubs) 
 
ESTIMATOR 
MEAN RMSE COVERAGE RATE 
B&E (2013) 
Replication (GAUSS) Replication (GAUSS) Replication (GAUSS) 
Version 9 Version 16 Version 9 Version 16 Version 9 Version 16 
POLS 0.5539 0.5539 0.5539 0.3416 0.3442 26.9 26.8 
2WFE 1.0224 1.0224 1.0221 0.0194 0.0196 46 46.7 
CCEP 1.0017 1.0017 1.0024 0.0015 0.0015 82.1 79.7 
FD-OLS 1.0023 1.0023 1.0018 0.0016 0.0017 82.7 82.2 
FE(inf) 0.9999 0.9999 1.0013 0.0013 0.0013 72.9 73.5 
CCEMG 0.9996 0.9996 0.9996 0.0007 0.0007 100 100 
AMG(i) 1.0045 1.0033 1.0034 0.0009 0.0010 100 100 
AMG(ii) 1.0132 1.0049 1.0047 0.0011 0.0011 100 100 
MG 1.1260 1.1260 1.1262 0.0492 0.0492 51.9 52.8 
MG(inf) 1.0000 1.0000 1.0000 0.0003 0.0003 100 100 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = Common Correlated Effect Pooled Estimator; FD-OLS = First 
Difference Ordinary Least Squares; FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG = Common Correlated 
Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with 
common unobservable factors); N =50, T= 30; 1000 iteration;  Average β = 1.000; RMSE = Root Mean Square Error. 
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Table 4.4 introduces a feedback effect whereby shocks to y in turn affect x with a one-
period lag.  As B&E remark, the reason for considering this case is that it “leads to bias in the 
FD-OLS, which carries over to the AMG estimators: due to differencing the 1, ti  are contained 
in both the errors and the regressors of the FD-OLS estimation equation, whereas this is not 
the case in the other (levels-based) estimators which account for common factors” (B&E, page 
5).  This effect on bias for the FD-OLS and AMG estimators is clearly evidenced in the table, 
as all three estimators now have mean coefficient estimates that are substantially less than 1. 
As one would expect, this poor performance on bias spills over into coverage rates.  In 
particular, the coverage rates for the FD-OLS estimator are extremely low, less than 10%.  
Turning to the other estimators, I see that none of the pooled estimators does 
particularly well.  CCEP is the best of the lot, but it shows slightly more bias than in previous 
cases, and its coverage rates are worse than before, below 90%.  The only estimator that seems 
to perform well in this environment is the CCEMG estimator.  It displays a very slight bias, but 
its efficiency remains good and its coverage rate is very close to 95%. 
The very last case I consider in this analysis is that of “Beta Clubs.”  The results are 
reported in Table 4.5. The two pooled estimators, CCEP and FD-OLS, perform well with 
respect to bias and efficiency.  However, coverage rates range between approximately 80 and 
83%, so that hypothesis testing would produce an over-rejection of the null hypothesis.  The 
other pooled estimators continue to perform poorly, with the POLS estimator displaying severe 
bias. The CCEMG, AMG(i), and AMG(ii) estimators perform best among the mean group 
estimators, but their coverage rates are distorted.  Unlike the pooled estimators, they estimate 
standard errors that are too wide, so that 100% of the 95% confidence intervals contain the true 
value of the slope coefficient. Note that this is true even for the infeasible MG estimator 
(MG(inf)).  In defence of the estimators, the coverage rates are counted as including the true 
value when they include 1, and not 0.75 or 2.  That is, it is assumed that the econometrician 
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does not know that there are two clubs, and hence makes no effort to assign cross-sectional 
units to different groups.  Thus the confidence intervals and associated null hypotheses can be 
viewed as misspecified, and so it is not surprising that coverage rates should deviate greatly 
from 95%.   
Before proceeding to additional simulations, it is good to summarize my results so far.  
Over all four experimental scenarios (Baseline, Heterogeneous Trends, Feedback, Beta Clubs), 
no single estimator was found to perform “relatively good” in every case. However, several 
estimators generally performed well, especially if one considers that the coverage rates for the 
Beta Clubs case are “misspecified.”  Among the pooled estimators, CCEP performed well on 
the dimensions of bias and efficiency, though it tended to produce standard errors that were 
biased downwards, causing coverage rates to sometimes fall below 90%, but not by a large 
amount.  Among the mean group estimators, CCEMG performed best.  It consistently produced 
mean values of the slope coefficient close to 1, had relatively small RMSE values, and 
generally produced relatively good coverage rates.  The one case where it did not perform well 
on coverage rates was the Beta Clubs case.  As noted above, this is somewhat unfair because 
coverage rates in this case were calculated with respect to the mean value of  (=1), rather 
than the individual true values of 0.75 and 2. 
 
4.4. Simulation II: Replication and Extension of Bond and Eberhardt (2013a) for 
specific N & T Dimensions  
 
4.4.1 Data Generating Process (DGP) Set-up 
This subsection reproduces the general experimental design from the previous 
subsection but analyses estimator performance across different N and T values.  The goal is to 
choose estimators for application in the next chapter when I will estimate datasets for “fragile” 
African countries (N=28 and T=21), “non-fragile” African countries (N=23 and T=21), and for 
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all African countries (N=51 and T=21). The best performing estimator(s) will be used to 
estimate the income elasticity of health care spending in Chapter 5. To address the wider range 
of RMSE values that I will encounter, I add another category to the table of performance 
criteria, “Relatively Very Bad”.  Estimators for which RMSE is larger than 0.1000 will be 
colour-coded brown (see Table 4.6 below). 
Table 4.6: Revised Performance Criteria 
 
 RMSE COVERAGE RATE (= CVR) 
Relatively Good 
(Green) 
RMSE ≤ 0.0050 0.90 ≤ CVR ≤ 0.99 
Relatively Neutral 
(White) 
0.0050 < RMSE ≤ 0.0100 
(i) 0.85 ≤ CVR < 0.90 
(ii) 0.99 < CVR < 1.00 
Relatively Bad 
(Red) 
0.0100 < RMSE ≤ 0.1000 
(i) CVR < 0.85 
(ii) CVR = 1.00 
Relatively Very Bad 
(Brown) 
RMSE > 0.1000 --- 
 
4.4.2 Simulation Results 
Results of the Monte Carlo experiments for panel datasets with dimensions N=28 and 
T=21 (“Fragile States”) are reported in Tables 4.7-4.10, where Cases I through IV are 
sequentially analysed.  Tables 4.11-4.14 report results for datasets having dimensions N=23 
and T=21 (“Non-Fragile States”), and Tables 4.15-4.18 do the same for datasets with 
dimensions N=51 and T=21 (“All States”). All the results use Version 16 of GAUSS. 
Having already discussed the individual estimators’ performances in Tables 4.2-4.5, it 
is not necessary to give a detailed discussion of the results from Tables 4.7-4.18.  In the 
preceding section, I determined that the CCEP and the CCEMG estimators generally performed 
better than the other estimators.  My interpretation of Tables 4.7-4.18 is that this conclusion is 
largely confirmed. 
While there are instances where other estimators perform as well or slightly better on 
some dimensions – for example, among pooled estimators, see FD-OLS in Table 4.8; among 
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mean group estimators, see the AMG estimators in Table 4.7 – these estimators also have 
instances where they perform poorly.   
For example, in Table 4.9, the FD-OLS estimator is more biased than the CCEP 
estimator, has a substantially higher RMSE, and a coverage rate under 50%.   Likewise, in the 
same table, both AMG estimators show greater bias, lower efficiency, and poorer coverage 
rates than the CCEMG estimator. Thus, while changing the dimensions of the datasets causes 
some modification of the respective estimators’ performances, the overall conclusion remains 
the same at this point: The CCEP and CCEMG produce the most reliable results across a wide 
variety of testing environments, including datasets having the same dimensions as those I will 
analyse in Chapter 5.   
Up to this point in my simulation studies, I have stayed within the parameter settings 
established by B&E.  In the next, and final, set of simulation experiments, I modify the testing 
environment to try and get closer to the characteristics of the data I will be analysing in my 





Table 4.7: Performance Comparisons 
(Case I -- Baseline, N=28, T=21, “Fragile States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 1.1121 0.1074 29.8 
2WFE 1.0491 0.0111 61.2 
CCEP 1.0016 0.0016 93.2 
FD-OLS 1.0065 0.0020 90.7 
FE(inf) 1.0022 0.0009 92.7 
CCEMG 1.0026 0.0017 96.9 
AMG(i) 1.0076 0.0017 95.6 
AMG(ii) 1.0058 0.0017 95.0 
MG 1.1240 0.0440 39.2 
MG(inf) 1.0020 0.0010 99.0 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = 
Common Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; 
FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG 
= Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 





Table 4.8: Performance Comparisons 
(Case II – Heterogeneous Trends, N=28, T=21, “Fragile States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 1.1059 0.1947 32.1 
2WFE 1.0457 0.0387 58.1 
CCEP 1.0017 0.0033 90.1 
FD-OLS 1.0064 0.0021 91.9 
FE(inf) 1.0022 0.0031 83.9 
CCEMG 1.0024 0.0035 96.0 
AMG(i) 1.0075 0.0017 95.8 
AMG(ii) 1.0052 0.0026 97.3 
MG 1.1240 0.0440 39.2 
MG(inf) 1.0014 0.0033 97.1 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = 
Common Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; 
FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG 
= Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 










Table 4.9: Performance Comparisons 
(Case III – Feedback, N=28, T=21, “Fragile States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 1.1121 0.1074 29.8 
2WFE 1.0438 0.0104 62.6 
CCEP 0.9832 0.0019 89.1 
FD-OLS 0.9192 0.0086 42.3 
FE(inf) 0.9900 0.0010 91.2 
CCEMG 0.9794 0.0021 96.0 
AMG(i) 0.9608 0.0033 85.7 
AMG(ii) 0.9553 0.0037 80.5 
MG 1.1090 0.0396 42.3 
MG(inf) 0.9851 0.0012 97.9 
 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = 
Common Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; 
FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG 
= Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 









Table 4.10: Performance Comparisons 
(Case IV – Beta Clubs, N=28, T=21, “Fragile States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 1.3687 0.4099 49.8 
2WFE 1.0979 0.0349 53.4 
CCEP 1.0203 0.0033 86.4 
FD-OLS 1.0279 0.0041 83.2 
FE(inf) 1.0205 0.0027 81.8 
CCEMG 1.0193 0.0017 100 
AMG(i) 1.0240 0.0021 100 
AMG(ii) 1.0269 0.0024 100 
MG 1.1411 0.0440 70.9 
MG(inf) 1.0190 0.0010 99.5 
 
 
POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = Common 
Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; FE(inf) 
= Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG = 
Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 









Table 4.11: Performance Comparisons 
(Case I – Baseline, N=23, T=21, “Non-Fragile States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 0.9631 0.1094 34.1 
2WFE 1.0008 0.0021 92.7 
CCEP 1.0014 0.0018 93.1 
FD-OLS 1.0007 0.0026 88.6 
FE(inf) 1.0020 0.0011 94.8 
CCEMG 1.0018 0.0020 97.3 
AMG(i) 1.0005 0.0020 92.5 
AMG(ii) 1.0012 0.0021 89.5 
MG 1.1238 0.0500 36.7 
MG(inf) 1.0016 0.0011 98.2 
 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = 
Common Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; 
FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG 
= Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 









Table 4.12: Performance Comparisons 
(Case II – Heterogeneous Trends, N=23, T=21, “Non-Fragile States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 0.9705 0.2190 33.1 
2WFE 0.9971 0.0165 89.1 
CCEP 1.0016 0.0033 91.2 
FD-OLS 1.0008 0.0026 89.8 
FE(inf) 0.9998 0.0040 83.1 
CCEMG 1.0017 0.0038 96.0 
AMG(i) 1.0005 0.0020 92.3 
AMG(ii) 1.0021 0.0026 97.5 
MG 1.1238 0.0500 36.7 
MG(inf) 0.9999 0.0042 96.2 
 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = 
Common Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; 
FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG 
= Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 









Table 4.13: Performance Comparisons 
(Case III – Feedback, N=23, T=21, “Non-Fragile States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 0.9631 0.1093 34.0 
2WFE 0.9942 0.0020 92.6 
CCEP 0.9825 0.0021 91.0 
FD-OLS 0.9079 0.0111 39.4 
FE(inf) 0.9896 0.0012 93.5 
CCEMG 0.9785 0.0023 95.1 
AMG(i) 0.9475 0.0048 74.5 
AMG(ii) 0.9448 0.0051 71.0 
MG 1.1089 0.0451 39.7 
MG(inf) 0.9855 0.0013 98.7 
 
 
POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = Common 
Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; FE(inf) 
= Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG = 
Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 









Table 4.14: Performance Comparisons 
(Case IV – Beta Clubs, N=23, T=21, “Non-Fragile States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 2.401 1.9063 0 
2WFE 1.0188 0.0099 87.3 
CCEP 1.0208 0.0040 84.0 
FD-OLS 1.0198 0.0054 82.0 
FE(inf) 1.0220 0.0029 85.0 
CCEMG 1.0233 0.0020 100.0 
AMG(i) 1.0209 0.0027 100.0 
AMG(ii) 1.0262 0.0031 100.0 
MG 1.1453 0.0500 71.0 
MG(inf) 1.0231 0.0011 100.0 
 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = 
Common Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; 
FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG 
= Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 










Table 4.15: Performance Comparisons 
(Case I – Baseline, N=51, T=21, “All States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 0.9603 0.0527 33.6 
2WFE 1.0015 0.0009 92.2 
CCEP 1.0017 0.0008 93.1 
FD-OLS 1.0019 0.0012 88.1 
FE(inf) 1.0014 0.0005 94.1 
CCEMG 1.0019 0.0008 98.0 
AMG(i) 1.0011 0.0009 94.0 
AMG(ii) 1.0018 0.0009 91.8 
MG 1.1257 0.0502 25.6 
MG(inf) 1.0011 0.0005 98.9 
 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = 
Common Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; 
FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG 
= Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 












Table 4.16: Performance Comparisons 
(Case II – Heterogeneous Trends, N=51, T=21, “All States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 0.9755 0.1034 33.9 
2WFE 1.0006 0.0075 88.1 
CCEP 1.0017 0.0016 90.9 
FD-OLS 1.0019 0.0012 89.6 
FE(inf) 1.0021 0.0018 84.5 
CCEMG 1.0016 0.0018 96.6 
AMG(i) 1.0011 0.0009 94.0 
AMG(ii) 1.0016 0.0013 97.1 
MG 1.1257 0.0502 25.6 
MG(inf) 1.0018 0.0020 97.0 
 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = 
Common Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; 
FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG 
= Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 










Table 4.17: Performance Comparisons 
(Case III – Feedback, N=51, T=21, “All States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS 0.9603 0.0527 33.7 
2WFE 0.9944 0.0009 92.1 
CCEP 0.9820 0.0011 88.5 
FD-OLS 0.9086 0.0094 13.4 
FE(inf) 0.9887 0.0006 91.3 
CCEMG 0.9776 0.0013 94.3 
AMG(i) 0.9490 0.0035 57.5 
AMG(ii) 0.9462 0.0038 51.5 
MG 1.1105 0.0453 28.0 
MG(inf) 0.9846 0.0007 97.8 
 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = 
Common Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; 
FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG 
= Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 









Table 4.18: Performance Comparisons 
(Case IV – Beta Clubs, N=51, T=21, “All States”) 
 
 
ESTIMATOR MEAN RMSE 
COVERAGE 
RATE 
POLS -0.0654 1.1272 0.0 
2WFE 0.9959 0.0041 86.7 
CCEP 0.9965 0.0017 84.8 
FD-OLS 0.9975 0.0022 81.2 
FE(inf) 0.9961 0.0012 86.9 
CCEMG 0.9971 0.0008 100 
AMG(i) 0.9997 0.0110 100 
AMG(ii) 0.9999 0.0012 100 
MG 1.1210 0.0502 51.5 
MG(inf) 0.9965 0.0005 100 
 
 
NOTE: POLS = Pooled Ordinary Leasy Square; 2WFE = Two-Way Fixed Effects; CCEP = 
Common Correlated Effect Pooled Estimator; FD-OLS = First Difference Ordinary Least Square; 
FE(inf) = Infeasible Fixed Effect (FE augmented with common unobservable factors); CCEMG 
= Common Correlated Effect Mean Group; AMG = Augmented Mean Group Estimator; MG = 
Mean Group Estimator; MG(inf) = Infeasible Mean Group (MG augmented with common 




4.5  Conclusion 
This chapter examined the performance of standard panel data estimators (such as 
POLS, FE, 2WFE, and FD-OLS) in the presence of slope heterogeneity, cross-sectional 
dependence, non-stationarity of observable and unobservable variables, and endogeneity. I 
compared the performance of these pooled type estimators with more recently developed, mean 
group type estimators such as MG, CCEMG, and AMG.  
All the estimators were assessed using the general experimental design employed in 
Bond and Eberhardt (2013a), henceforth B&E, who graciously provided me their code.  I made 
a number of extensions and modifications to their code for my analysis. I conducted three sets 
of simulation experiments. The first experiment replicated the original paper and extended it 
by adding additional performance metrics for efficiency and coverage rates. The second set of 
experiments reproduced the first set of experiments, but with different panel data dimensions 
(N and T) to better simulate the kinds of datasets I will be analysing in my next chapter. 
The purpose of undertaking these experiments was to identify the “best” estimator(s) 
for analysing the income elasticity of health care expenditures for selected African countries, 
the subject of my next chapter. I conclude on the basis of my experiments that, overall, the 
CCEMG estimator is the “best” on the dimensions of bias, efficiency, and coverage rates.  
However, it was not best in all circumstances.  In particular, coverage rates for the CCEMG 
were distorted when cross-sectional units were characterized by “beta clubs.”  Further, 
CCEMG had poor efficiency performance when the influence of the shared common factor (
tf ,2  in the notation used above) was minimized in Tables 4.19-4.22.  As a result, my analysis 
next chapter will include a selection of other pooled type (POLS and 2WFE) and mean group 













Chapter 5: Health Expenditure and Income in Africa: Evidence 




















 In this chapter, I consider income as a key factor influencing changes in health 
expenditure across countries. Despite the plethora of empirical evidence on the nexus between 
health spending and income as cited in Costa‐Font et al. (2011), most of the studies are for 
developed countries with very few papers on developing nations,  especially African countries. 
In this study, I therefore use a cross-sectional time series dataset for African countries to 
determine the “income elasticity of health expenditure” using newly developed panel data 
estimators (examined in Chapter 4). The outcomes from the simulation experiments in Chapter 
4 are used as a guide in selecting the appropriate econometric methods for testing whether 
health is a “luxury” or a “necessity” good in Africa.  
5.1.2 Overview 
 Health expenditure is a metric that quantifies the current purchases of health goods and 
services for final consumption. The expenditure on health is from both public and private 
sources and pays for medical goods and services, public health and prevention programmes, 
and administration (OECD, 2016). Spending on health is naturally bound by budget constraints 
such as the current and expected income level. Policy makers around the world worry about 
rising health care spending – often for the following reasons. 
First, an increasing share of health spending is financed by the public sector and paid 
through taxes (Gerdtham & Jönsson, 2000a). Raising taxes to finance health care bills can 
escalate concerns among tax payers and also increase the demand for health care services by 
tax payers (Leu (1986). This is particularly pressing in times of increasing budget deficits 
(OECD, 2016).  
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Another issue concerns the relationship between public and private spending levels. 
Bird (1970)  argues that public financing of health care services crowds out private spending 
to the extent that it lowers the overall spending on health. Pryor (1968, p. 171)  also concludes 
that public and private health expenditures are close substitutes. 
As a complication for analytical purposes, health spending is likely to exhibit strong 
path dependence. Increased health expenditures lead to better health outcomes and better 
current health outcomes may, in turn, reduce future health spending (Kleiman (1974, p. 67).  
Also, the stock of health and expenditure on health-augmenting consumption (such as better 
diets, better quality housing, etc.) are positively related to income. The substitution and income 
effects can increase the level of health consumption relative to income. Many studies take this 
view (see Bunn, LeRoux, Reinold, & Surico, 2017; Carroll, 1994; Christelis, Georgarakos, 
Jappelli, Pistaferri, & van Rooij, 2017; Hau & Mishkin, 1982; Roberts, 2000; Selvanathan & 
Selvanathan, 1993).  
Whatever the mechanism, there is general agreement that income is a strong predictor 
of health care spending (Culyer (1988, 1989a, 1989b), Newhouse and Phelps (1974), 
Newhouse (1977) and there is a general consensus that the share of income expended on health 
care services rises as a country’s per capita income increases (Baltagi, Lagravinese, Moscone, 
& Tosetti, 2016; Hall & Jones, 2007). However, there is still conflicting evidence on the degree 
(or magnitude) of the responsiveness of health care expenditures to changes in per capita 
income. Studies reviewed in Culyer (1988), Gerdtham and Jönsson (2000a), and Costa‐Font et 
al. (2011) have examined the income elasticity of health expenditure with the goal of 
establishing whether health is a “luxury” (i.e.,  with income elasticity greater than one) or a 
“necessity” (income elasticity less than one). 
The determination of the income elasticity of health expenditure has two major policy 
implications. First, according to Culyer (1988), if health care is a necessity good, more 
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government involment through financing is encouraged in order to reduce the financial burden 
placed on households, especially in poor countries with low per capita income. If health is a 
luxury good, out-of-pocket spending and private insurance coverage (both as components of 
private health expenditures) should account for a larger share of total health spending and be 
used as a partial subsitute for public healthcare spending to reduce budget deficits. 
Second, ascertaining the size of the elasticity coefficient helps to understand the nature 
of -- and the reasons for -- the demand for healthcare services. According to Newhouse (1977), 
when health care is a luxury good, the demand may relate more to preventation or caring; when 
it is a necessity good, it may reflect curing of life threatening diseases. The latter type is 
common in developing countries  (see Gerdtham & Jönsson, 2000a, p. 22; V. N. R. Murthy & 
A. A. Okunade, 2009).   
A wide range of elasticity coefficients have been reported in the literature. Several 
factors can contribute to the differences in the documented outcomes. These include: biases in 
aggregating components of health expenditure (Costa‐Font et al., 2011), use of different 
datasets (Getzen, 2000), adoption of different econometric methods (Chakroun, 2010; 
Gerdtham & Jönsson, 2000a, p. 20), model misspecification (McGuire, Parkin, Hughes, & 
Gerard, 1993), spurious relationships and wrong modelling of non-stationary variables, cross-
sectionally correlated and cointegrated health-income variables (Baltagi & Moscone, 2010; 
Hansen & King, 1996, 1998; Okunade & Karakus, 2001), assumptions about homogeneity or 
heterogeneity of the elasticity coefficient across countries (Baltagi et al., 2016; Baltagi & 
Moscone, 2010), neglecting to account for unobservable common health shocks (Moscone & 
Tosetti, 2010), and failure to address endogeneity31. These issues are discussed in detail in 
                                                          
31 In recent literature such as Barro (2013) a two to three-way nexus among income, health spending and health 
outcome has been acknowledged but treating one or two of the variables as endogenous is rare.  In this chapter, I 
present a novel approach by using modern panel data estimators to account for endogeneity emanating from health 
expenditure being a predictor of income and health outcomes. Unobservable common health risk factors and 
geographical patterns of diseases across countries constitute another potential sources of endogeneity. The latter 
source is discussed in detail below. 
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subsequent sections and an effort is made to address the problems using novel estimation 
approaches.  
Another important but neglected area is the differential degree of responsiveness of  
private vs. public health expenditure to changes in income. This difference has also contributed 
to the conflicting outcomes regarding whether the income elasticity is greater or less than unity 
(see Gerdtham & Jönsson, 2000a, p. 23). The share of private health expenditure in total 
medical expenditure varies widely across countries. The variation can reflect a country’s level 
of development, income per capita growth, and attitudes towards equity. In countries with 
relatively high incomes (such as the OECD and transitional economies of Europe), there tends 
to be significant government involvement in financing healthcare expenses (Newhouse, 1977), 
compared to low income countries such as India, many Asian countries, and – importantly for 
the purposes of this chapter – countries in Sub-Saharan Africa (see Gerdtham & Jönsson, 
2000a, p. 15).  
5.2 Health and Income in Africa: Stylized Facts 
The African continent is lagging behind in the attainment of health related Millennium 
Development Goals (MDGs) (OECD, 2014). For example, the African region accounts for 
90% of globally reported malaria deaths with the highest incidence among under-5 year-old 
children (WHO, 2014). In 2014, based on World.Bank (2015) estimates for African countries 
(see Table 5.1), the average life expectancy at birth stood at 61.2 years and 50% of the countries 
were below the group average. Africa is dominated by low income countries (see Figure 5.1) 
struggling to mobilise revenue domestically due to high poverty prevalence and deteriorating 
human welfare (see OECD, 2014; WHO, 2014; World.Bank, 2015).  
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Official Development Assistance (ODA) and remittances account for a major share of 
government spending on health care. Estimates from the WHO (2014) Global Health 
Observatory (GHO) indicate that ODA disbursement for health per capita in the African region 
increased by 263% between 2002 and 2010 -- from US$2.7 to US$9.8. Over 50% of the 
disbursement for health in 2010 was committed in MDG 6 - combat of HIV/AIDS, malaria and 
other diseases. These economic and social challenges are more severe for countries faced with 
civil war and political crises. These are countries categorised as fragile states and defined by 
“deep structural economic and political constraints” (Maier, 2010). Some of the analyses in 
this chapter focus on a subset of countries classified as fragile and conflict-affected African 
(FCA) states.  
                                                          
32 http://bit.ly/2mJ1FNZ  
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Across our overall sample (see Table 5.1), 6% of GDP was allocated by the public and 
private sector for health spending in 2014 (THEG). There is a slight difference in the public 
(PHT, 50.3%) and private (OTHE, 34.2%) sector share of total health expenditure, while out-
of-pocket expenditure as a share of total private health spending is around 68.4% (OPRE). 
African countries with higher income spend more on healthcare service provisions (see 
Figure 5.2). Looking beyond income, the amount a particular country spends on medical 
services and the rate at which it grows over time can be the result of economic, social and 
political factors, as well as the financing and organisational structure of the country’s health 
system (OECD, 2015). Some of the plausible factors that explain the presented plot in Figure 
5.2 for sampled African countries are identified and described in subsequent sections.  
Table 5.1: Macroeconomic Indicators of African Countries (2014 Estimates) 
 
No. Country THEG PHT OTHE OPRE GDPG ODA LEX P15 P65 
1 Algeria 7.2 72.8 26.5 97.3 1.8 4.0 74.8 28.2 5.8 
2 Angola 3.3 64.3 24.0 67.0 1.4 9.5 52.3 47.9 2.3 
3 Benin 4.6 49.0 39.1 76.7 3.6 56.2 59.5 42.5 2.9 
4 Botswana 5.4 59.0 5.2 12.7 1.2 44.4 64.4 32.2 3.5 
5 Burkina Faso 5.0 52.3 39.1 81.9 1.0 63.4 58.6 45.8 2.4 
6 Burundi 7.5 52.7 21.0 44.5 1.3 46.1 56.7 44.6 2.5 
7 Cabo Verde 4.8 74.7 22.2 88.0 0.5 445.7 73.1 30.0 4.7 




4.2 49.0 46.2 90.6 -0.9 126.4 50.7 39.4 3.9 
10 Chad 3.6 54.6 39.2 86.3 3.4 28.4 51.6 48.0 2.5 
11 Comoros 6.7 32.9 45.1 67.1 -0.4 95.8 63.3 40.5 2.8 
12 Congo, Dem. Rep. 4.3 36.9 38.8 61.5 5.6 31.7 58.7 46.2 3.0 
13 Congo, Rep. 5.2 81.8 17.5 96.0 4.2 23.4 62.3 42.6 3.6 
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No. Country THEG PHT OTHE OPRE GDPG ODA LEX P15 P65 
14 Cote d'Ivoire 5.7 29.4 50.8 71.9 5.9 41.4 51.6 42.7 3.0 
15 Djibouti 10.6 63.9 35.8 99.2 4.6 186.9 62.0 33.0 4.1 
16 Egypt, Arab Rep. 5.6 38.2 55.7 90.1 0.0 39.2 71.1 33.0 5.2 
17 Equatorial Guinea 3.8 77.1 20.1 87.9 -3.6 0.7 57.6 39.4 2.9 
18 Eritrea 3.3 45.8 54.2 100.0 --- --- 63.7 --- --- 
19 Ethiopia 4.9 58.7 32.3 78.1 7.5 36.5 64.0 42.1 3.5 
20 Gabon 3.4 68.4 21.9 69.2 2.0 65.7 64.4 37.3 5.2 
21 Gambia, The 7.3 68.7 17.0 54.5 -2.3 51.0 60.2 46.3 2.3 
22 Ghana 3.6 59.8 26.8 66.8 1.6 41.8 61.3 38.9 3.4 
23 Guinea 5.6 48.5 45.3 88.0 -2.3 45.7 58.7 42.7 3.1 
24 Guinea-Bissau 5.6 20.5 49.5 62.2 0.1 60.3 55.2 41.0 3.1 
25 Kenya 5.7 61.3 26.1 67.4 2.6 58.8 61.6 42.1 2.8 
26 Lesotho 10.6 76.1 16.5 69.0 3.2 48.8 49.7 36.3 4.2 
27 Liberia 10.0 31.5 30.7 44.8 -1.7 169.2 60.8 42.6 3.0 
28 Libya 5.0 73.5 26.5 100.0 ---- 33.1 71.7 29.7 4.5 
29 Madagascar 3.0 48.4 41.4 80.2 0.5 24.6 65.1 42.0 2.8 
30 Malawi 11.4 52.7 10.6 22.5 2.5 55.5 62.7 45.4 3.4 
31 Mali 6.9 22.9 47.7 61.8 3.9 72.2 58.0 47.5 2.6 
32 Mauritania 3.8 49.6 43.8 87.0 1.7 64.8 63.0 40.3 3.2 
33 Mauritius 4.8 49.2 46.4 91.3 3.6 38.6 74.2 19.8 9.1 
34 Morocco 5.9 33.9 58.4 88.3 1.1 65.7 74.0 27.3 6.1 
35 Mozambique 7.0 56.4 9.5 21.8 4.5 77.0 55.0 45.5 3.3 
36 Namibia 8.9 60.0 7.2 17.9 4.0 93.0 64.7 36.9 3.5 
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No. Country THEG PHT OTHE OPRE GDPG ODA LEX P15 P65 
37 Niger 5.8 55.2 34.3 76.7 2.8 47.8 61.5 50.4 2.6 
38 Nigeria 3.7 25.1 71.7 95.7 3.5 13.7 52.8 44.1 2.7 
39 Rwanda 7.5 38.1 28.1 45.4 4.5 90.3 64.0 41.4 2.7 
40 
Sao Tome and 
Principe 
8.4 43.2 11.2 19.7 4.0 206.7 66.4 42.9 3.2 
41 Senegal 4.7 51.8 37.3 77.4 1.1 75.2 66.4 43.8 3.0 
42 Seychelles 3.4 92.2 2.3 30.0 1.6 106.1 73.2 23.2 6.8 
43 Sierra Leone 11.1 17.0 61.0 73.4 2.3 139.7 50.9 42.7 2.7 
44 Somalia --- --- --- --- --- 105.1 55.4 46.9 2.8 
45 South Africa 8.8 48.2 6.5 12.5 0.0 19.6 57.2 29.5 5.0 
46 South Sudan 2.7 41.5 54.2 92.6 -0.6 163.3 55.7 42.4 3.5 
47 Sudan 8.4 21.4 75.5 96.1 0.5 22.0 63.5 40.9 3.3 
48 Swaziland 9.3 75.7 10.3 42.4 1.3 67.0 48.9 37.6 3.5 
49 Tanzania 5.6 46.4 23.2 43.3 3.6 50.7 64.9 45.2 3.2 
50 Togo 5.2 38.4 46.2 75.1 3.1 29.1 59.7 42.4 2.8 
51 Tunisia 7.0 56.7 37.7 87.1 1.8 84.6 74.1 23.3 7.5 
52 Uganda 7.2 24.9 41.0 54.6 1.8 42.9 58.5 48.3 2.5 
53 Zambia 5.0 55.3 30.0 67.2 1.5 62.6 60.0 46.1 2.9 
54 Zimbabwe 6.4 38.3 35.9 58.3 1.5 48.9 57.5 41.6 3.0 
 Average 6.0 50.3 34.2 68.4 2.0 70.9 61.2 39.9 3.6 
NOTE: THEG = Health expenditure, total (% of GDP); PHT = Health expenditure, public (% of total health 
expenditure); OTHE = Out-of-pocket health expenditure (% of total expenditure on health); OPRE = Out-of-pocket 
health expenditure (% of private expenditure on health); GDPG = GDP per capita growth (annual %); ODA = Real 
net official development assistance and official aid received per capita (constant 2013 US$); LEX = Life expectancy 
at birth, total (years); P15 = Population ages 0-14 (% of total); P65 = Population ages 65 and above (% of total).  




Figure 5.233: Total Health Expenditure vs. Income for African Countries (2014 Estimates) 
 
 
As discussed in the next section, this study contributes to the existing literature on the 
determinants of health care expenditure in a number of ways. This includes: (i) examining the 
income elasticity of public and private healthcare expenditure in a baseline framework; (ii) 
assessing the robustness of the baseline analyses to changes in model specification, estimation 
methods, and datasets decomposed by country’s fragility34 status, income group35, and 
region36.  
5.3 Empirical Review 
Numerous studies have been conducted on the health-income nexus over the past four 
decades, following the seminal contributions by Grossman (1972a) and Newhouse and Phelps 
(1974). The macro-level attention paid to the relationship between health expenditure and 
income, mostly for OECD countries, can be traced back to earlier works of  Kleiman (1974) 
and Newhouse (1977). Income has been one of the key factors believed to explain variation in 
                                                          
33 http://bit.ly/2n8Zb8K  
34 Classification based on OECD (2014) Fragile States Index 
35 World Bank (2017) income group classification 




the level of health expenditure across countries (Costa‐Font et al., 2011; Gerdtham & Jönsson, 
2000b; Kea, Saksenaa, & Hollyb, 2011; V. N. R. Murthy & A. A. Okunade, 2009).  
Previous studies can be categorised into three major groups. The first group of studies 
(Barros, 1998; Clemente, Marcuello, Montañés, & Pueyo, 2004; Farag et al., 2012; Gerdtham 
& Jönsson, 1992; Getzen, 2000; Hitiris, 1997; Jaunky & Khadaroo, 2008; Liu, Li, & Wang, 
2011; Mehrara, Musai, & Amiri, 2010; Newhouse, 2006) corroborate the “luxury good 
hypothesis” of income elasticity of health expenditure greater than one. The second group 
(Baltagi & Moscone, 2010; Å. G. Blomqvist & R. A. Carter, 1997; Culyer, 1988; Di Matteo, 
2003; Farag et al., 2012; Hitiris & Posnett, 1992; Lv & Zhu, 2014; Parkin, McGuire, & Yule, 
1987; Sen, 2005) conclude that health is a “necessity good” with income elasticity less than 
one. This implies that health expenditure responds to changes in income less than 
proportionally. The last strand of studies (Gbesemete & Gerdtham, 1992; Hitiris & Posnett, 
1992; Lago-Peñas, Cantarero-Prieto, & Blázquez-Fernández, 2013; Murthy & Ukpolo, 1994) 
conclude that the response of health expenditure to income change is proportional, i.e., income 
elasticity is unity.  
In a meta-analysis investigation by Costa‐Font et al. (2011) for 167 studies, income 
elasticity ranging from 0.4 to 0.8 was found, refuting the hypothesis that health care is a luxury 
good. They concluded that heterogeneity of empirical results among the 167 studies for 
developed countries might be attributed to publication selection and data aggregation biases. 
Glaeser, Sacerdote, and Scheinkman (2003) had earlier noted that most of the evidence 
confirming the “luxury good hypothesis” is based on aggregate or national level datasets. This 
makes it difficult to draw inference about sectoral, sub-regional or individual behaviour.  
Disaggregation of health expenditure into public and private sector components is 
gradually receiving attention in the literature. Empirical results of such disaggregated analyses 
have been conflicting. Using cross-sectional data, Schieber and Maeda (1999) found the two 
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forms of expenditure to be income elastic but more so for public health care spending. 
Musgrove, Zeramdini, and Carrin (2002) reported that the income elasticity of government 
health expenditure is greater than one, while it is less than one for out-of-pocket (private) health 
expenditure. Using panel data for 143 countries from 1995 to 2008, Kea et al. (2011) found no 
significant difference in the income elasticity of public and private health expenditure among 
developing nations. Contrary to previous findings,J. A. Khan and Mahumud (2015), using 
panel data for nine South-East Asian Regional (SEAR) countries for the period 1995-2010, 
found public health expenditure to be income inelastic and private health expenditure elastic. 
In conclusion, the empirical evidence on the relationship between income and health spending 
categorised into public and private has been limited in scope and inconsistent.  
Furthermore, the dearth of studies on the relationship between total healthcare 
expenditure and income for African countries is striking. This may be due to data availability 
as most previous studies employed cross-sectional data (Gbesemete & Gerdtham, 1992; 
Murthy, 2004; V. N. R. Murthy & A. A. Okunade, 2009; Okunade, 2005) and very few used 
cross-sectional time series data (Jaunky & Khadaroo, 2008; Lv & Zhu, 2014). All previous 
studies on Africa except for Jaunky and Khadaroo (2008) conclude that health is a necessity 
rather than a luxury good (see Table 5.2). Jaunky and Khadaroo (2008) found public health 
expenditure to be a luxury good and private health expenditure a necessity good.37 
                                                          
37 An extensive review of previous studies on the income elasticity of health expenditure both in developed and 






Table 5.2: Coefficients and Nature of Healthcare Services in Africa (1984-2009) 
 





Categorisation of  
   Health Expenditures 
Estimated  
Income elasticity 
Gbesemete and Gerdtham (1992) Cross-sectional  1984 26 Necessity 0.885 – 1.069 
Murthy (2004) Cross-sectional  2001 44 Unity 1.11 
Okunade (2005) Cross-sectional  1995 26 Necessity 0.46 – 0.70 
V. N. R. Murthy and A. A. 
Okunade (2009) 
Cross-sectional  2001 30 Necessity 1.089 – 1.118 
Jaunky and Khadaroo (2008) Panel 1991-2000 28 
Luxury for public expenditure  
Necessity for private expenditure 
Public (0.929 – 1.21); 
Private (0.661 – 0.909) 
Lv and Zhu (2014) Panel 1995-2009 42 Necessity 0.758 – 0.988 
 
SOURCE: Author’s compilation. 
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In this study, updated datasets are employed to identify the determinants of health 
expenditures in African. To the best of my knowledge, this study is the first to examine the 
income-health expenditure relationship for the most vulnerable and highly remittance 
dependent countries in Africa. These countries are characterized by fragility and long-term 
conflicts (OECD, 2014). The continent has fallen victim to political instability, civil war, 
devastating violence, religious extremism and xenophobia over the years (see King & 
Lawrence, 2005 -for a vivid account of civil war and conflicts in Africa from 1960s to early 
2000s). These have made it impossible for most of the countries in the region to experience 
sustainable and inclusive growth. The nonexistence of growth accompanied by poverty 
reduction, human capital development and good governance has made Africa a fragile region 
(Arbache & Page, 2010; Maier, 2010).  
5.4 Theoretical Framework for Model Specification 
There is no formal economic theory to predict the relationship between per capita 
healthcare expenditure and per capita income (H. N. Khan et al., 2016) or non-income 
determinants of health spending (Okunade, 2005). Leu (1986) made an attempt to provide a 
theoretical link between income and public-private mix spending through his public choice 
framework but it is largely ad hoc. Modelling of the inverse relationship (health expenditures 
 income) is much better established. In the area of economic growth, there is a well-
recognised theory that suggests that investment in health as a component of human capital 
promotes economic growth (Barro & Sala-i-Martin, 1995). An increase in the stock of physical 
and human capital determined by health expenditure may cause per capita GDP to rise (Solow, 
1956).  
Empirically, Fan and Savedoff (2014, p. 114) noted that income is the only factor 
agreed by most health economists to have a highly significant impact on health spending. 
Reviewing other previous studies (such as Chernew & Newhouse, 2012; Garibaldi, Martins, & 
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van Ours, 2010; Hall & Jones, 2007; Martins, Joaquim, & Bjørnerud, 2006; Murthy & 
Okunade, 2016; Okunade & Murthy, 2002), additional key determinants of health spending 
include: (i) changes in medical technology and practice; (ii) elderly population growth; (iii) 
rising prices; and (iv) changes in the financing and management of health care. Some studies 
(see e.g. Baltagi & Moscone, 2010; Chakroun, 2010; Di Matteo, 2000, 2003, 2005; Dreger & 
Reimers, 2005; Gerdtham, Søgaard, Andersson, & Jönsson, 1992; Ke et al., 2011; H. N. Khan 
et al., 2016; J. A. Khan & Mahumud, 2015; Moscone & Tosetti, 2010; Murthy & Okunade, 
2000; V. N. R. Murthy & A. A. Okunade, 2009; Murthy & Okunade, 2016; Rivera & Currais, 
1999; Roberts, 1999; Sen, 2005) expand this list to also include: population per number of 
medical personnel; population age structure (under 5, under 15, and 15-64); urbanization; 
payment system; political transition; the public finance share of GDP; government budget 
deficits; level of health research and development spending; official development assistance; 
income inequality; public corruption; political conflicts and internal discords; number of beds, 
disease patterns (i.e. prevalence of highly infectious diseases such as HIV, malaria, 
tuberculosis, diabetes, hypertension and cancer); life expectancy; maternal mortality rate; 
infant mortality rate; and the literacy rate.  
Based on the factors identified as important in previous studies of developing countries, 













   (5.1) 
where i 1, 2, …, N ; t 1, 2, …, T ; i  indexes the cross-section dimension (i.e. individual 
African countries); and t  denotes the time period (i.e., annual observations  from 1995 to 
2014). In country i at time t : itHCE is real per capita health expenditure. itHCE  is a composite 
of real per capita: total ( itTHE ), government ( itGHE ) and out-of-pocket health expenditures (
itOPE ); itGDP  is real per capita gross domestic expenditure as a proxy for real per capita 
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income; itLEX  is life expectancy at birth (years); itINM  is infant mortality rate at birth; itP65  
is the percentage of the population aged 65 and above; itP15  is the share under 15 years of age; 
itODA  is per capita real net official development assistance and official aid received; itGFC  is 
total governmental expenditure as a share of GDP (a proxy for government fiscal capacity);   
is the common intercept across groups; i is the unobservable country-specific effect; it  is the 
error term. The composite one-way error component is defined as: itiitu   ; 1 is the slope 
coefficient of GDP and is the income elasticity coefficient of health expenditures38; 72  are 
parameters for the non-income determinants of healthcare expenditure. All the variables in 
Equation (5.1) are expressed in natural logarithms. 
5.5 Variables Description and Theoretical Expectations 
 Government and private health expenditures are the two major components of total 
healthcare expenditure based on the sources of financing medical expenses. According to Ke 
et al. (2011), the government component of health expenditure consists of payment 
contributions made through all forms of taxation and insurance (either compulsory or 
voluntary). Private health expenditure consists of private insurance and out-of-pocket 
payments. The latter is made by patients at the point of receiving health care services. Each of 
the components may have a different relationship with the determinants or explanatory 
variables incorporated in model (5.1). For instance, government fiscal capacity measured as a 
ratio of total government expenditure to GDP is a metric that reflects the size of government 
resources. It may increase government health expenditure while reducing out-of-pocket 
expenditure. Also, Official Development Assistance can reduce household burden by financing 
                                                          
38 
1 represents the percentage change in health expenditure resulting from 1% change in income. Health care 
expenditures are luxury or necessity if, respectively, 11  and 11  , indicating that health expenditures 
increase faster or slower than income (Costa‐Font et al., 2011).  
135 
 
private health consumption at the point of receiving treatments, while increasing the level of 
resources available to the government to finance healthcare services.  
 The dependent variables according to the World Bank (2017) definition are described 
as follows:  
Total Health Expenditure 
Total health expenditure is the sum of per capita public and private health expenditures. 
It covers the provision of health services (preventive and curative), family planning activities, 
nutrition activities, and emergency aid designated for health. It does not include provision of 
water and sanitation. 
Government Health Expenditure 
Public health expenditure consists of recurrent and capital spending from government 
(central and local) budgets, external borrowings and grants (including grants and aid from 
international agencies and nongovernmental organizations), and social (or compulsory) health 
insurance funds. 
Out-of-Pocket Expenditure 
Out of pocket expenditure is any direct outlay by households, including gratuities and 
in-kind payments, to health practitioners and suppliers of pharmaceuticals, therapeutic 
appliances, and other goods and services whose primary intent is to contribute to the restoration 
or enhancement of the health status of individuals or population groups. 
The mechanism of impact of each of the explanatory variables on health expenditure as 
documented in previous literature is explained as follows. 
GDP as a Measure of Income 
In the context of modelling health expenditure and income in Africa, it is expected that 
the income elasticity coefficient will be less than unity as heath care is demanded more for 
curative reasons and less for prevention. This is consistent with previous findings (Gbesemete 
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& Gerdtham, 1992; Lv & Zhu, 2014; V. N. R. Murthy & A. A. Okunade, 2009; Okunade, 2005) 
for Africa within the last two and half decades. 
Life Expectancy 
Life expectancy can serve as an indicator to proxy quality of life (Hall & Jones, 2007), 
advancement in medical technology (Dreger & Reimers, 2005) and changes in disease patterns 
(Ke et al., 2011). For three decades in the health economics literature, technological progress39 
has been identified to be a positive and significant driver of health expenditure (e.g. A. G. 
Blomqvist & R. A. L. Carter, 1997; Dreger & Reimers, 2005; Fan & Savedoff, 2014; Hall & 
Jones, 2007; Ke et al., 2011; Murthy & Okunade, 2016; Roberts, 1999). Investment in medical 
technology and the use of advanced medical equipment can improve quality of life and 
longevity. On the other hand, life expectancy may reflect the pattern of prevalent diseases in a 
country. In countries where there is high prevalence of infectious diseases (like tuberculosis, 
malaria and HIV), life expectancy at birth is often low. Low average life expectancy can, in 
turn, drive the need to demand more healthcare services to improve the current stock of health, 
thus increases spending on health. Ke et al. (2011) also noted that life expectancy can determine 
the size of external aid a country receives for disease programmes. For the purposes of this 
study, life expectancy is therefore expected to increase health expenditure in Africa.  
Infant Mortality Rate 
Like life expectancy, infant mortality is another proxy for quality of life and medical 
technological advancement (Dreger & Reimers, 2005). In Africa, rising infant mortality rate is 
expected to increase investment in health technologies and development programmes to 
                                                          
39 Other measures of medical technological progress that have been considered for empirical analysis are: surgical 
procedure and number of specific medical equipment (Baker & Wheeler, 1998; T. P. Weil, 1995); infant mortality 
(Dreger & Reimers, 2005); time index (Gerdtham & Löthgren, 2000); time-specific intercepts (Di Matteo, 2005); 
and health research and development (R&D) expenditure (Murthy & Okunade, 2016). 
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achieve one of the health related Millennium Development Goals (MDGs)40 and this might 
increase demand for healthcare services. 
Population Structure 
Population structure is another factor often used in the literature to explain changes in 
health care expenditure. The commonly considered age groups among the few documented 
African studies are population under 15 (e.g. Gbesemete & Gerdtham, 1992) and over 65 years 
of age (e.g. V. N. R. Murthy & A. A. Okunade, 2009). Both of these metrics have a significant 
positive relationship with healthcare expenditure (e.g. Di Matteo, 2005; Hitiris & Posnett, 
1992; H. N. Khan et al., 2016; Lv & Xu, 2016; Moscone & Tosetti, 2010; Murthy & Okunade, 
2016; O'Connell, 1996; Sen, 2005).  
Official Development Assistance 
Most African countries are recipients of significant foreign aid and Official 
Development Assistance - often designated for addressing health-related issues and creating 
health programmes. In Africa, ODA can either account for a large share of the government 
health expenditure or may replace it totally. However, the weak governance and institutional 
framework in Africa, and the possibility of foreign aid being diverted from public investment 
to non-health consumption, make it difficult to account for the impact and effectiveness of 
ODA on health (Carlsson, Somolekae, & Van de Walle, 1997; H. A. Khan, 1998; Okunade, 
2005).  Ceteris paribus, net real ODA is expected to significantly increase health expenditure 
since it is the real source of inflow for health development in Africa. At the same time, its effect 
on out-of-pocket expenditure may be negative or insignificant because it is expected to reduce 
the financial burden on households.  
                                                          




The ODA data used in this study comprises external finance for health and non-health 
programmes and projects. Due to undocumented utilization of ODA funds and unavailability 
of data for health-related ODA, it is difficult to precisely determine the effect of ODA in driving 
health spending for Africa countries.  
Government Fiscal Capacity 
 Government fiscal capacity is the ratio of total government expenditure to GDP. It is 
an indicator of available resources at the disposal of the government. It is a metric often used 
to determine if a country’s health system development is a priority in a particular fiscal year 
depending on its relative share compared to other social and economic sectors. At the output 
level, public budget for health expenditure is expected to increase as more resources become 
available (Ke et al., 2011). There is a possibility of unconditioned ODA to increase the size of 
government total expenditure, then affect fiscal capacity for health. Like ODA, total 
government expenditure as a share of GDP is expected to reduce out-of-pocket expenditure. 
To the best of my knowledge, there is no study for African countries that models government 
fiscal capacity to explain changes in all forms of health care expenditure. Another closely 
related metric found in studies (Di Matteo, 2003, 2005) for developed countries is government 
revenue as a share of income.  
5.6 Data and Methods 
 The methodology for this study consists of five key sections: data description and 
sources; estimation strategy; pre-estimation diagnostic tests; post-estimation tests; and 
robustness checks. 
 
5.6.1 Data Description and Sources 
 A description of the variables required to conduct the baseline analyses and robustness 
checks is provided in Table 5.4. 
139 
 
Table 5.4: Data Description and Sources 
 
Notation Description Source 
THE Real Total Health expenditure per capita; WDI (2017) 
GHE Real Public Health expenditure per capita; WDI (2017) 
OPE Real Out-of-pocket health expenditure per capita; WDI (2017) 
GDP Real GDP Per Capita WDI (2017) 
LEX Life expectancy at birth, total (years); WDI (2017) 
INM Infant mortality (per 1,000 live births) WDI (2017) 
P65 Population aged 65 and above (% of total population). WDI (2017) 
P15 Population aged 0-14 (% of total population); WDI (2017) 
GFC Total Government Expenditure as a share of GDP WDI (2017) 
ODA 
Real Net Official Development Assistance (ODA) and 
Official Aid Received Per Capita; 
WDI (2017) 
NOTE: WDI = World Development Indicators 
 
5.6.2 Estimation Strategy and Baseline Model Specification 
It is a standard approach in econometrics literature to estimate specifications like 
Equation (5.1) using a fixed effect or random effect method (Baltagi, 2013; Greene, 2011; 
Wooldridge, 2010) if the data are pooled and the strict classical assumptions are maintained. 
However, severe biases can arise for pooled observations by assuming homogenous slope 
coefficients. Such an assumption is highly restrictive in a panel with heterogeneous 
units/individuals (Ando & Bai, 2015; Baltagi & Pesaran, 2007; Lin & Ng, 2012; Pesaran et al., 
1999; Pesaran & Smith, 1995).  
Evidence from Monte Carlo experiments by Robertson and Symons (1992) argues 
against homogeneous estimates through data pooling. Likewise, Pedroni (2007) shows that 
accounting for heterogeneity is essential to explain differences in observed patterns across 
countries. In Baltagi and Moscone (2010) similarly acknowledge that in the presence of 
heterogeneous intercepts across groups, the validity of hypotheses of homogenous income 
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elasticities and trend (as a proxy for technological advancement) are highly questionable. Also, 
Zerihun, Cunado, and Gupta (2017) reported evidence of asymmetric behaviour in modelling 
healthcare expenditure and income. That is, each country’s unique characteristics are reflected 
in the variables and a standard linear model is inadequate. To incorporate heterogeneity into 
my analysis of the health spending-income nexus for African countries, an extended version of 
Equation (5.1) is specified as follows: 
ititmimit uXHCE  ,,         (5.2) 
immim ,,            (5.3) 
ittiiit fu            (5.4) 
ii             (5.5) 
itmtnminmtmimtmimimitm vffgx ,,,,1,1,,,, ...        (5.6) 
ttt ff   1          (5.7) 
ttt gg   1          (5.8) 
where i 1, 2, …, N ; t 1, 2, …, T ; m 1, 2, …, k ; and tmt ff . ; im,  is a k  x 1 vector of 
slope coefficients of k  number of explanatory variables that vary across countries (i.e. 
heterogeneous);  im,  follows a random coefficients process as defined in Equation (5.3); m  
is the common slope vector and im,  is a group-specific random term; itu  is the composite 
error term in the multifactor residual model (5.4) employed to model cross-sectional 
dependence41; i  is the unobservable group-specific fixed effects; tf  is the time-variant 
                                                          
41 The multifactor error model can also be used to study common macroeconomic shocks across groups such as 
the global financial crisis or oil price shocks. Also, it provides a framework that allows for heterogeneous 
responses to “common shocks” through a heterogeneous factor loading, i  (Baltagi, 2013, p. 287; Moon & 
Perron, 2004) and accommodates a complex covariance structure (Hsiao & Pesaran, 2004). 
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unobserved common factor with heterogeneous factor loading, i , and it can follow a non-
stationary process as expressed in Equation (5.7). The factor loading, i , follows a random 
coefficient process as shown in Equation (5.5); it  is the idiosyncratic error assumed to be 
independently distributed across groups ( i  ), tf , and itx  with zero mean and constant 
variance.  
In Equation (5.6), itmx , are the k  observable explanatory variables: itGDP , itLEX , 
itINM , itP65 , itP15 , itODA and itGFC  as specified in Equation (5.1). It is expressed as a linear 
function of: (i) a country specific fixed effect, im, ; (ii) time-variant unobserved common 
factors tmg , and tmf ,  with respective heterogeneous factor loadings of im, and im, for k  
explanatory variables; and (iii) an idiosyncratic error term itv  assumed to be independent and 
identically distributed. The common unobservable factors tf  and tg  are potentially non-
stationary ( 1 , 1 ) as shown in Equations (5.7) and (5.8).  
The factors model (5.4) is adopted to account for unobservable risk factors associated 
with health spending (Baltagi & Moscone, 2010) such as geographic patterns42 of diseases 
induced by environmental factors; diet; lifestyle (Haining, 2003); border proximity; intra-
continental migration; unobservable heterogeneous effects of fragility, conflicts and civil wars 
on health care spending; inter-dependent health policy programmes; and health reforms. These 
factors can induce unobservable cross-sectional correlation in the empirical model set-up43 
(Equations 5.2 – 5.8). This framework has been recently used in a number of high profile 
                                                          
42 The differential geographic concentration of diseases (such as malaria, polio, tuberculosis and HIV/AIDS that 
are common in Africa) is a plausible contributor to the variation in health expenditure across countries and a 
determinant of foreign aid size to be received by the African countries.  
43 It is essential to note that the highlighted factors are common to these groups of countries but not identical 
across countries.  
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studies (in Baltagi & Moscone, 2010; Bond & Eberhardt, 2013a; Eberhardt, Helmers, & 
Strauss, 2013; Eberhardt & Presbitero, 2015; Eberhardt & Teal, 2012, 2013a, 2013b, 2014; 
Kapetanios et al., 2011; Pesaran, 2006).   
It is clear from the empirical model set-up that the unobservable common factors tf  
affect the composite error term  itu  (Equation (5.4)) and the k  vector of explanatory variables 
itmx ,  (Equation (5.6)). This yields two main effects: (i) the unobservable common shocks tf  
affect health care expenditure ( itHCE ) through the multifactor error model (Equation (5.4)) 
and a set of exogenous variables (Equation (5.6)); and (ii) it induces endogeneity through 
correlation between itmx ,  and itu . The latter makes it difficult to identify the slope coefficients 
im,  from the heterogeneous factor loadings i  and im,  (Eberhardt & Teal, 2012; Kapetanios 
et al., 2011). Comparatively, the empirical framework adopted here is different from the model 
set-up of Equation (5.1) in three ways: (i) heterogeneous effects of the regressors and 
unobserved common factors on health care expenditure; (ii) potential non-stationarity of the 
observables ( itHCE  and itmX , )  and unobservables ( tf  and tg ); and (iii) endogeneity
44 of the 
explanatory variables induced by the common factors. It is conventional in the literature to 
estimate the extended empirical model framework with respect to the first feature alone. This 
can be achieved using Swamy (1970) Random Coefficients Model estimation method to obtain 
a weighted average of the panel-specific OLS estimates. Also, the Pesaran and Smith (1995) 
Mean Group estimator can be applied by estimating country specific OLS and taking the simple 
average of all the countries’ estimates. Unlike the Swamy’s RCM method, the mean group 
estimator is super consistent if the regressors are I(1) (Pesaran & Smith, 1995). The MG 
                                                          
44 Other sources of endogeneity are identified and described under the introductory section of this chapter.. 
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estimator has been found to perform poorly under the considered set-up as demonstrated in 
Chapter 4 using Monte Carlo simulation.  
However, the above two estimators (RCM and MG) ignore cross-sectional dependence 
and a multifactor error structure. To implement the set-up empirically with all its potential 
features ( [i], [ii] and [iii]), the estimators capable of accounting for the issues are: the Common 
Correlated Effects Mean Group estimator by Pesaran (2006) and the Augmented Mean Group 
estimator by Eberhardt and Teal (2012) and Bond and Eberhardt (2009). In the set-ups 
considered in Chapter 4, CCEMG was found to perform well and AMG was generally less 
effective in addressing endogeneity. In this chapter, CCEMG is used for estimating the baseline 
model, while AMG is used for robustness checks. 
The CCEMG estimation procedure follows two steps. The first step involves estimating 
country-specific regressions with additional covariates - tLRHEPC  and  tmx , - as proxies for 
the unobserved common factors tf . The second step consists of obtaining the simple average 








(for more details, see Pesaran, 2006).  
The AMG estimator follows a three-step approach. The first step requires estimation of 
the pooled OLS regression in first difference augmented with T-1 year dummies. The estimated 
coefficients (

t̂ , known as “common dynamic process”) on the differenced year dummies are 
obtained. They represent the estimated cross-sectional averages of the evolution of 
unobservables over time. Second, N group-specific regressions of Equation (5.2) augmented 
with 

t̂  and heterogeneous linear trends are estimated. Finally, an average of the estimated 







ˆˆ   (for an extensive discussion, see 
Bond & Eberhardt, 2013a). Both CCEMG and AMG follow the MG approach in determining 
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the average slope coefficient of individual group estimates.  As demonstrated in Chapter 4, the 
two estimators are desirable for large panels in the presence of parameter heterogeneity, serial 
and cross-sectional correlation. 
A test of slope homogeneity was performed as a robustness check using the test statistic 
suggested by Swamy (1970). The test examines the difference between group-specific OLS 
estimate of the slope coefficient, while ignoring the panel data structure and the matrix-
weighted average of the group-specific OLS estimates (see Johnston and DiNardo (1997) for 
details).  
On the basis of the described estimation framework adopted for this study, model (5.1) 














The linear time trends ( trend ) incorporated in model (5.9) is used as a proxy for 
medical technological progress (A. G. Blomqvist & R. A. L. Carter, 1997; Di Matteo, 2005; 
Gerdtham & Löthgren, 2000; Okunade & Murthy, 2002; Roberts, 1999), and changes in 
medical practices and innovations over time (Ke et al., 2011). To the best of my knowledge, 
no panel study for African countries has ever made an attempt to model medical technical 
progress for explaining the determinants of health expenditure. Also, despite the plethora of 
empirical research in this area for developed countries, as far as I know, no existing OECD 
studies (e.g. Baltagi & Moscone, 2010; De Mello-Sampayo & De Sousa-Vale, 2014; Moscone 
& Tosetti, 2010) use the heterogeneous trends framework to examine the relationship between 
health expenditure and income. The identified gaps (for African and OECD studies) are filled 
in this study by estimating the baseline model (5.9) with heterogeneous ( 8,i ) linear time trends 
 trend . 
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For Equation (5.9), 1,i  is the country-specific income elasticity of healthcare 
expenditure; and 72, i are the heterogeneous parameters for the set of explanatory variables as 
previously defined. All other parameters follow the heterogeneous model set-up framework 
(5.2 – 5.8) described above. 
5.6.3 Pre-Estimation Diagnostic Tests 
5.6.3.1  Testing for Cross-Sectional Dependence 
As argued throughout this thesis, the presence of cross-sectional correlation in residuals 
has severe implications for standard panel data estimators’ (such as POLS, RE, and FE) 
efficiency and consistency attributes. This study therefore tests for cross-sectional correlation 
of variables in the empirical model (5.2). Baltagi and Moscone (2010, p. 807) emphasise the 
need to do so using Pesaran’s (2004) procedure. Due to potential inconsistency in Pesaran’s 
(2004) CD test for large N, another alternative is to employ the bias-adjusted variant of Breusch 
and Pagan (1980) Lagrange Multiplier (BALM) test statistic developed by Pesaran, Ullah, and 
Yamagata (2008).  
The BALM test has desirable finite sample properties, successfully controls for size 
and maintains appropriate power when the regressors are exogenous and errors are normal. 
However, the BALM test statistic is only valid for static models unlike Pesaran’s (2004) CD 
test statistic that extends to dynamic models. Also, the BALM test requires a strongly balanced 
panel and can only be used as a post-estimation test of error cross-sectional independence. 
Pesaran’s (2004) CD test is valid for pre and post estimation tests. In this study, the Pesaran’s 
(2004) CD test is used for pre-estimation diagnostic checks and to justify the need to use the 
recently developed panel data estimators. 
5.6.3.2  Testing for Panel Unit Root 
The Fisher’s combined p-values test proposed by Maddala and Wu (1999) is a 
heterogeneous Panel Unit Root Test and a first generation test. The test combines p-values 
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from individual specific unit root models to test for non-stationarity in panel data. Unlike the 
Im et al. (2003) (henceforth, IPS) PURT, Fisher’s test uses different lag lengths for individual 
Augmented Dickey-Fuller regressions and does not require a balanced panel. Maddala and Wu 
(1999) improve the power of the Fisher’s test with bootstrap-based critical values (Baltagi, 
2013, p. 283). This combined test is found to be superior to the IPS test and Levin, Lin, and 
Chu (2002) (henceforth, LLC) PURT (Maddala, Wu, & Liu, 2000), and performs better when 
N is small (Choi, 2001). For the purpose of this chapter, the Fisher’s PURT is the only first 
generation test considered to examine the stationarity of the incorporated series in Equation 
(5.1).45  
The restrictive assumption of cross-sectional independence of individual time series 
underlying first generation PURTs (see Baltagi and Kao (2000) for an extensive review) limits 
their size and power performance. Therefore, to account for cross-sectional dependence, 
“second generation” PURTs (with different residual factor structures) have been developed 
(Breitung & Pesaran, 2008). Of interest to this study is the Pesaran (2007) cross-sectionally 
augmented Im, Pesaran and Shin (2003) (henceforth, CIPS) PURT. The test is based on the 
augmented individual cross-section ADF (CADF) regressions of ity  with cross-section 








1 and ty  (to account for 
residual cross-sectional dependence) and lagged first difference of the individual series, stiy  ,
, sty  , for s 1, 2, …, to deal with likely residuals’ serial correlation (Pesaran, 2007; Pesaran, 
Smith, & Yamagata, 2013). The CIPS test statistic is the simple average of the individual 







. Using Monte Carlo experiments, Pesaran 
(2007) shows that the CIPS test has desirable small sample properties in the presence of a single 
                                                          
45 Other first generation PURTs (such as Levin et al. (2002), Breitung (2001) and Hadri (2000)) require a 
strongly balanced panel that is not available for this study. 
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unobserved common factor and is also valid for panels with large N and T .  Gengenbach, 
Palm, and Urbain (2009) demonstrate that the test can exhibit size distortion if the number of 
common factors exceeds one. An extension of the CIPS test in a case of multifactor error 
structure (CIPSM) is provided in Pesaran et al. (2013). The CIPS test is robust to cross-
sectional dependence, individual specific residual serial correlation and incidental 
deterministic intercepts and trends (Pesaran, 2007).  
In this study, I consider the truncated version of the CIPS test (CIPS*) where the group-
specific CADF statistics are conveniently truncated (CADF*) to avoid nuisance parameters. 
The adopted PURTs in this study have the null hypothesis that all individual series in the panel 
have a unit root against the alternative that allows for a fraction of the individual series to 
contain unit roots (Baltagi, 2013).  
5.6.4 Post-Estimation Residual Based Tests 
5.6.4.1   Inspecting Size of Cross-Sectional Dependence 
 The cross-sectional correlation of residuals generated from estimating Equation (5.9) is 
examined using the Pesaran (2004) CD test. This is to inspect the absolute size of the cross-
sectional coefficient of the residuals and justify the robustness of adopted panel data estimators 
(CCEMG and AMG). The estimators are not designed to eliminate cross-sectional correlation 
entirely but  to reduce its size in order to derive consistent and efficient estimates (De Hoyos 
& Sarafidis, 2006). For consistency purpose, I made an attempt to implement the  bias-adjusted 
variant of Breusch and Pagan (1980) Lagrange Multiplier test statistic proposed by Pesaran et 
al. (2008) but the available dataset is not sufficiently balanced to perform the test. 
 
5.6.4.2  Testing for Cointegration 
Cointegration between health spending and income for African countries is determined 
using a residual-based method that accounts for cross-sectional dependence, heterogeneity, and 
148 
 
potential serial correlation. If Pesaran’s (2007) CIPS test statistic is significant, it indicates that 
the residual series is stationary and the null hypothesis of no cointegration is rejected46. For the 
purpose of this study, the CIPS test approach is used despite unavailability of testing critical 
values as a residual based cointegration technique compared to other Error Correction Model 
(ECM) based tests. This includes Westerlund (2007)47 test that does not implicitly account for 
cross-sectional dependence and assumes a common factor structure for cross-sectional 
dependence. For consistency checks, I made an attempt to implement the Gengenbach, Urbain, 
and Westerlund (2009) ECM approach and the Pesaran et al. (2013) CIPSM residual based 
cointegration techniques but the available dataset is not sufficiently balanced to perform  the 
tests. Then, I applied a coinetgration test developed by Pedroni (1999, 2004) that comprises of 
four pooled and three group-mean statistics. The null hypothesis of all the seven tests is “no 
cointegration”.48 
 
5.6.5 Robustness and Consistency Checks of Estimators and Tests 
 The robustness and consistency checks used in this study are summarized in Table 5.5.
                                                          
46 The appropriate critical values for CIPS procedures test in testing for cointegration is not available as at the 
time of this research. My approach here is ad hoc and might be less robust but other earlier empirical studies 
(Baltagi & Moscone, 2010; Baltagi et al., 2012; Hashiguchi & Hamori, 2012) have used CIPS as a cointegration 
technique. 
47 The implementation of the Westerlund’s (2007) cointegration technique requires strongly balanced panel 
without gaps and total number of variables not more than 6. Both of which a not available for this study. 
48The Pedroni (1999, 2004)  tests can only be implemented whwn the number of regressors in the model is not 





Table 5.5: Methodological Summary for Baseline Analysis and Analytical Checks 
 
Methods Baseline Analysis Robustness Checks Consistency Checks 
Estimator CCEMG Homogenous: 2WFE & POLS Heterogeneous: AMG  
CD Test PCD test   
PURT 
Fisher's combined MW test 
and CIPS test 
  
Panel Cointegration Residual based: CIPS test  
Pooled and Group-mean panel 
cointegration tests (Pedroni, 1999, 
2004) 
NOTE: 2WFE = Two-Way Fixed Effect; PCD = Pesaran’s (2014) Cross-sectional Dependence; MW = Maddala & Wu (1999). 
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5.6.7 Robustness Checks of the Model Specification and Sub-Sample Analysis  
 As a robustness check, I have modified the baseline model specification in three ways: 
(i) baseline model re-estimated without a linear time trend, (ii) samples reclassified based on 
trending exchange rate fluctuations, and (iii) data sub-samples. The objective of the checks is 
to examine the extent to which the estimated income elasticity of healthcare expenditure in 
African countries is robust to: (i) changes in model specification, (ii) exclusion of countries 
with high exchange rate volatility driven by PPP adjustment, and (iii) decomposition of the 
pooled dataset into sub-samples. The income elasticity coefficient from each category is 
compared with the baseline elasticity estimate from Equation (5.9). Also, a visual inspection 
of the differences in the estimates is provided by plotting the average income elasticity 
coefficient and the upper and lower confidence intervals for the estimated coefficient. The 
floating bars plot is used to indicate the extent to which the income elasticity estimates from 
each category differ from the baseline average elasticity coefficient.  
Model Re-Specification 














  (5.10) 
Model (5.10) is estimated using CCEMG to determine if the baseline income elasticity 
coefficient is driven by inclusion of the heterogeneous linear time trends. The size and 
significance of the elasticity coefficient are compared with the estimate from (5.9).  
Country Split by Exchange Rate Variation 
All the variables incorporated in model (5.9) excluding the demographic indicators 
(LEX, INM, P65 and P15) are measured in real level using purchasing power parity (PPP) 
conversion. I investigate whether the elasticity estimates are being driven by PPP adjustment 
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considering the level of exchange rate fluctuations across African countries vis-à-vis the U.S. 
dollar. The plots (Figures 5.3 - 5.6) of the consumption version of the PPP and the log of real 
total health expenditure per capita are used to select countries for exclusion from the dataset.  
Countries with high exchange rate variation relative to the total health expenditure per 
capita include: Burundi, Congo Dem. Rep., Guinea, Madagascar, Sierra Leone, Tanzania, and 
Uganda. These seven countries are categorised as an “unstable sub-sample” for the purposes 
of this robustness check. The elasticity estimates from the stable and unstable sub-samples are 
compared with the elasticity coefficient from the baseline model (5.9).  
To the best of my knowledge, the country split approach for testing the robustness of 
the baseline model to exchange rate variation in Africa is novel. For OECD countries, Narayan 
et al. (2010) used a different approach by comparing the elasticity estimates between variables 
adjusted by the GDP deflator and those adjusted using a country-specific healthcare price 
 






















index. They found that the use of the GDP deflator produces biased estimates and can lead to 
wrong policy inference in determining whether health is a necessity or luxury good. 
 
Geo-Political Sub-Sample Analysis 
 The full sample of countries used in the baseline analysis consists of 47 out of 54 
African states (Table 5.6). Seven countries had to be excluded due to lack of data. These 
countries are: Cabo Verde, Ethiopia, Lesotho, Sao Tome and Principe, Somalia, South Sudan 
and Zambia (highlighted in yellow in Table 5.6). The period from 1995 to 2014 is chosen for 
this study due to data availability across countries; still, the dataset is not strongly balanced49. 
In further robustness checks, the full sample is split into sub-samples based on the 
World Bank (2017) regional classification and income groups and the Peace (2016)fragile state 
                                                          
49 The unbalanced nature of the panel dataset limits the choice of robustness and diagnostic tests performed in 
this study.  
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index50 (Table 5.6). The first classification involves grouping the countries into geographical 
regions with similar economic and social characteristics. It is conventional to categorise 
African countries into Sub-Saharan Africa (SSA; 41 countries) and North Africa (6 countries). 
SSA can be further split into the West (17 countries), East (11 countries), South (8 countries) 
and Central (5 countries) sub-regions. The SSA and North Africa datasets are used to 
individually estimate Equation (5.9). Then, the income elasticity coefficients are compared 
with the baseline estimate. 
In a second classification, Equation (5.9) is estimated for four different African income 
groups51: lower middle income (13 countries), upper middle income (9 countries), low income 
(24 countries), and high income (1 country). Only Seychelles is in the high income group and 
a time series OLS estimator is used instead of CCEMG. Income elasticity estimates from each 
of the income groups are compared with the baseline estimate. 
 
Table 5.6: Classification of African Countries by Region, Income and Fragility Status 
 









1 Algeria NA NA UMI NFR 78.3 
2 Angola SSA SA UMI FRA 90.5 
3 Benin SSA WA LIN NFR 78.9 
4 Botswana SSA SA UMI NFR 63.5 
5 Burkina Faso SSA WA LIN FRA 89.4 
6 Burundi SSA EA LIN FRA 100.7 
7 Cabo Verde SSA WA LMI FRA 71.5 
8 Cameroon SSA WA LMI NFR 97.8 
                                                          
50 Details and ranking of the FSI 2016 can be retrieved from: http://fsi.fundforpeace.org/rankings-2016  
51 See Figure 5.1 for Africa’s income distribution map. 
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SSA CA LIN FRA 112.1 
10 Chad SSA WA LIN FRA 110.1 
11 Comoros SSA EA LIN NFR 83.8 
12 Congo, Dem. Rep. SSA CA LIN FRA 110 
13 Congo, Rep. SSA CA LMI FRA 92.2 
14 Côte d'Ivoire SSA WA LMI FRA 97.9 
15 Djibouti NA NA LMI FRA 89.7 
16 Egypt, Arab Rep. NA NA LMI FRA 90.2 
17 Equatorial Guinea SSA CA UMI NFR 85.2 
18 Eritrea SSA EA LIN FRA 98.6 
19 Ethiopia SSA EA LIN FRA 97.2 
20 Gabon SSA CA UMI NFR 72 
21 Gambia, The SSA WA LIN FRA 86.8 
22 Ghana SSA WA LMI NFR 71.2 
23 Guinea SSA WA LIN FRA 103.8 
24 Guinea-Bissau SSA WA LIN FRA 99.8 
25 Kenya SSA EA LMI FRA 98.3 
26 Lesotho SSA SA LMI NFR 80.9 
27 Liberia SSA WA LIN FRA 95.5 
28 Libya NA NA UMI FRA 96.4 
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29 Madagascar SSA EA LIN NFR 84.2 
30 Malawi SSA SA LIN FRA 87.6 
31 Mali SSA WA LIN FRA 95.2 
32 Mauritania SSA WA LMI FRA 95.4 
33 Mauritius SSA EA UMI NFR 43.2 
34 Morocco NA NA LMI NFR 74.2 
35 Mozambique SSA SA LIN FRA 87.8 
36 Namibia SSA SA UMI NFR 71.1 
37 Niger SSA WA LIN FRA 98.4 
38 Nigeria SSA WA LMI FRA 103.5 
39 Rwanda SSA EA LIN FRA 91.3 
40 
São Tomé and 
Principe 
SSA CA LMI NFR 72.9 
41 Senegal SSA WA LIN NFR 83.6 
42 Seychelles SSA EA HIN NFR 60.2 
43 Sierra Leone SSA WA LIN FRA 91 
44 Somalia SSA EA LIN FRA 114 
45 South Africa SSA SA UMI NFR 69.9 
46 South Sudan SSA EA LIN FRA 113.8 
47 Sudan SSA EA LMI FRA 111.5 
48 Swaziland SSA SA LMI FRA 87.6 
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49 Tanzania SSA EA LIN NFR 81.8 
50 Togo SSA WA LIN NFR 85.8 
51 Tunisia NA NA LMI NFR 74.6 
52 Uganda SSA EA LIN FRA 97.7 
53 Zambia SSA SA LMI FRA 86.3 
54 Zimbabwe SSA SA LIN FRA 100.5 
NOTE: SSA = Sub-Saharan Africa; NA = North Africa; CA = Central Africa; EA = East Africa; WA = West 
Africa; SA = Southern Africa; UMI = Upper middle income; LIN = Low income; LMI = Lower middle income; 
HIN = High income; FRA = Fragile; NFR = Non-Fragile 
 
Lastly, the countries are categorised into fragile and non-fragile African states using the 
2016 fragile state index (FSI). The FSI is a composite of 12 indices: demographic pressures; 
refugees and Internally Displaced People (IDPs); group grievance; human flight; uneven 
development; poverty and economic decline; legitimacy of the state; public services; human 
rights; security apparatus; factionalized elites; and external intervention. Each of the indices 
has a 10-point score ranging from 1 (very good) to 10 (very poor). The FSI has a total of 120 
points. Countries with FSI of 86 and above are classified as fragile (34 countries) and those 
with FSI less than 86 are grouped as non-fragile (20 countries). The FSI sub-samples are used 
to estimate Equation (5.9) and the estimated income elasticity coefficients are compared with 
the baseline elasticity estimate.   
A summary of all robustness checks considered in this study is presented in Table 5.7.
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Table 5.7: Summary of Robustness Checks 
 
No. Type of Robustness Check Model Dataset Method Parameter 
1 Baseline Analysis Eq. (5.9) Full sample CCEMG 1,i  
2 Model Re-Specification: 
 Baseline model without trends Eq. (5.10) Full sample CCEMG 
TR
i 1,  
3 
Country Split by Exchange Rate 
Variation: 
    
 Stable exchange rate fluctuation Eq. (5.9) Stable sample CCEMG 
ST
i 1,  
 Unstable exchange rate fluctuation Eq. (5.9) Unstable sample CCEMG 
US
i 1,  
4 Estimation Methods: 
 Pooled type estimators Eq. (5.9) Full sample POLS & 2WFE 
PO
i 1,  
 Mean group type estimator Eq. (5.9) Full sample AMG 
MG
i 1,  
5 Data Decomposition: 
 [A] Income group:  
       Lower middle income Eq. (5.9) LMI dataset CCEMG 
LM
i 1,  
       Upper middle income Eq. (5.9) UMI dataset CCEMG 
UM
i 1,  
       Low income Eq. (5.9) LIN dataset CCEMG 
LI
i 1,  
       High income Eq. (5.9) HIN dataset OLS 
HI
1  
  [B] Geographical region:  
       Sub-Saharan Africa Eq. (5.9) SSA dataset CCEMG 
SSA
i 1,  
       North Africa Eq. (5.9) NA dataset CCEMG 
NA
i 1,  
  [C] Fragility status:  
       Fragile countries Eq. (5.9) Fragile dataset CCEMG 
FA
i 1,  
       Non-fragile countries Eq. (5.9) Non-fragile dataset CCEMG 
NFA
i 1,  
 Note: LMI = Lower middle income group; UMI = Upper middle income group; LIN = Lower income group; 





5.6.9 Descriptive Analysis 
Descriptive statistics (annual values across countries) are presented in Table 5.8. The health 
expenditure and income variables have more variation than other indicators used in this study. 
For instance, real total health expenditure per capita has a mean of $208.6 and ranges from 
$5.94 (Congo Democratic Republic) to $1,768.7 (Equatorial Guinea). Government expenditure 
averages $114.5 per person. On average, each person spends $66.3 annually out of their 
disposable income (excluding private insurance contribution) to access healthcare services. 
Mauritius has the highest out-of-pocket health expenditure per capita (at $416.1) while 
Mozambique has the lowest ($2.37). Real GDP per capita has a mean of $2,335.2 with a 
maximum of $25,732.7 (Equatorial Guinea) and a minimum of $115.4 (Liberia). 
The demographic and health status variables display less variation across countries 
within the considered years and sampled countries. The average shares of the population 
younger than 15 and older than 64 are 41.4% and 3.50%, respectively. Life expectancy at birth 
has a mean of 56.5 years with a minimum of 31.6 years (Rwanda) and a maximum of 74.8 
years (Algeria). Infant mortality ranges from 11.9 per 1,000 live births (Liberia) to 158.3 
(Libya).  
Most of the African countries in the sample are net recipients of foreign aid and ODA 
with a mean of $65.5 per person and a maximum of $1,052.9 per capita (in Seychelles). 
Equatorial Guinea is the only African country that donated more than they received (-$16.3) 
during the sample period.  
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Table 5.8: Descriptive Statistics 
 
Variable Obs Mean Std Dev Min Max 
Real Total Health expenditure per capita ($) (THE) 932 208.6 245.3 5.94 1,768.7 
Real Government Health expenditure per capita ($) (GHE) 932 114.5 168.6 0.18 1,483.0 
Real Out-of-pocket Health expenditure per capita ($) (OPE) 932 66.3 74.2 2.37 416.1 
Real GDP per capita ($) (GDP) 930 2,335.2 3,457.2 115.4 25,732.7 
Life expectancy at birth (in years) (LEX) 934 56.5 8.14 31.6 74.8 
Infant mortality (per 1,000 live births) (INM) 940 68.7 30.4 11.9 158.3 
Population aged less than 15 (% of total) (P15) 937 41.4 6.29 19.8 50.4 
Population aged 65 and above (% of total) (P65) 937 3.50 1.22 1.70 9.13 
Real net ODA and official aid received per capita ($) (ODA) 937 63.6 65.5 -16.3 1,052.9 
Government final consumption expenditure (% of GDP) (GFC) 913 15.4 7.09 2.05 69.5 
 
NOTE: The sample consists of annual data for years 1995-2014 from 47 African countries.
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The average size of total government resources available for allocation across sectors 
of the economy (including health) is 15.4% of GDP. It ranges from 2.05% (Zimbabwe) to 
69.5% (Eritrea). Data from the World Bank (2017) WDI indicates that public health spending 
as a share of total government expenditure ranges from 1.6% (Congo Dem. Rep.) to 28.2% 
(Tanzania) -- with an average share of 9.7% between 1995 and 2014. Some African countries 
(such as Tanzania, Malawi, Central African Republic, Ethiopia, Rwanda, Liberia, Chad, 
Uganda, Congo Democratic Republic and Burkina Faso) in some years allocated more than 
twice the average share to the health sector. Often, this can be traced to periods of debt 
cancellation by the African Development Bank, civil conflicts, boarder disputes, inter-country 
war, and increases in health-conditioned ODA.  
5.6.9 Pre-Estimation Diagnostics Results 
 The cross-sectional dependence and panel unit root properties of the health expenditure, 
income and demographic variables used in this study are examined and the corresponding 
results are shown in Table 5.9. Pesaran’s (2004) cross-sectional correlation test results reveal 
high absolute off-diagonal correlation coefficients ranging from 0.60 to 0.94 for health 
expenditures (lnTHE and lnGHE), income (lnGDP), health status (lnLEX and lnINM), and 
demographic (lnP15 and lnP65) panel series. Out-of-pocket health expenditure per capita 
(lnOPE), ODA per capita (lnODA) and government fiscal capacity (lnGFC) series appear to 
be less correlated across countries. The null hypothesis of “cross-sectional independence” is, 
however, rejected for all variables. 
 Using the CIPS test by Pesaran (2007) that (correctly) assumes cross-sectional 
dependence, the null hypothesis of “non stationarity” is rejected for health expenditures (total, 
government, and out-of-pocket) per capita, income per capita, life expectancy at birth, and 
ODA per capita. The rejection of the CIPS null hypothesis indicates that it is only a fraction of 
the countries not all the panel units have stationary series (Pesaran, 2012). The infant mortality 
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rate, government fiscal capacity, population aged less than 15, and the share of ageing 
population series are shown to be non-stationary at level when using the CIPS. This implies 
that cross-sectionally correlated, stationary as well as non-stationary variables are used in this 
study. This motivates the use of a robust estimation method, the CCEMG, as the baseline 
estimators in subsequent sections.  
5.7 Results and Discussion 
 The baseline panel model (5.9) for total health expenditure, government health 
spending and out-of-pocket health expenditure is estimated using CCEMG (Table 5.10). 
Afterwards, post estimation diagnostics and robustness tests are performed to determine the 
reliability and consistency of the baseline income elasticity estimate to changes in model 
specification, estimation methods, and data decomposition. These include: baseline model re-
specification without a linear time trend (Table 5.11); sample decomposition by exchange rate 
variation (Table 5.12); different estimation methods (Table 5.13); and sample decomposition 
by income group (Table 5.14), geographical region (Table 5.15), and fragility status (Table 
5.16).  In addition, the summary of all the income elasticities estimated in this chapter for each 
of the health expenditure variables is shown in Table 5.17. The associated lower and upper 
confidence intervals at the 95% significance level in Table 5.17 are used to create floating bar 
plots presented in Figures 5.7. 5.8, and 5.9.  
The empirical results for each of the three categories of health expenditure are discussed 
below. 
5.7.1 Total Health Expenditure 
Income: Changes in real GDP per capita have a positive and significant effect on 
changes in real total health expenditure per capita (Table 5.10, column 1). For a 1% increase 
in income, total health expenditure significantly increases by 0.58%, on average. Therefore, 
the results indicate that health is income inelastic and a necessity good. Also, when formally 
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Table 5.9: Pre-Estimation Diagnostics Test Results 
 
  
Pesaran (2004)  
CD Test 
Maddala & Wu (1999) PURT Pesaran (2007) CIPS PURT 
Level FD Level FD 
 
 No Trend Trend No Trend Trend No Trend Trend No Trend Trend 
(1) (2) (3) (4) (5) (6) (7) (8) (9) (10) 
ln(THE) 83.0*** 0.659 1 1 0*** 0*** 0*** 0** 0*** 0*** 
ln(GHE) 79.79*** 0.611 1 1 0*** 0*** 0*** 0* 0*** 0*** 
ln(OPE) 31.41*** 0.497 1 1 0*** 0*** 0*** 1 0*** 0*** 
ln(GDP) 51.44*** 0.610 1 1 0*** 0*** 0*** 1 0*** 0*** 
ln(LEX) 113.1*** 0.847 0*** 0*** 0*** 0*** 0*** 0*** 0*** 0*** 
ln(INM) 133.7*** 0.941 0*** 0*** 0*** 1 1 1 0* 1 
ln(P15) 58.69*** 0.712 0*** 0*** 0** 0*** 1 1 1 1 
ln(P65) -1.24*** 0.697 0*** 0*** 0*** 0*** 1 1 1 1 
ln(ODA) 8.12*** 0.315 0*** 0*** 0*** 0*** 0*** 0* 0*** 0*** 
ln(GFC) 4.00*** 0.349 0*** 0*** 0*** 0*** 1 1 0*** 0*** 
Note: CD = Cross-sectional dependence; PURT = Panel Unit Root Test; CIPS = Cross-sectional augmented Im, Pesaran & Shin (2003); FD = 
First Difference;  = average absolute value of the off-diagonal elements of the cross-sectional correlation matrix of the series;  = 
Pesaran (2004) CD test; Null hypothesis for Maddala & Wu (1999)  and Pesaran (2007) CIPS tests is “no stationarity” i.e. series is I(1); MW test 
assumes cross-section independence; CIPS test assumes cross-sectional dependence in form of a single unobserved common factor. * 10%, ** 
5%, and *** 1% significance level respectively; 1 = Not stationary, i.e. series is I(1); 0 = Stationary, i.e. series is I(0). Lag 1 is used for all the 









































































Obs. 896 896 896 
N 47 47 47 
RMSE 0.030 0.055 0.039 
AIC -2687.3 -2223.3 -2484.8 
̂  0.293 0.296 0.299 
PESCD  -0.69 -1.39 -0.71 
CIPS PURT (Residual) I(0) I(0) I(0) 
NOTE:  Dependent variables: THE (Real total health expenditure per capita); GHE (Real government 
health expenditure per capita); and OPE (Real out-of-pocket health expenditure per capita). RMSE = 
Root mean squared error. AIC = Akaike Information Criteria. ̂  = average absolute value of the off-
diagonal elements of the cross-sectional correlation matrix of the series. PESCD  = Pesaran (2004) cross-
sectional dependence (CD) test. Cross-sectionally augmented Im, Pesaran & Shin (2003) panel unit root 
test (PURT) at lag 1 is used as a residual based cointegration test. I(0) indicates the relationship is 
cointegrated and the residual is stationary at level. I(1) = Non-stationary and not cointegrated. Unless 
otherwise noted, numbers in parentheses are z-statistics corresponding to coefficient estimates. All the 
estimation used robust standard errors. *, **, and *** indicate statistical significance at the 10%, 5%, 




Table 5.11: Robustness Check #1 -- Model Re-Specification without Trends and 
Pedroni’s Cointegration Test 
 
Variable 
























































Trend ---- ---- ---- 
Obs. 896 896 896 
N 47 47 47 
RMSE 0.034 0.062 0.043 
AIC -2592.8 -2137.1 -2413.2 
̂  0.286 0.287 0.289 
PESCD  -2.15** -1.57 -1.92* 
CIPS PURT (Residual) I(0) I(0) I(0) 
NOTE:  Dependent variables: THE (Real total health expenditure per capita); GHE (Real government 
health expenditure per capita); and OPE (Real out-of-pocket health expenditure per capita). RMSE = 
Root mean squared error. AIC = Akaike Information Criteria. ̂  = average absolute value of the off-
diagonal elements of the cross-sectional correlation matrix of the series. PESCD  = Pesaran (2004) cross-
sectional dependence (CD) test. Cross-sectionally augmented Im, Pesaran & Shin (2003) panel unit root 
test (PURT) at lag 1 is used as a residual based cointegration test. I(0) indicates the relationship is 
cointegrated and the residual is stationary at level. I(1) = Non-stationary and not cointegrated. Unless 
otherwise noted, numbers in parentheses are z-statistics corresponding to coefficient estimates. All the 
estimation used robust standard errors. *, **, and *** indicate statistical significance at the 10%, 5%, 





Table 5.11.1: Pedroni’s (2004) Coinetgration Tests 
Statistic 







Panel: v  -5.9*** 
-4.781*** -4.957*** 
Panel: rho 
5.904*** 6.044*** 6.379*** 
Panel: t 
-15.15*** -12.78*** -11.64*** 
Panel: ADF 
11.27*** 5.918*** 1.105 
Group: rho 
8.756*** 8.937*** 9.366*** 
Group: t 
-19.1*** -15.6*** -14.41*** 
Group: ADF 
11.87*** 11.79*** 5.239*** 
N 47 47 47 
T (average per unit) 19 19 19 
Number of Regressors 7 7 7 
Standardised Critical Values (one-tail): 1% 5% 10% 
 2.326 1.645 1.282 
Null Hypothesis: “No Cointegration” Reject Reject Reject 
NOTE:  Dependent variables: THE (Real total health expenditure per capita); GHE (Real government 
health expenditure per capita); and OPE (Real out-of-pocket health expenditure per capita). All the 
regressors in Equation (5.10) are used for this test. *, **, and *** indicate statistical significance at the 



















Table 5.12: Robustness Check #2 -- Country Split by Exchange Rate Variation 
 
Variable 























































































































Obs. 756 756 756 140 140 140 
N 40 40 40 7 7 7 
RMSE 0.026 0.042 0.037 0.032 0.080 0.036 
AIC -2357.5 -2055.5 -2127.3 -385.3 -273.7 -371.6 
̂  0.293 0.297 0.312 0.299 0.28 0.287 
PESCD  -1.02 -0.14 -0.13 0.57 -0.73 -0.57 
CIPS PURT (Residual) I(0) I(0) I(0) I(0) I(0) I(0) 
 NOTE:  Dependent variables: THE (Real total health expenditure per capita); GHE (Real government health 
expenditure per capita); and OPE (Real out-of-pocket health expenditure per capita). RMSE = Root mean 
squared error. AIC = Akaike Information Criteria. ̂  = average absolute value of the off-diagonal elements 
of the cross-sectional correlation matrix of the series. PESCD  = Pesaran (2004) cross-sectional dependence 
(CD) test. Cross-sectionally augmented Im, Pesaran & Shin (2003) panel unit root test (PURT) at lag 1 is used 
as a residual based cointegration test. I(0) indicates the relationship is cointegrated and the residual is 
stationary at level. I(1) = Non-stationary and not cointegrated. Unless otherwise noted, numbers in parentheses 
are z-statistics corresponding to coefficient estimates. All the estimation used robust standard errors. *, **, and 
*** indicate statistical significance at the 10%, 5%, and 1% level, respectively. 
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Obs. 896 896 896 896 896 896 886 886 886 
N 47 47 47 47 47 47 46 46 46 
RMSE 0.175 0.298 0.249 0.140 0.241 0.176 0.065 0.104 0.078 
AIC -530.7 429.3 103.9 -1040.7 -212.5 -631.5 -2089.5 -1719.6 -1945.2 
̂  0.376 0.356 0.421 0.314 0.336 0.313 0.222 0.23 0.226 
PESCD  0.5 -0.28 1.70 * 3.02** 1.72* 1.68* -1.94* -2.05** -1.21 
CIPS PURT (Residual) I(1) I(0) I(1) I(0) I(0) I(0) I(1) I(1) I(1) 
NOTE:  Dependent variables: THE (Real total health expenditure per capita); GHE (Real government health expenditure per capita); and OPE (Real out-of-
pocket health expenditure per capita). RMSE = Root mean squared error. AIC = Akaike Information Criteria. ̂  = average absolute value of the off-diagonal 
elements of the cross-sectional correlation matrix of the series. PESCD  = Pesaran (2004) cross-sectional dependence (CD) test. Cross-sectionally augmented 
Im, Pesaran & Shin (2003) panel unit root test (PURT) at lag 1 is used as a residual based cointegration test. I(0) indicates the relationship is cointegrated and 
the residual is stationary at level. I(1) = Non-stationary and not cointegrated. Unless otherwise noted, numbers in parentheses are z-statistics corresponding to 



















































































































































































































































































Obs. 253 253 253 163 163 163 466 466 466 14 14 14 
N 13 13 13 9 9 9 24 24 24 1 1 1 
RMSE 0.026 0.043 0.032 0.025 0.038 0.048 0.027 0.058 0.024 0.141 0.141 0.133 
AIC -768.9 -656.4 -723.1 -489.4 -429.4 -395.6 -1431.0 -1115.7 -1469.0 -11.5 -11.6 -15.1 
̂  0.31 0.295 0.266 0.306 0.283 0.328 0.329 0.307 0.312 0.924 0.915 0.729 
𝑪𝑫𝑷𝑬𝑺 -0.06  2.21** -0.65 0.63 -0.82 -0.19 0 -0.75 -0.95 129.66*** 128.53*** 68.42*** 
CIPS PURT 
(Residual) 
I(0) I(0) I(0) I(0) I(0) I(0) I(0) I(0) I(0) I(1) I(1) I(1) 
 NOTE:  Dependent variables: THE (Real total health expenditure per capita); GHE (Real government health expenditure per capita); and OPE (Real out-of-pocket 
health expenditure per capita). RMSE = Root mean squared error. AIC = Akaike Information Criteria. ̂  = average absolute value of the off-diagonal elements of the 
cross-sectional correlation matrix of the series. PESCD  = Pesaran (2004) cross-sectional dependence (CD) test. Cross-sectionally augmented Im, Pesaran & Shin (2003) 
panel unit root test (PURT) at lag 1 is used as a residual based cointegration test. I(0) indicates the relationship is cointegrated and the residual is stationary at level. I(1) 
= Non-stationary and not cointegrated. Unless otherwise noted, numbers in parentheses are z-statistics corresponding to coefficient estimates. All the estimation used 
robust standard errors. *, **, and *** indicate statistical significance at the 10%, 5%, and 1% level, respectively.  
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Table 5.15: Robustness Check #5: Data Decomposition by Geographical Region 
 
Variable 























































































































Obs. 793 793 793 103 103 103 
N 41 41 41 6 6 6 
RMSE 0.026 0.046 0.039 0.010 0.016 0.011 
AIC -14.1 -13.1 -12.1 -11.1 -10.1 -9.1 
̂  0.306 0.312 0.325 0.311 0.301 0.281 
𝑪𝑫𝑷𝑬𝑺 -0.95 -1.06 -0.48 -1.05 -1.35 -1.19 
CIPS PURT (Residual) I(0) I(0) I(0) I(0) I(0) I(0) 
 NOTE:  Dependent variables: THE (Real total health expenditure per capita); GHE (Real government 
health expenditure per capita); and OPE (Real out-of-pocket health expenditure per capita). RMSE = 
Root mean squared error. AIC = Akaike Information Criteria. ̂  = average absolute value of the off-
diagonal elements of the cross-sectional correlation matrix of the series. PESCD  = Pesaran (2004) cross-
sectional dependence (CD) test. Cross-sectionally augmented Im, Pesaran & Shin (2003) panel unit root 
test (PURT) at lag 1 is used as a residual based cointegration test. I(0) indicates the relationship is 
cointegrated and the residual is stationary at level. I(1) = Non-stationary and not cointegrated. Unless 
otherwise noted, numbers in parentheses are z-statistics corresponding to coefficient estimates. All the 
estimation used robust standard errors. *, **, and *** indicate statistical significance at the 10%, 5%, 






Table 5.16: Robustness Check #6 -- Data Decomposition by Fragility Status 
 
  Variable 























































































































Obs. 545 545 545 351 351 351 
N 29 29 29 18 18 18 
RMSE 0.028 0.055 0.033 0.033 0.043 0.038 
AIC -8.1 -7.1 -6.1 -5.1 -4.1 -3.1 
̂  0.297 0.315 0.305 0.304 0.295 0.293 
𝑪𝑫𝑷𝑬𝑺 0.23 -0.64 1 -2.09 ** -2.33** -0.85 
CIPS PURT (Residual) I(0) I(0) I(0) I(0) I(0) I(0) 
 NOTE:  Dependent variables: THE (Real total health expenditure per capita); GHE (Real government 
health expenditure per capita); and OPE (Real out-of-pocket health expenditure per capita). RMSE = 
Root mean squared error. AIC = Akaike Information Criteria. ̂  = average absolute value of the off-
diagonal elements of the cross-sectional correlation matrix of the series. PESCD  = Pesaran (2004) cross-
sectional dependence (CD) test. Cross-sectionally augmented Im, Pesaran & Shin (2003) panel unit root 
test (PURT) at lag 1 is used as a residual based cointegration test. I(0) indicates the relationship is 
cointegrated and the residual is stationary at level. I(1) = Non-stationary and not cointegrated. Unless 
otherwise noted, numbers in parentheses are z-statistics corresponding to coefficient estimates. All the 
estimation used robust standard errors. *, **, and *** indicate statistical significance at the 10%, 5%, 




Table 5.17: Summary -- Income Elasticity of Health Expenditures Per Capita 
 
 Models 






















Baseline B1 0.582* -0.100 1.263 C1 1.375** 0.263 2.487 D1 1.131** 0.193 2.069 
Specification 
Without Trend 
B2 0.570 -0.122 1.262 C2 1.206** 0.149 2.263 D2 1.174*** 0.438 1.909 
Stable PPP B3 0.867*** 0.185 1.549 C3 1.570*** 0.334 2.806 D3 0.859*** -0.013 1.731 
Unstable PPP B4 0.785 -0.627 2.198 C4 4.384 -5.295 14.064 D4 0.747** 0.094 1.400 
POLS B5 0.851*** 0.773 0.929 C5 0.828*** 0.692 0.965 D5 0.800*** 0.696 0.903 
2WFE B6 0.743*** 0.528 0.958 C6 0.959*** 0.498 1.421 D6 0.678*** 0.423 0.933 
AMG B7 0.847*** 0.424 1.271 C7 1.357*** 0.672 2.041 D7 0.832*** 0.266 0.266 
Low Middle Income B8 0.322 -1.262 1.906 C8 0.750 -2.061 3.560 D8 -2.108 -5.040 0.824 
Upper Middle 
Income 
B9 -0.176 -2.007 1.655 C9 -0.444 -3.078 2.190 D9 0.261 -1.903 2.426 
Low Income B10 0.635 -0.380 1.651 C10 0.684 -1.011 2.380 D10 0.778 -0.249 1.806 
High Income B11 0.665 -1.380 2.710 C11 0.757 -1.319 2.833 D11 1.175 -1.288 3.638 
SSA B12 0.228 -0.636 1.093 C12 0.942 -0.188 2.072 D12 0.619 -0.202 1.440 
North Africa B13 0.695 -3.934 5.323 C13 0.462 -6.141 7.065 D13 0.487 -3.135 4.109 
Fragile States B14 1.270*** 0.560 1.979 C14 1.893*** 0.454 3.331 D14 1.179** 0.245 2.114 
Non-Fragile States B15 0.640 -0.650 1.930 C15 0.070 -2.265 2.405 D15 0.289 -1.386 1.963 
CI = Confidence Interval at 95% level. *, **, and *** indicate statistical significance at the 10%, 5%, and 1% level, respectively.  
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tested using confidence intervals (see Table 5.17 and Figure 5.7), it indicates that the income 
elasticity coefficients from most of the estimators are less than one.”  
Health status: Life expectancy at birth and infant mortality have insignificant effects 
on total health expenditure per capita. The signs of the effects contradict the theoretical 
expectations.   
Demographic structure: The share of the population younger than 15 has an 
insignificant effect on real total health expenditure per capita. Likewise, an increase in the share 
of the elderly is not statistically significant.   
Net foreign aid and ODA received: Overall, net foreign aid and ODA received for 
health and non-health programmes per capita is positively associated with total healthcare 
spending. However, the relationship is statistically insignificant.  
Government fiscal capacity: The total final government consumption as a share of 
GDP is positively related to total health spending contributions from both the private and public 
sectors of the economy. However, the effect is again statistically insignificant. 
Robustness checks: As shown in Table 5.17 and Figure 5.7, the income elasticity 
coefficient of total health expenditure from the baseline model (0.582) is found robust to almost 
all considered checks. An important exception is the sub-sample of fragile states which yields 
an income elasticity estimate of 1.270, i.e., greater than one (see Table 5.16). This implies that 
the sum of public and private health expenditures grows faster than income in African countries 
that experience intense fragility emanating from a high poverty rate, unequal access to quality 
healthcare services, and civil war. According to Akaike Information Criteria (AIC) values of 
the analysed 15 models, the baseline model performs the best. Also, the residual series 
generated from the baseline specification are cross-sectionally independent and stationary at 














5.7.2 Government Healthcare Expenditure 
Income. Public health expenditure as a component of total health spending is positively 
associated with real GDP per capita as a measure of income. As shown in Table 5.10 (column 
2) the income elasticity coefficient is 1.375 and is statistically significant at the 5% significance 
level. This indicates that public budget allocation to the health sector grows by 1.38% with a 
1% change in real income, on average. Also, in formal testing using the reported confidence 
interval values in Table 5.17 and and Figure 5.8,  it clearly shows that most of theincome 
elasticity estimates are less than one. This supports my findings that government health 
expenditure is not a luxury good. 
Health status. As reported for total health expenditure, increases in life expectancy at 
birth and infant mortality lead to a decrease in public health spending on medical services. The 
effects are theoretically unexpected.  However, they are not statistically significant.  
Demographic structure. Changes in both young and elderly population as shares of 
total population have negative (but statistically insignificant) effects on government healthcare 
expenditure per capita. This again contradicts my expectations.  
Net foreign aid and ODA received. Health and non-health conditioned aid and ODA 
received from abroad are positively related to changes in government medical expenditure 
across African countries. But again, the estimate is statistically insignificant and close to zero. 
Government fiscal capacity. An increase in government consumption significantly 
increases government health care expenditure per capita. For a 1% increase in government 
fiscal capacity, public health spending increases by 0.44%.  
Robustness checks. The elasticity estimate (1.375) from the baseline model estimation 
is robust to specifications that exclude a heterogeneous linear time trend, decompose the dataset 
and use different estimation methods (see Table 5.17 and Figure 5.8). The estimate for fragile 
African states is close 2.0, i.e., noticeably higher than the baseline estimate for the full sample. 
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However, the income elasticity estimate from the baseline and fragile states models are not 
statistically distinct (Chi2 = 0.50, p-value = 0.4808). 
Again, the baseline model has the lowest AIC value. The residual-based, post-
estimation test results for model (5.10, column 2) suggest that CCEMG successfully addresses 
the issue of cross-section dependence. 
5.7.3 Out-of-pocket health expenditure 
Income: Real GDP per capita is positively and significantly associated with changes in 
out-of-pocket payments per person (Table 5.10, column 3). Increasing income by 1% leads to 
rise in out-of-pocket expenditure by 1.13%.  However, the confidence interval values reported 
in Table 5.17 and Figure 5.9 show that the estimates coefficients are less than one. This 
indicates that out-of-pocket payment as health financing option makes health a necessity good.. 
Health status. The effects of life expectancy and infant mortality on out-of-pocket 
payment are negative and insignificant. Similar findings were reported for total healthcare 
expenditure and government health spending in columns 1 and 2 of Table 5.10. 
Demographic structure. An increase in the share of population aged 65 and above 
causes out-of-pocket payment to decrease. This does not conform with theoretical expectation. 
On the other hand, an increase in the share of population aged less than 15 increases out-of-
pocket payment. However, neither of the variables are statistically significant.  
Net foreign aid and ODA received. Out-of-pocket health expenditure seems to be 
crowded-out by net foreign aid and ODA. This is plausible as an increase in net ODA reduces 
the burden on households by providing more coverage through the public sector. However, the 
estimate is statistically insignificant.  
Government fiscal capacity. The ratio of government expenditure as a share of GDP 
positively influences out-of-pocket health expenditure per capita. This effect, while 






















Robustness checks.  Statistically significant estimates from robustness checks are 
similar to the baseline elasticity of 1.131 (Table 5.17 and Figure 5.9). A comparison of AIC 
values shows that the baseline specification is the best.  The post estimation diagnostics test 
results in Table 5.10 reveal that the estimated residual series from the baseline model is cross-
sectionally independent and stationary at level.  
5.8 Summary, Conclusion and Recommendations 
 This chapter contributes to the existing literature on the income elasticity of health 
expenditure in Africa by: (i) investigating the income elasticity of public and private health 
expenditure separately; (ii) focusing on Africa, which has received limited attention in the past; 
(iii) being the first study, to the best of my knowledge, to examine the health-income nexus for 
fragile countries and primarily focusing on African countries characterised by low income, 
high poverty prevalence, deteriorating human welfare, high health burden, and a large official 
aid receipt; and (iv) carefully addressing data properties that make standard panel data 
estimators (POLS, FE, and 2WFE) biased. 
The study sampled 47 out of 54 African countries for the period 1995-2014. The 
adopted baseline model regressed aggregate and disaggregated health care expenditures on 
measures of income, health status, demographic structure, net foreign aid, and government 
fiscal capacity. Results from Chapter 4 suggest CCEMG is the best estimator in a wide variety 
of data environments, and hence I use that for my baseline estimation52.  
Based on the baseline coefficient estimates, my findings suggest that total health 
expenditure is income inelastic, i.e., health care is a necessity good in the considered African 
countries as a group. This is consistent with the findings reported for Africa using cross-
sectional data on total health spending ( Gbesemete and Gerdtham (1992); Murthy (2004), 
                                                          
52 The slope homogeneity test indicated that the null hypothesis “homogeneous income elasticity coefficient” 
is rejected at 1% significance level as shown in Table A5.2 (see the Appendix) 
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Okunade (2005), V. N. R. Murthy and A. A. Okunade (2009)), and panel data on aggregate 
health expenditure ( Lv and Zhu (2014)). In regards to studies for other regions, my results 
complement the findings of Baltagi and Moscone (2010) that used a similar empirical model 
set-up for aggregate health spending across 20 OECD countries. But, my disaggregated 
analyses showed that public and private health expenditures are income elastic. This is 
consistent with the finding of Jaunky and Khadaroo (2008) that public health expenditure is a 
luxury good. Also, results for fragile African states yielded income elasticity coefficients 
greater than one. This is similar to the findings of J. A. Khan and Mahumud (2015) who 
employed a homogenous slope model set-up for South-East Asian countries in their 
disaggregated analysis. 
Some of the non-income determinants (such as net ODA per capita and government 
fiscal capacity) were consistently found important across different model specifications. This 
is similar in spirit to the findings of Stubbs, Kentikelenis, Stuckler, McKee, and King (2017) 
for West African countries that ODA per capita significantly increases government health 
spending when there is instituted IMF policy conditioning the utilization of the aid for health 
programmes.  
However, after accounting for different econometric issues and testing the hypotheses 
that health expenditures are either income elastic or inelastic for Africa, the overall results from 
the plots show strong support to conclude that health is a necessity good because the estimated 
coefficients from most of the models are below one. However, there is need for more data 




































 This chapter provides brief summary of each of the analytical section of the thesis. This 
includes an overview of the identified problem, justification for the study, methods (data 
source, sample description, models and methods), key empirical results, conclusion and areas 
of further research. The summary covers chapter 2 to 5 excluding chapter 1 and 7 that 
respectively presents the introduction to this thesis and estimation codes for replication 
purpose. 
6.2 Replication of Hartwig’s (2008) (Chapter 2) 
 The plethora of empirical studies on income determinant of health spending motivates 
me to examine the non-income factors to explain the growth in healthcare spending across 
countries. Also, the lack of established theory to explain the growth using either income or 
non-income factors prompted my choice to revisit Baumol (1967) model of “unbalanced 
growth”. This is done by first replicating the most cited study in this area, Hartwig (2008. HW 
employed Barros (1998) model to test that wage increases in excess of labour productivity 
growth (i.e. Baumol’s variable) is a significant determinant of healthcare expenditure for a 
sample 19 OECD countries from the period 1960 to 2005 using standard panel data estimators. 
 I replicated HW’s split and un-split models using the same original dataset but different 
econometric package (Stata 14.1 instead of Eviews). HW’s split model regress HCE on real 
wages per employee, real GDP, and total employment. The un-split model merged the 
regressors in the split model as a Baumol’s variable. HW’s provided strong supports for the 
BCD after estimating the un-split model that was incorrectly justified and derived from the 
split panel model using a set of coefficient restrictions. 
 The estimates from my replicated models are very similar to HW but the standard errors 
and t-statistics are substantially different and this might be due to the way degree of freedom 
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is calculated between Stata and Eviews. However, further robustness checks revealed that the 
variables and the extracted residuals from the models in the pure replication are not cross-
sectionally independent. Outcomes from the first set of diagnostic tests revealed that the 
standard panel data estimators employed by HW are not robust in the presence of cross-
sectional dependence. Also, test of slope homogeneity using the random coefficient model 
indicated that the relationship HCE and Baumol’s variable is heterogeneous. The second set of 
my robustness checks accommodated the identified problems of cross-sectional dependence, 
slope heterogeneity and non-stationarity using recently developed panel data estimators 
(CCEMG and AMG). These estimators produced estimates of the effect of wage-labour 
productivity gap growth on HCE per capita growth that were smaller in magnitude than those 
found by HW. 
 Lastly, after testing the right set of coefficient restrictions, I found that it is wrong in all 
the considered model cases to combine wages, productivity and labour as a single Baumol 
variable i.e. aggregating the split model to derive the un-split model. However, Chapter 2 
concludes that the Baumol’s effect in the health sector is smaller in magnitude than HW’s 
estimates and the empirical model used by HW is not theoretically motivated using key 
Baumol’s Cost Disease axioms. Despite the theoretical gap identified in HW’s study and later 
addressed in Chapter 3, there are still some areas that require further research. This includes 
the use of GMM based common correlated effect (CCE) mean-group estimator developed by 
Neal (2015a, b) to account for endogeneity that might arise due to the effect of output shock 
on Baumol variable through wages and productivity as noted in Bates and Santerre (2013).  
6.3 Theoretical Modelling and Testing of Baumol’s Cost Disease (Chapter 3) 
 The lack of strong theoretical framework to Hartwig’s (2008) empirical analysis 
motivates this chapter to develop models that directly test the key BCD hypotheses using 
observable variables. The derived empirical models incorporates the underlying Baumol 
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(1967) axioms and properties. The two empirically testable hypotheses examines the effect of 
economy-wide productivity on the share of labour employed in the health sector and the ratio 
of health to non-health price index. Also, I extended the derived models to control for age and 
gender composition of the population, health outcomes (life expectancy at birth and infant 
mortality), health-related behaviour (tobacco and alcohol consumption per capita), and 
economic growth.  
 For the empirical test, the data for the period of 1995 – 2013 for 27 OECD countries 
were fitted using pooled and mean-group type estimators. For the two BCD hypotheses, 
estimates from the pooled OLS and two-way fixed effect show strong support for BCD but 
when fixed effect and country-specific time trends are incorporated into the analyses, the 
support for Baumol’s positions disappear as productivity estimates become negative and 
statistically insignificant. The inconsistent outcomes serves as motivation to perform additional 
post-estimation robustness checks such as Ramsey’s specification error test, joint significance 
test of country and time effects, and Bayesian Information Criteria (BIC) least value. The test 
outcomes revealed that the model with heterogeneous trend is the most preferred specification 
to test the BCD hypotheses. Also, additional diagnostic test indicated that there is issue of 
cross-sectional dependence and non-stationarity, and evidence from addressing the issues 
through the use of heterogeneous panel data estimators did not change the outcome. The 
chapter concludes that there is no significant relationship to support the BCD predictions for 
OECD countries. This may be due to the failure of the BCD model for “non-progressive” 
sectors like health care to account for technology improvements and the resulting 
substitutability of capital for labour inputs.  
 However, one of the key areas for further research is the use of dynamic model to test 
the BCD predictions for the health sector. This includes the use of robust panel data estimator 
such as GMM based CCE by Neal (2015a, 2015b) to capture the endogeneity that can emanate 
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from price and labour supply shocks effect on productivity in the health sector due to 
technological changes. Lastly, future study should extend the dataset to cover more period and 
countries in order to have a more balanced panel data. The identified areas of further research 
in this chapter will provide more validity and generalisation (or otherwise) to the reported 
outcomes. 
6.4 Monte Carlo Simulation Experiments of Heterogeneous Panel Data Estimators 
(Chapter 4) 
 In previous chapters, it was shown that most of the variables used in modelling the 
economic relationship suffer from three major issues, cross-sectional dependence, non-
stationarity and non-homogeneity of slope. Failure to address the issues in estimation might 
results to highly biased policy inference and the use of standard panel data estimators when 
they exist can make the estimates inconsistent and biased. This motivates this chapter to test 
the performance of the pooled type estimators in the presence of the highlighted econometric 
issues including endogeneity induced by common unobservable factors. Then, I compared the 
outcomes with the performance metrics of the recently developed panel data estimators 
designed to accommodate those problems.  
 The simulation set-ups used in chapter 4 was similar to the DGP used in Bond and 
Eberhardt (2013b). Two sets of experiments were conducted. The first simulation replicates 
the experiments in B&E (2013) using the same Monte Carlo DGP (i.e. simulated dataset) set-
ups. It then extends the analysis to incorporate additional performance metrics -(RMSE and 
coverage rate)- for comparing the pooled type (POLS, 2WFE, CCEP, FE, and FD-OLS) 
estimators relative to the mean-group (MG, CCEMG and AMG) methods.  The second 
experiment specifically replicates the first simulation for three sets of panel data dimensions 
that were used in chapter 5. For each of the experiment set-up, I considered four different 
implementation cases, baseline model, heterogeneous linear trends, feedback effect, and beta 
clubs. However, the overall results indicated that CCEMG is the “best” estimator assessed 
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based on biasness, efficiency and coverage rate. Also, the AMG estimator is relatively good 
but less robust in addressing endogeneity issue. But, the pooled type estimators, POLS and 
2WFE are found to be least biased. The simulation experiment outcomes guided the choice of 
estimation methods used in examining the income elasticity of healthcare expenditures in 
chapter 5. 
6.5 Income Elasticity of Health Expenditures Analyses using an African Dataset 
(Chapter 5) 
  The dearth of empirical studies on income elasticity of health expenditure for African 
countries motivate the analyses in chapter 5. In testing whether health is a “luxury” or a 
“necessity” good in Africa, I employed disaggregated and aggregated approaches using the                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             
dependent variable, set of regressors, sampled countries, and estimation methods. The income 
and non-income factors incorporated in the empirical model are selected from previous studies 
for developing countries. The baseline model regress healthcare expenditure per capita on real 
GDP per capita, life expectancy, infant mortality rate, share of population under 15 and above 
65, per capita net official development assistance, government expenditure as a share of GDP, 
and heterogeneous liner trends. The total healthcare spending was decomposed into 
government and out-of-pocket health expenditure. For the baseline analysis, 47 African 
countries were sampled for the period from 1995 to 2014.  
 The pre-estimation diagnostic test results revealed that most of the considered variables 
are non-stationary and cross-sectionally dependent.  Estimates from the CCEMG indicated that 
real income per capita has significant and positive effect on total, government and out-of-
pocket expenditures with coefficients of 0.582, 1.375, and 1.131 respectively. But, plots of the 
confidence interval values for each of the elasticity coefficient clearly showed that they are less 
than one. This indicates that health is a “necessity” good in Africa. Further robustness checks 
yield consistent income elasticity coefficients for all the considered cases. 
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 However, to further generalise the empirical outcomes, there is need for further 
research. First, more robust estimation method such as GMM based common correlated effect 
(CCE) estimator developed by Neal (2015a, 2015b) need to be implemented to address 
endogeneity emanating from the simultaneous relationship among GDP, LEX, INM and GFC. 
Health expenditure can impact health outcomes (LEX and INM) through productivity, and 
vice-versa. The Monte Carlo simulation experiments by Neal (2015a, 2015b) revealed that the 
GMM based CCE method is more robust to endogenous regressors in both static and dynamic 
panel data models. Also, additional data points across more countries is required to have 
sufficient observations to be able to implement dynamic panel model and the cointegration 


















































 The econometric packages used in this thesis are: E-Views 8, Stata 14.1 and GAUSS 
(9 and 16). The codes provided by Hartwig (2008) in E-Views were replicated in Stata for 
consistency checks and flexibility to perform more rigorous robustness tests in Chapter 2. The 
tests of the designed BCD hypotheses were performed using Stata 14.1 in Chapter 3. The 
simulation experiments in Chapter 4 were conducted using GAUSS version 9 and 16. The 
original replication commands provided by Bond and Eberhardt (2013) were written using 
GAUSS 9.0. I replaced obsolete commands to enable implementation in version 16 and also 
wrote additional diagnostic programmes. The original and modified codes are presented in 
section 6.4. Lastly, Chapter 5 that investigates the income elasticity of health care spending 
used Stata 14.1. 
7.2 Replication of Hartwig (2008b) 
//Change the .ado file directory to my P drive 
sysdir set OLDPLACE "P:\Desktop\ado" 
 




xtset cid year 
 
summarize dlhcep dlwspe dlgdpr dlemp dlprod baumolv 
 
by country, sort: summarize dlhcep dlwspe dlgdpr dlemp dlprod baumolv 
 
//'Baumol variable ' split 
// Pooled OLS 
reg dlhcep dlwspe dlgdpr dlemp, vce(cluster cid) 
 
// Cross-section R.E 
xtreg dlhcep dlwspe dlgdpr dlemp, re sa vce(cluster cid) 
 
// Time Period R.E 
xtreg dlhcep dlwspe dlgdpr dlemp i.year, re sa vce(cluster cid) 
 
 
//'Baumol variable ' Unsplit 
// Pooled OLS 
reg dlhcep baumolv, vce(cluster cid) 
 
// Cross-section R.E 




// Time Period R.E 
xtreg dlhcep baumolv i.year, re sa vce(cluster cid) 
 
 
//**Robustness Check #1 ***// 
///*************Panel Time Series Cross-sectional dependence TesT******* 




////***********Estimated Residual Cross-sectional dependence Tests 
*********** 
qui: xtreg dlhcep dlwspe dlgdpr dlemp, re sa vce(cluster cid) 
xtcsd, pesaran abs 
xtcsd, friedman abs 
xtcsd, frees abs 
 
qui: xtreg dlhcep dlwspe dlgdpr dlemp i.year, re sa vce(cluster cid) 
xtcsd, pesaran abs 
xtcsd, friedman abs 
xtcsd, frees abs 
 
qui: xtreg dlhcep baumolv, re sa vce(cluster cid) 
xtcsd, pesaran abs 
xtcsd, friedman abs 
xtcsd, frees abs 
 
qui: xtreg dlhcep baumolv i.year, re sa vce(cluster cid) 
xtcsd, pesaran abs 
xtcsd, friedman abs 
xtcsd, frees abs 
 
 
//**Robustness Check #2 ***// 
//'Baumol variable ' split 
//RCM 
xtrc dlhcep dlwspe dlgdpr dlemp, vce(conventional) 
 
//MG 
xtmg dlhcep dlwspe dlgdpr dlemp, robust res(sp1) 
xtmg dlhcep dlwspe dlgdpr dlemp, trend robust res(sp2) 
 
//CCEMG 
xtmg dlhcep dlwspe dlgdpr dlemp, cce robust res(sp3) 




xtmg dlhcep dlwspe dlgdpr dlemp, aug robust res(sp5) 
xtmg dlhcep dlwspe dlgdpr dlemp, aug trend robust res(sp6) 
 
 




//'Baumol variable ' Unsplit 
//RCM 





xtmg dlhcep baumolv, robust res(up1) 
xtmg dlhcep baumolv, trend robust res(up2) 
 
//CCEMG 
xtmg dlhcep baumolv, cce robust res(up3) 




xtmg dlhcep baumolv, aug robust res(up5) 
xtmg dlhcep baumolv, aug trend robust res(up6) 
 
 






//Wald Parameters Restriction Test 
qui: reg dlhcep dlwspe dlgdpr dlemp, vce(cluster cid) 
test dlwspe - dlgdpr + dlemp = 0 
test dlwspe - dlgdpr + dlemp = 1 
 
qui: xtreg dlhcep dlwspe dlgdpr dlemp, re sa vce(cluster cid) 
test dlwspe - dlgdpr + dlemp = 0 
test dlwspe - dlgdpr + dlemp = 1 
 
qui: xtreg dlhcep dlwspe dlgdpr dlemp i.year, re sa vce(cluster cid) 
test dlwspe - dlgdpr + dlemp = 0 
test dlwspe - dlgdpr + dlemp = 1 
 
 
qui: xtrc dlhcep dlwspe dlgdpr dlemp, vce(conventional) 
test dlwspe - dlgdpr + dlemp = 0 
test dlwspe - dlgdpr + dlemp = 1 
 
qui: xtmg dlhcep dlwspe dlgdpr dlemp, robust  
test dlwspe - dlgdpr + dlemp = 0 
test dlwspe - dlgdpr + dlemp = 1 
 
qui: xtmg dlhcep dlwspe dlgdpr dlemp, trend robust 
test dlwspe - dlgdpr + dlemp = 0 
test dlwspe - dlgdpr + dlemp = 1 
 
 
qui: xtmg dlhcep dlwspe dlgdpr dlemp, cce robust  
test dlwspe - dlgdpr + dlemp = 0 
test dlwspe - dlgdpr + dlemp = 1 
 
qui: xtmg dlhcep dlwspe dlgdpr dlemp, cce trend robust 
test dlwspe - dlgdpr + dlemp = 0 




qui: xtmg dlhcep dlwspe dlgdpr dlemp, aug robust  
test dlwspe - dlgdpr + dlemp = 0 




qui: xtmg dlhcep dlwspe dlgdpr dlemp, aug trend robust 
test dlwspe - dlgdpr + dlemp = 0 
test dlwspe - dlgdpr + dlemp = 1 
 
 
qui: reg dlhcep baumolv, vce(cluster cid) 
test baumolv = 0 
test baumolv = 1 
 
qui: xtreg dlhcep baumolv, re sa vce(cluster cid) 
test baumolv = 0 
test baumolv = 1 
 
qui: xtreg dlhcep baumolv i.year, re sa vce(cluster cid) 
test baumolv = 0 
test baumolv = 1 
 
qui: xtrc dlhcep baumolv, vce(conventional) 
test baumolv = 0 
test baumolv = 1 
 
qui: xtmg dlhcep baumolv, robust  
test baumolv = 0 
test baumolv = 1 
 
qui: xtmg dlhcep baumolv, trend robust  
test baumolv = 0 
test baumolv = 1 
 
qui: xtmg dlhcep baumolv, cce robust  
test baumolv = 0 
test baumolv = 1 
 
qui: xtmg dlhcep baumolv, cce trend robust  
test baumolv = 0 
test baumolv = 1 
 
 
qui: xtmg dlhcep baumolv, aug robust 
test baumolv = 0 
test baumolv = 1 
 
qui: xtmg dlhcep baumolv, aug trend robust  
test baumolv = 0 






use "\\file\UsersA$\aaa121\Home\Desktop\Stata\average values by cross-
section.dta"  
label var dlhcep "Av. HCE Per Capita Growth" 
label var dlwspe " Av. Wages Per Employee Growth" 
label var baumol "Av. Wage-Productivity Gap Growth" 
label var dlgdpr "Av. Real GDP Growth" 
label var dlprod "Av. Productivity Per Employee Growth" 
 
 




replace pos = 9 if country == "Iceland" 
replace pos = 9 if country == "Austria" 
replace pos = 12 if country == "Italy" 
replace pos = 8 if country == "Germany" 
replace pos = 3 if country == "UK" 
replace pos = 9 if country == "Finland" 
replace pos = 12 if country == "France" 
replace pos = 9 if country == "USA" 
 
graph twoway (lfitci dlhcep baumol) (scatter dlhcep baumol, mlabel(country) 
mlabv(pos)), title("HCE per capita Growth by Baumol variable") ytitle("HCE 
Per Capita Growth Rate") xtitle("Wage-Productivity Gap Growth Rate") 





use "\\file\UsersA$\aaa121\Home\Desktop\Stata\hartwig.dta"  
twoway (line dlhcep year) (line dlwspe year, yaxis(2)), by(country) 
 
//Figure 2.3A 





use "\\file\UsersA$\aaa121\Home\Desktop\Stata\average values by cross-
section.dta"  
label var dlhcep "Av. HCE Per Capita Growth" 
label var dlwspe " Av. Wages Per Employee Growth" 
label var baumol "Av. Wage-Productivity Gap Growth" 
label var dlgdpr "Av. Real GDP Growth" 
label var dlprod "Av. Productivity Per Employee Growth" 









replace pos = 6 if country == "Iceland" 
replace pos = 12 if country == "Ireland" 
replace pos = 9 if country == "Austria" 
replace pos = 12 if country == "Italy" 
replace pos = 8 if country == "Germany" 
replace pos = 3 if country == "UK" 
replace pos = 9 if country == "Finland" 
replace pos = 12 if country == "France" 
replace pos = 9 if country == "USA" 
graph twoway (scatter rcm sample, mlabel(country) mlabv(pos)), 
title("Effect of Baumol's Variable on HCE Per Capita Growth") 
subtitle("Heterogeneous Effect Size across OECD Countries") ytitle("Effect 
Size") xtitle("Sample") legend(ring(0) pos(5) order(2 "linear fit" 1 "95% 




replace pos = 3 if country == "Iceland" 
replace pos = 9 if country == "Ireland" 
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replace pos = 9 if country == "Austria" 
replace pos = 12 if country == "Italy" 
replace pos = 6 if country == "Germany" 
replace pos = 12 if country == "Denmark" 
replace pos = 12 if country == "South Korea" 
replace pos = 3 if country == "UK" 
replace pos = 6 if country == "Finland" 
replace pos = 12 if country == "France" 
replace pos = 9 if country == "USA" 
graph twoway (scatter mg sample, mlabel(country) mlabv(pos)), title("Effect 
of Baumol's Variable on HCE Per Capita Growth") subtitle("Heterogeneous 
Effect Size across OECD Countries") ytitle("Effect Size") xtitle("Sample") 
legend(ring(0) pos(5) order(2 "linear fit" 1 "95% CI")) note("Source: 







replace pos = 3 if country == "Iceland" 
replace pos = 9 if country == "Ireland" 
replace pos = 9 if country == "Austria" 
replace pos = 3 if country == "Italy" 
replace pos = 3 if country == "Germany" 
replace pos = 3 if country == "Denmark" 
replace pos = 3 if country == "South Korea" 
replace pos = 3 if country == "UK" 
replace pos = 9 if country == "Switzerland" 
replace pos = 3 if country == "Finland" 
replace pos = 12 if country == "France" 
replace pos = 12 if country == "USA" 
graph twoway (scatter ccemg sample, mlabel(country) mlabv(pos)), 
title("Effect of Baumol's Variable on HCE Per Capita Growth") 
subtitle("Heterogeneous Effect Size across OECD Countries") ytitle("Effect 
Size") xtitle("Sample") legend(ring(0) pos(5) order(2 "linear fit" 1 "95% 
CI")) note("Source: Estimates from Common Correlated Effect Mean Group 






replace pos = 3 if country == "Iceland" 
replace pos = 9 if country == "Ireland" 
replace pos = 9 if country == "Austria" 
replace pos = 3 if country == "Italy" 
replace pos = 3 if country == "Germany" 
replace pos = 3 if country == "Denmark" 
replace pos = 3 if country == "South Korea" 
replace pos = 3 if country == "UK" 
replace pos = 9 if country == "Switzerland" 
replace pos = 3 if country == "Finland" 
replace pos = 12 if country == "France" 
replace pos = 12 if country == "USA" 
graph twoway (scatter amg sample, mlabel(country) mlabv(pos)), 
title("Effect of Baumol's Variable on HCE Per Capita Growth") 
subtitle("Heterogeneous Effect Size across OECD Countries") ytitle("Effect 
Size") xtitle("Sample") legend(ring(0) pos(5) order(2 "linear fit" 1 "95% 







use "\\file\UsersA$\aaa121\Home\Desktop\Stata\effect size by estimator.dta"  
graph hbar est, over( models, axis(off) sort(1) ) blabel(group, pos(base) 
color(bg)) ytitle( "Average Cross-sectional Effect Size" ) title("Baumol's 
Effect Size in OECD by Estimators") 
 
7.3 Test of BCD Hypotheses 
clear 
//Change the .ado file directory to my P drive 
sysdir set OLDPLACE "P:\Desktop\ado" 
 






ge phpnh = 100*phn 
 
ge lhl = 100*lhsl 
 
 
summ phpnh lhl prod pop14 pop65 male lex infmo tobaco alcohc gdpg 
replace lhl = log(lhl) 
 
xtset cid year 
 
////Panel Series CD Test 
xtcd lhl phpnh prod  
xtcd pop14 pop65 male gdpg 
xtcd llex linfmo lalcohc 
 
 
//////////////Maddala & Wu (1999) & Pesaran (2007) [CIPS] Panel Unit Root 
test///////////// 
///Levels 
multipurt lhl phpnh lprod, lags(1) 
multipurt pop14 pop65 male gdpg, lags(1) 
multipurt llex linfmo, lags(1) 
multipurt ltobaco, lags(1) 
multipurt lalcohc, lags(1) 
 
///First Difference 
////Genereate First Difference Series///// 
gen dlhl = d.lhl 
gen dphpnh = d.phpnh 
gen dlprod = d.lprod 
gen dpop14 = d.pop14 
gen dpop65 = d.pop65 
gen dmale = d.male 
gen dgdpg= d.gdpg 
gen dllex = d.llex 
gen dlinfmo = d.linfmo 
gen dltobaco = d.ltobaco 
gen dlalcohc = d.lalcohc 
 
multipurt dlhl dphpnh dlprod, lags(1) 
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multipurt dpop14 dpop65 dmale dgdpg, lags(1) 
multipurt dllex dlinfmo, lags(1) 
multipurt dltobaco, lags(1) 
multipurt dlalcohc, lags(1) 
 
 
//For LHL models 1-9// 
reg lhl lprod pop14 pop65 male llex linfmo 
predict le1, residuals 
estat ic 
estat ovtest  
 
reg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc 
predict le2, residuals 
estat ic 
estat ovtest  
 
reg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc gdpg 
predict le3, residuals 
estat ic 
estat ovtest  
 
reg lhl lprod pop14 pop65 male llex linfmo  i.year i.cid 
predict le4, residuals 
estat ic 
estat ovtest  
 
reg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc  i.year i.cid 
predict le5, residuals 
estat ic 
estat ovtest  
 
reg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc gdpg i.year 
i.cid 
predict le6, residuals 
estat ic 
estat ovtest  
 
reg lhl lprod pop14 pop65 male llex linfmo cid##c.year 
predict le7, residuals 
estat ic 
estat ovtest  
 
 
reg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc cid##c.year 
predict le8, residuals 
estat ic 
estat ovtest  
 
reg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc gdpg cid##c.year 
predict le9, residuals 
estat ic 
estat ovtest  
estat ovtest  
 
//CROSS-SECTION DEPENDENCE & PURT TEST// 
//For the Predicted Residuals// 
 
xtcd le1 le4 le7 
 




//For PHPNH models 1-9// 
reg phpnh prod pop14 pop65 male lex infmo 
predict pe1, residuals 
estat ic 
estat ovtest  
 
reg phpnh prod pop14 pop65 male lex infmo tobaco alcohc 
predict pe2, residuals 
estat ic 
estat ovtest  
 
reg phpnh prod pop14 pop65 male lex infmo tobaco alcohc gdpg 
predict pe3, residuals 
estat ic 
estat ovtest  
 
reg phpnh prod pop14 pop65 male lex infmo  i.year i.cid 
predict pe4, residuals 
estat ic 
estat ovtest  
 
reg phpnh prod pop14 pop65 male lex infmo tobaco alcohc  i.year i.cid 
predict pe5, residuals 
estat ic 
estat ovtest  
 
reg phpnh prod pop14 pop65 male lex infmo tobaco alcohc gdpg i.year i.cid 
predict pe6, residuals 
estat ic 
estat ovtest  
 
reg phpnh prod pop14 pop65 male lex infmo cid##c.year 
predict pe7, residuals 
estat ic 
estat ovtest  
 
reg phpnh prod pop14 pop65 male lex infmo tobaco alcohc cid##c.year 
predict pe8, residuals 
estat ic 
estat ovtest  
 
reg phpnh prod pop14 pop65 male lex infmo tobaco alcohc gdpg cid##c.year 
predict pe9, residuals 
estat ic 
estat ovtest  
 
 
//CROSS-SECTION DEPENDENCE & PURT TEST// 
//For the Predicted Residuals// 
 
xtcd pe1 pe4 pe7 
 
multipurt pe1 pe4 pe7, lags(1) 
 
  
///*******TEST OF SERIAL CORRELATION********//// 
tabulate cid, gen(cid) 
forvalues i = 1/27 { 




//**LHL Model 7**// 
xtserial lhl lprod pop14 pop65 male llex linfmo cid1-cid27 year cidyear1-
cidyear27 
//**LHL Model 8**// 
xtserial lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc cid1-cid27 
year cidyear1-cidyear27 
//**LHL Model 9**// 
xtserial lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc gdpg cid1-
cid27 year cidyear1-cidyear27 
 
 
//**PHN Model 7**// 
xtserial phpnh prod pop14 pop65 male lex infmo cid1-cid27 year cidyear1-
cidyear27 
//**PHN Model 8**// 
xtserial phpnh prod pop14 pop65 male lex infmo tobaco alcohc cid1-cid27 
year cidyear1-cidyear27 
//**PHN Model 9**// 
xtserial phpnh prod pop14 pop65 male lex infmo tobaco alcohc gdpg cid1-
cid27 year cidyear1-cidyear27 
 
 
//PCSE:- LHL Model 7// 






//Heterogeneous Slopes Estimators with Group-Specific Trends// 
//LHL Model 7// 
xtmg lhl lprod pop14 pop65 male llex linfmo, trend res(let1) 
xtmg lhl lprod pop14 pop65 male llex linfmo, cce trend res(let2) 
xtmg lhl lprod pop14 pop65 male llex linfmo, aug trend res(let3) 
 
//LHL Model 8// 
xtmg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc, trend 
res(let4) 
xtmg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc, cce trend 
res(let5) 
xtmg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc, aug trend 
res(let6) 
 
//LHL Model 9// 
xtmg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc gdpg, trend 
res(let7) 
xtmg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc gdpg, cce trend 
res(let8) 
xtmg lhl lprod pop14 pop65 male llex linfmo ltobaco lalcohc gdpg, aug trend 
res(let9) 
 
//PCSE:- PHPNH Model 7// 






//PHPNH Model 7// 
xtmg phpnh prod pop14 pop65 male lex infmo, trend res(pet1) 
xtmg phpnh prod pop14 pop65 male lex infmo, cce trend res(pet2) 
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xtmg phpnh prod pop14 pop65 male lex infmo, aug trend res(pet3) 
 
//PHPNH Model 8// 
xtmg phpnh prod pop14 pop65 male lex infmo tobaco alcohc, trend res(pet4) 
xtmg phpnh prod pop14 pop65 male lex infmo tobaco alcohc, cce trend 
res(pet5) 
xtmg phpnh prod pop14 pop65 male lex infmo tobaco alcohc, aug trend 
res(pet6) 
 
//PHPNH Model 9// 
xtmg phpnh prod pop14 pop65 male lex infmo tobaco alcohc gdpg, trend 
res(pet7) 
xtmg phpnh prod pop14 pop65 male lex infmo tobaco alcohc gdpg, cce trend 
res(pet8) 
xtmg phpnh prod pop14 pop65 male lex infmo tobaco alcohc gdpg, aug trend 
res(pet9) 
 
//END OF Heterogeneous Slopes Estimation for MG, CCEMG and AMG// 
 
 
//RESIDUAL CROSS_SECTION DEPENDENCE TEST// 
xtcd let1 let2 let3 
xtcd let4 let5 let6 
xtcd let7 let8 let9 
 
 
xtcd pet1 pet2 pet3 
xtcd pet4 pet5 pet6 
xtcd pet7 pet8 pet9 
 
///////Residual Based Cointegration Technique/////// 
multipurt let1 let2 let3, lags(1) 
multipurt let4 let5 let6, lags(1) 
multipurt let7 let8 let9, lags(1) 
 
multipurt pet1 pet2 pet3, lags(1) 
multipurt pet4 pet5 pet6, lags(1) 
multipurt pet7 pet8 pet9, lags(1) 
 
7.4 Monte Carlo Simulation Experiments 
/********************************************* 
**                                          ** 
** Monte Carlo Program                     ** 
**                                          ** 
**  MC 2e                                   ** 
**                                          ** 
**  (a) Nonstationary variables             ** 
**  (b) common f's                          ** 
**  (c) factor overlap btw x & y            ** 
**  (d) loadings on f's are heterog         ** 
**  (e) heterog parameters on x in y        ** 
**  (f) RMSE, Coverage & Efficiency Rates   ** 
**                                          ** 
**  24th April 2016                         ** 








"MC2(e) simulated on: "  datestr(0) "  at   "  timestr(0); 
"Case: heterog beta, common factors with heterog loadings, "; 




*   Replications   * 
*******************/ 
iter    = 5000;       @ # of iterations @ 




*   Panel dimensions  * 
**********************/ 
  
/* Time-series dimension */ 
let jj[6,1]= 10 20 30 50 100 150; 
for j1(2,2,1); 
    jj1=jj[j1,1]; 
    /* Cross-section dimension */ 
     
    let jjj[6,1]= 10 20 30 50 100 150; 
    for j2(3,3,1); 
        jj2=jjj[j2,1]; 
        /***************** 
        *   Paramaeters  * 
        *****************/ 
        /* Variation in beta (no/yes) */ 
         
        let jjjj[2,1]= 0 1; 
        for j3(2,2,1); 
            jj3=jjjj[j3,1]; 
            /* Drift/intercept in the f-equation (no/yes) */ 
            /* note: f's might be 'turned off' below! */ 
             
            let jjjjj[2,1]= 0 1; 
            for j4(2,2,1); 
                jj4=jjjjj[j4,1]; 
                /* Variation in the unobserved f in the y-equation (no/yes) 
*/ 
                /* note: f's might be 'turned off' below! */ 
                 
                let jjjjjj[2,1]= 0 1; 
                for j5(2,2,1); 
                    jj5=jjjjjj[j5,1]; 
                    /* Linear trend in the y-equation (no/yes) */ 
                     
                    let jjjjjjj[2,1]= 0 1; 
                    for j6(1,1,1); 
                        jj6=jjjjjjj[j6,1]; 
                        /* Recap of other parameter and iteration values */ 
                        tt      = jj1;      @ # of T observations @ 
                        nn      = jj2;      @ # of N observations @ 
                        betac    = 1;        @ coefficient on x (mean) @ 
                        seed    = 1974; 
                        /* Pesaran setup: factors are nonstationary */ 
                        rho_1=1;  
                        rho_2=1; 
                        rho_3=1;  
203 
 
                        /* Factor loadings on common observed effect 
(intercepts in y- and x-equations (fixed) */ 
                        {alpha_i,seed}=rndu(nn,1,seed); 
                        alpha_i=2.5 + (alpha_i-1); 
                        {a_i,seed}=rndu(nn,1,seed); 
                        a_i=6+ 2 .* (a_i-1); 
                        /*the drift terms in the unobserved common factor 
equation */ 
                        mu_1=0.015;      /* baseline value: 0.015 */ 
                        mu_2=0.012;      /* baseline value: 0.012 */ 
                        mu_3=0.01;       /* baseline value: 0.01 */ 
                        /*the factor loadings (means) on the unobserved f's 
in the x- and y-equations */ 
                        /* Note: these might be 'turned off' in the 
construction of heterogeneous loadings below */ 
                        gamma_y1=0.5;   /* baseline value: 0.5, thus range 
in theory [0, 1] */ 
                        gamma_y2=0.75;  /* baseline value: 0.75, thus range 
in theory [0.25, 1.25] */ 
                        gamma_x1=0.5;   /* baseline value: 0.5, thus range 
in theory [0, 1]  */ 
                        gamma_x3=0.75;  /* baseline value: 0.75, thus range 
in theory [0.25, 1.25]   */ 
                         
                        /* parameter on the simultaneity/feedback term */ 
                        gamma_eps=0;  /* baseline value: 0, no 
simultaneity/feedbacks */ 
                        /* autoregressive component of the x-equation 
errors */ 
                        ar_x=0.25;       /* baseline: 0.25 */ 
                        /* autoregressive component of the y-equation 
errors */ 
                        ar_eps=0;       /* Baseline: 0 - cointegration, no 
AR */ 
                        
/**************************************************************************
********************/ 
                        /************************************** 
                        *   Storage-vectors for the estimates * 
                        **************************************/ 
                        /* Technology parameters in the y-equation */ 
                        alphaM  = zeros(iter,1); /* TFP level */ 
                        betaM   = zeros(iter,1); /* capital coefficient */ 
                        /* THE POOLED REGRESSIONS */ 
                        /* POLS estimator (year-dummy augmented)*/ 
                        olsb    = zeros(iter,1) ; 
                        olsst   = zeros(iter,1); 
                        olst    = zeros(iter,1); 
                        /* Fixed effects estimator (year-dummy augmented)*/ 
                        feb    = zeros(iter,1) ; 
                        fest   = zeros(iter,1); 
                        fet    = zeros(iter,1); 
                        /* CCEP*/ 
                        cceb    = zeros(iter,1) ; 
                        ccest   = zeros(iter,1); 
                        ccet    = zeros(iter,1); 
                        /* First difference OLS */ 
                        fdb    = zeros(iter,1) ; 
                        fdst   = zeros(iter,1) ; 
                        fdt     = zeros(iter,1) ; 
                        /* Infeasible Pooled */ 
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                        inffeb    = zeros(iter,1) ; 
                        inffest   = zeros(iter,1) ; 
                        inffet    = zeros(iter,1) ; 
                         
                        /* THE AVERAGED COUNTRY REGRESSIONS */ 
                        /* CCEMG */ 
                        ccemgb  = zeros(iter,1) ; 
                        ccemgst = zeros(iter,1) ; 
                        ccemgt  = zeros(iter,1) ; 
                        /* AMG (i) & (ii)*/ 
                        amgb = zeros(iter,1); 
                        amgst = zeros(iter,1) ; 
                        amgt = zeros(iter,1) ; 
                        amg2b = zeros(iter,1); 
                        amg2st = zeros(iter,1) ; 
                        amg2t = zeros(iter,1) ; 
                        /* Naive MG */ 
                        mgb = zeros(iter,1); 
                        mgst = zeros(iter,1) ; 
                        mgt = zeros(iter,1) ; 
                        /* Infeasible MG */ 
                        infmgb = zeros(iter,1); 
                        infmgst = zeros(iter,1) ; 
                        infmgt = zeros(iter,1) ; 
                         
                        /*********************  
                        *    STORAGE: RMSE   *  
                        *********************/ 
                        mseols=zeros(iter,1); 
                        msefe=zeros(iter,1); 
                        msecce=zeros(iter,1); 
                        msefd=zeros(iter,1); 
                        mseinffe=zeros(iter,1); 
                        mseccemg=zeros(iter,1); 
                        mseamg=zeros(iter,1); 
                        mseamg2=zeros(iter,1); 
                        msemg=zeros(iter,1); 
                        mseinfmg=zeros(iter,1); 
                         
                        /*********************  
                        *    STORAGE: Coverage   *  
                        *********************/ 
                        cintols=zeros(iter,1); 
                        cintfe=zeros(iter,1); 
                        cintcce=zeros(iter,1); 
                        cintfd=zeros(iter,1); 
                        cintinffe=zeros(iter,1); 
                        cintccemg=zeros(iter,1); 
                        cintamg=zeros(iter,1); 
                        cintamg2=zeros(iter,1); 
                        cintmg=zeros(iter,1); 
                        cintinfmg=zeros(iter,1); 
                         
                        cuols=zeros(iter,1); 
                        cufe=zeros(iter,1); 
                        cucce=zeros(iter,1); 
                        cufd=zeros(iter,1); 
                        cuinffe=zeros(iter,1); 
                        cuccemg=zeros(iter,1); 
                        cuamg=zeros(iter,1); 
                        cuamg2=zeros(iter,1); 
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                        cumg=zeros(iter,1); 
                        cuinfmg=zeros(iter,1); 
                         
                        clols=zeros(iter,1); 
                        clfe=zeros(iter,1); 
                        clcce=zeros(iter,1); 
                        clfd=zeros(iter,1); 
                        clinffe=zeros(iter,1); 
                        clccemg=zeros(iter,1); 
                        clamg=zeros(iter,1); 
                        clamg2=zeros(iter,1); 
                        clmg=zeros(iter,1); 
                        clinfmg=zeros(iter,1); 
                        
                        
/**************************************************************************
********************/ 
                        /*********************  
                        *    OUTPUT: Setup   *  
                        *********************/ 
                        format /rd 2,2; 
                         
                        if jj4==1; 
                            "Drift in all f-equations"; 
                        elseif jj4==0; 
                            "No drift in the f-equations"; 
                        endif; 
                         
                        if jj5==1; 
                            "Common factors have heterogeneous factor 
loadings across countries"; 
                        elseif jj5==0; 
                            "Common factors have the same factor loadings 
across countries"; 
                        endif; 
                         
                        format /rd 2,2; 
                        "Autoregressive errors in x: ar_u coefficient " 
ar_x; 
                        "Feedback coefficient: gamma_eps " gamma_eps; 
                        
"************************************************************************"; 
                        
/**************************************************************************
********************/ 
                        /*****************************  
                        *    ITERATIONS BEGIN HERE   * 
                        *****************************/ 
                          
                        for i(1,iter,1); 
                            seed=1974; 
                            seed_i=seed+i; 
                            seed_i2=seed+i+2; 
                            seed_i3=seed+i+3; 
                            seed_i4=seed+i+4; 
                            seed_i5=seed+i+5; 
                            seed_i6=seed+i+6; 
                            seed_i7=seed+i+i; 
                            /************************************ 
                            *   Observed common factors (d)     * 
                            ************************************/ 
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                            /* intercepts in x- & y-equations */ 
                            d_t=ones(tt+50,1);  
                            /************************************** 
                            *   Unobserved common factors (f)     * 
                            ***************************************/ 
                            f_1t=zeros(tt+50,1); 
                            f_2t=zeros(tt+50,1); 
                            f_3t=zeros(tt+50,1); 
                            seed_i=seed+i; 
                            {v_ft1,seed_i}=rndn(tt+50,1,seed_i); 
                            v_ft1=sqrt(0.00125).*v_ft1; 
                             
                            {v_ft2,seed_i2}=rndn(tt+50,1,seed_i2); 
                            v_ft2=sqrt(0.00125).*v_ft2; 
                             
                            {v_ft3,seed_i3}=rndn(tt+50,1,seed_i3); 
                            v_ft3=sqrt(0.00125).*v_ft3; 
                             
                            /* benchmark value: 0.00125 */  
                             
                            for j(2,tt+50,1); 
                                f_1t[j,1]=jj4*mu_1+rho_1*f_1t[j-
1,1]+v_ft1[j,1]; 
                                f_2t[j,1]=jj4*mu_2+rho_2*f_2t[j-
1,1]+v_ft2[j,1]; 
                                f_3t[j,1]=jj4*mu_3+rho_3*f_3t[j-
1,1]+v_ft3[j,1]; 
                             
                            endfor; 
                            f_1tlag=zeros(1,1)|f_1t[1:rows(f_1t)-1,.]; 
                            f_2tlag=zeros(1,1)|f_2t[1:rows(f_2t)-1,.]; 
                            f_3tlag=zeros(1,1)|f_3t[1:rows(f_3t)-1,.]; 
                             
                            /* Result: 3 unobserved common factors f_1t, 
f_2t, f_3t */ 
                            
/********************************************************* 
                            *    Errors in the x equation (vary across 
countries i)  * 
                            
*********************************************************/ 
                            u_it=zeros(tt+50,nn); 
                            {v_sig,seed_i2}=rndu(nn,1,seed_i2); 
                            v_sig=2+ 2 .*(v_sig -0.5); 
                            v_sig=v_sig ./ 1000; /* benchmark: ./ 1000 */ 
                            {vt,seed_i3}=rndn(tt+50,1,seed_i3); 
                             
                            for j(1,nn,1); 
                                u_it[.,j]=sqrt(v_sig[j,1]).* vt; 
                                 
                            endfor; 
                            /* variance ranges from sqrt(0.001) to 
sqrt(0.003) */ 
                            /*  error matrix (tt by n)  */ 
                            
/*************************************************** 
                            *    Factor loadings of observed common effects    
* 




                            /* alpha_i & a_i are fixed across replications 
--- see above */ 
                            
/********************************************************************* 
                            *   Parameters on the unobserved common factor 
in the y equation     * 
                            
*********************************************************************/ 
                             
                            {gamma_y1i,seed_i5}=rndu(nn,1,seed_i5); 
                            gamma_y1i=gamma_y1+jj5*(gamma_y1i -0.5); 
                             
                            {gamma_y2i,seed_i4}=rndu(nn,1,seed_i4); 
                            gamma_y2i=gamma_y2+jj5*(gamma_y2i -0.5); 
                             
                            {gamma_x1i,seed_i6}=rndu(nn,1,seed_i6); 
                            gamma_x1i=gamma_x1+jj5*(gamma_x1i -0.5); 
                          
                            {gamma_x3i,seed_i7}=rndu(nn,1,seed_i7); 
                            gamma_x3i=gamma_x3+jj5*(gamma_x3i -0.5); 
                             
                           
                            /* Factor loadings on lagged factors: rho * 
gamma_xi */ 
                            gamma_x1ilag=ar_x .* gamma_x1i; 
                            gamma_x3ilag=ar_x .* gamma_x3i; 
                             
                            /*  
                            No common factors  
                            gamma_y1i=0*(rndus(nn,1,seed_i5)-0.5); 
                            gamma_y2i=0*(rndus(nn,1,seed_i4)-0.5);  
                            gamma_x1i=0*(rndus(nn,1,seed_i6)-0.5);  
                            gamma_x3i=0*(rndus(nn,1,seed_i2)-0.5); 
                             
                            Common factors, but no overlap btw x and y: 
                            gamma_y1i=0*(rndus(nn,1,seed_i5)-0.5); 
                            gamma_y2i=gamma_y2+(rndus(nn,1,seed_i4)-0.5);  
                            gamma_x1i=0*(rndus(nn,1,seed_i6)-0.5);  
                            gamma_x3i=gamma_x3+(rndus(nn,1,seed_i2)-0.5); 
                             
                            Factor overlap: 
                            gamma_y1i=gamma_y1+jj5*(rndus(nn,1,seed_i5)-
0.5); 
                            gamma_y2i=gamma_y2+jj5*(rndus(nn,1,seed_i4)-
0.5); 
                             
                            gamma_x1i=gamma_x1+jj5*(rndus(nn,1,seed_i6)-
0.5); 
                            gamma_x3i=gamma_x3+jj5*(rndus(nn,1,seed_i2)-
0.5); 
                            */ 
                            /************************ 
                            *    beta parameters    * 
                            ************************/ 
                            @ beta_i: either they do not vary (1), or they 
uniformly over [0.75, 1.25] with mean 1 @ 
                            {beta_i,seed_i}=rndu(nn,1,seed_i); 
                            beta_i=betac+jj3*((beta_i-0.5)/2);  
                            betaM[i,1]=meanc(beta_i); 




                            *    Errors in the y equation (vary across i)  
* 
                            
***********************************************/ 
                            /* benchmark value: 0.00125 */ 
                            {eps_it,seed_i4}=rndn(tt+50,nn,seed_i4);  
                            eps_it=sqrt(.00125).*eps_it; 
                            /*  Result: an error matrix (tt by n)  */ 
                            /* lagged errors (may be used in later 
simulations) */ 
                             
                            
eps2=zeros(1,cols(eps_it))|eps_it[1:rows(eps_it)-1,.]; 
                            
eps3=zeros(2,cols(eps_it))|eps_it[1:rows(eps_it)-2,.]; 
                             
                            /************************ 
                            *     X and Y series    * 
                            ************************/ 
                            gammas= zeros(tt+50,nn); 
                            y_it=zeros(tt+50,nn); 
                            x_it=zeros(tt+50,nn); 
                             
                            
                            for k(1,nn,1); 
                                for p(2,tt+50,1); 
                                    x_it[p,k]=((1-ar_x).*a_i[k,1]) + 
(gamma_x1i[k,1]*f_1t[p,1]) - (gamma_x1ilag[k,1] .* f_1tlag[p,1]) + 
(gamma_x3i[k,1]*f_3t[p,1]) - (gamma_x3ilag[k,1] .* f_3tlag[p,1]) + 
(ar_x.*x_it[p-1,k]) + u_it[p,k]; 
                                     
                                endfor; 
                                 
                            endfor; 
                             
                            for k(1,nn,1);  
                                y_it[.,k]=alpha_i[k,1].*(d_t) + 
beta_i[k,1].*x_it[.,k] + gamma_y1i[k,1] .* f_1t+ gamma_y2i[k,1] .* f_2t + 
eps_it[.,k]; 
                                 
                            endfor; 
                             
                            x_it=x_it[51:rows(x_it),.]; 
                            y_it=y_it[51:rows(y_it),.]; 
                            f_1t=f_1t[51:rows(f_1t),.]; 
                            f_2t=f_2t[51:rows(f_2t),.]; 
                            f_3t=f_3t[51:rows(f_3t),.]; 
                            f_1tlag=f_1tlag[51:rows(f_1tlag),.]; 
                            f_2tlag=f_2tlag[51:rows(f_2tlag),.]; 
                            f_3tlag=f_3tlag[51:rows(f_3tlag),.]; 
                            eps_it=eps_it[51:rows(eps_it),.]; 
                            /* Result: x matrix (tt by nn), y matrix (tt by 
nn) */ 
                            /* For the pooled regressions */ 
                            /******************************/ 
                            /* Prep OLS and FE */ 
                            /*******************/ 
ydum=eye(tt); 
ydum2=ydum[.,2:cols(ydum)]; /* year dummies */ 




cdum=  cdum .*. ones(tt,1); /* country dummies */ 
 
 
/* OLS */ 
xols=vec(x_it)~ones(tt*nn,1)~ydum2; /* ~ydum2 */ 
yols=vec(y_it); 
 
/* FE  */ 









xsec=eye(nn) .*. xxxt; 





/* Prep FD */ 
/***********/ 
ydumfd=ydum[2:rows(ydum),2:cols(ydum)]-ydum[1:rows(ydum)-1,2:cols(ydum)]; 
ydumfd=ones(nn,1) .*. ydumfd;             /* year dummies in first 







dx=vec(dxxx);     /* x in FD */ 
dx=dx~ydumfd;     /* ~ydumfd RHS */                              
dy=vec(dyyy);     /* y in FD */ 
 
 
/* Prep Infeasible FE */ 
/**********************/ 
tfp3=eye(nn) .*. f_1t ~ eye(nn) .*. f_2t; 
cdum=eye(nn); 









*    ESTIMATION RESULTS    * 
***************************/ 
zstat=cdfNi(0.975); 
/* Pooled estimates */ 
 
/********************************* 





olsbi = invpd(xols'xols)*(xols'yols); 
e  = yols - xols*olsbi; 
s2 = (e'e)/(nn*tt-1-(tt-1)-1); /* df = obs - k - (t-1) - intercept */ 
v  = s2*invpd(xols'xols); 







if (clols[i,1] <= olsb[i,1]) AND (olsb[i,1] <= cuols[i,1]); 






*    FE with T-1 year dummies   * 
********************************/ 
 
febi = invpd(xfe'xfe)*(xfe'yfe); 
e  = yfe - xfe*febi; 
s2 = (e'e)/(nn*tt-1-(tt-1)-nn); /* df = obs - k - (t-1) - N intercepts */ 
v  = s2*invpd(xfe'xfe); 








if (clfe[i,1] <= feb[i,1]) AND (feb[i,1] <= cufe[i,1]); 








*    CCEP   * 
************/ 
 
ccepbi = invpd(xc'xc)*(xc'yc); 
e  = yc - xc*ccepbi; 
s2 = (e'e)/(nn*tt-(nn*2)-1-nn); /* df = obs - (k*N) - k - N intercepts */ 
v  = s2*invpd(xc'xc); 








if (clcce[i,1] <= cceb[i,1]) AND (cceb[i,1] <= cucce[i,1]); 









*   FD OLS  * 
************/ 
 
fdbi = invpd(dx'dx)*(dx'dy); 
e  = dy - dx*fdbi; 
s2 = (e'e)/(nn*tt-1-(tt-1)-0); /* df = obs - k - year dummies - no 
intercepts */ 
v  = s2*invpd(dx'dx); 








if (clfd[i,1] <= fdb[i,1]) AND (fdb[i,1] <= cufd[i,1]); 





dx = dx~ydumfd; 
fdbi = invpd(dx'dx)*(dx'dy); 
*/ 





*    Infeasible FE   * 
*********************/ 
 
inffebi = invpd(x'x)*(x'y); 
e  = y - x*inffebi; 
s2 = (e'e)/(nn*tt-1-(2*nn)-nn); /* df = obs - k - number of f's*N  - N 
intercepts */ 
v  = s2*invpd(x'x); 








if (clinffe[i,1] <= inffeb[i,1]) AND (inffeb[i,1] <= cuinffe[i,1]); 














/* Country regressions */ 
 
 
/* Prep CCEMG and AMG */ 
/**********************/ 
xxxt=meanc(x_it.'); 
yyyt=meanc(y_it.'); /* vector of period averages for t=1,...,T*/ 
 
indx=vec(x_it)~ones(tt*nn,1); 
xsec=ones(nn,1) .*. xxxt; 
ysec=ones(nn,1) .*. yyyt; 
indMy=vec(y_it); 
indMya=vec(y_it)- ones(nn,1) .*. cdp; 
indMx=indx~ysec~xsec; 
indM0x=vec(x_it)~ysec~xsec; 
trends=ones(nn,1) .*. seqa(0,1,tt); 
tfp=ones(nn,1) .*. cdp; 


























indccemgb1i  = invpd(indx'indx)*(indx'indy); 
e  = indy - indx*indccemgb1i ; 
s2 = (e'e)/(tt-4); 
v  = s2*invpd(indx'indx); 
se = sqrt(diag(v)); 
indccemgb1[j,.]=indccemgb1i[1,1]; 








indamgb1i  = invpd(indx'indx)*(indx'indy); 
e  = indy - indx*indamgb1i; 
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s2 = (e'e)/(tt-3); 
v  = s2*invpd(indx'indx); 










amg2b1i  = invpd(infx'infx)*(infx'infy); 
e  = infy - infx*amg2b1i; 
s2 = (e'e)/(tt-4); 
v  = s2*invpd(infx'infx); 



















infmgb1i  = invpd(infx'infx)*(infx'infy); 
e  = infy - infx*infmgb1i; 
s2 = (e'e)/(tt-4); 
v  = s2*invpd(infx'infx); 







/* End of loop of N country regressions */ 
 
/* Construct mean estimates from country estimates */ 
ccemgb[i,1]  = meanc(indccemgb1); 
amgb[i,1] = meanc(indamgb1); 
amg2b[i,1] = meanc(amg2b1); 
mgb[i,1] = meanc(mgb1); 
infmgb[i,1] = meanc(infmgb1); 
 










/* Construct standard errors for MG-type estimators */ 
ccemgdev=zeros(nn,1); 



































if (clccemg[i,1] <= ccemgb[i,1]) AND (ccemgb[i,1] <= cuccemg[i,1]); 






if (clamg[i,1] <= amgb[i,1]) AND (amgb[i,1] <= cuamg[i,1]); 






if (clamg2[i,1] <= amg2b[i,1]) AND (amg2b[i,1] <= cuamg2[i,1]); 






if (clmg[i,1] <= mgb[i,1]) AND (mgb[i,1] <= cumg[i,1]); 
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if (clinfmg[i,1] <= infmgb[i,1]) AND (infmgb[i,1] <= cuinfmg[i,1]); 



































    "Heterogeneous beta with mean: " betai; 
elseif jj3==0; 




*    OUTPUT: Results   * 
***********************/ 
format /rd 2,0; 
 
t1 = date; 
timing=round((ethsec(t0,t1)/100)); 
if timing<=60; 
print "Total time since start of simulation: " timing " seconds"; 
elseif timing>60; 






"Monte Carlo results: " iter "iterations  T=" tt " N=" nn ; 
"**************************************************************************
***************************"; 
format /rd 2,4; 
"               Mean      Median      emp.ste     mean ste    mean RMSE    
Coverage    Efficiency Rate"; 
"--------------------------------------------------------------------------
----------------------------"; 
"POLS           " meanc(olsb) "    " median(olsb) "     " stdc(olsb) "     
" meanc(olsst) "     " meanc(mseols) "     " meanc(cintols)*100 "     " 
effols; 
"FE             " meanc(feb) "    " median(feb) "     " stdc(feb) "     " 
meanc(fest) "     " meanc(msefe) "     " meanc(cintfe)*100 "     " efffe; 
"CCEP           " meanc(cceb) "    " median(cceb) "     " stdc(cceb) "     
" meanc(ccest) "     " meanc(msecce) "     " meanc(cintcce)*100 "     " 
effcce; 
"FD             " meanc(fdb) "    " median(fdb) "     " stdc(fdb) "     " 
meanc(fdst) "     " meanc(msefd) "     " meanc(cintfd)*100  "     " efffd; 
"Infeasible FE  " meanc(inffeb) "    " median(inffeb) "     " stdc(inffeb) 
"     " meanc(inffest) "     " meanc(mseinffe) "     " meanc(cintinffe)*100 
"     " effinffe; 
"--------------------------------------------------------------------------
------------------------------"; 
"CCEMG          " meanc(ccemgb) "    " median(ccemgb) "     " stdc(ccemgb) 
"     " meanc(ccemgst) "     " meanc(mseccemg) "     " meanc(cintccemg)*100 
"     " effccemg; 
"AMG(i)         " meanc(amgb) "    " median(amgb) "     "  stdc(amgb) "     
" meanc(amgst) "     " meanc(mseamg) "     " meanc(cintamg)*100 "     " 
effamg; 
"AMG(ii)        " meanc(amg2b) "    " median(amg2b) "     "  stdc(amg2b) "     
" meanc(amg2st) "     " meanc(mseamg2) "     " meanc(cintamg2)*100 "     " 
effamg2; 
"MG             " meanc(mgb) "    " median(mgb) "     " stdc(mgb) "     " 
meanc(mgst) "     " meanc(msemg) "     " meanc(cintmg)*100 "     " effmg; 
"MG (true f's)  " meanc(infmgb) "    " median(infmgb) "     " stdc(infmgb) 
"     " meanc(infmgst) "     " meanc(mseinfmg) "     " meanc(cintinfmg)*100 

















7.5 Income Elasticity of Healthcare Expenditure 
clear 
//Change the .ado file directory to my P drive 
sysdir set OLDPLACE "P:\Desktop\ado" 
 




use "\\file\UsersA$\aaa121\Home\Desktop\Fragile paper 
Rework\Data\Estimation\H-I 54 African Countries Full.dta" 
 
cd "\\file\UsersA$\aaa121\Home\Desktop\Fragile paper 
Rework\Data\Estimation" 
 




//Somalia and South sudan have missing observations for all the variables 
excluding LEX, INM 
 
drop if country == "Somalia" 
 




//use "\\file\UsersA$\aaa121\Home\Desktop\Fragile paper 




//**********Exclude countries with over 10 observations for GFC ********// 
 
/**/ 
drop if country == "Cabo Verde" 
drop if country == "Ethiopia" 
drop if country == "Lesotho" 
drop if country == "Sao Tome and Principe" 





summarize the ghe ope gdp lex inm p15 p65 oda gfc 
 
gen lthe = log(the) 
gen lghe = log(ghe) 
gen lope = log(ope) 
gen lgdp = log(gdp) 
gen llex = log(lex) 
gen linm = log(inm) 
gen lp15 = log(p15) 
gen lp65 = log(p65) 
gen loda = log(oda) 
gen lgfc = log(gfc) 
 
 
gen dlthe = d.lthe 
gen dlghe = d.lghe 
gen dlope = d.lope 
gen dlgdp = d.lgdp 
gen dllex = d.llex 
gen dlinm = d.linm 
gen dlp15 = d.lp15 
gen dlp65 = d.lp65 
gen dloda = d.loda 









//matrix list e(b) 
eststo m1: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc, cce trend robust 
res(ba11) 
di e(trend_sig) 
test lgdp = 1 
 
eststo m2: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc, cce trend robust 
res(ba21) 
di e(trend_sig) 
test lgdp = 1 
 
eststo m3: xtmg lope lgdp llex linm lp65 lp15 loda lgfc, cce trend robust 
res(ba31) 
di e(trend_sig) 
test lgdp = 1 
 
esttab m1 m2 m3 using baselineresults.csv, star(* 0.10 ** 0.05 *** 0.01)  
 
xtcd ba11 ba21 ba31 
multipurt ba11 ba21 ba31, lags(1) 
 
***************************** 
/** Test of Slope Heterogeneity**/ 
***************************** 
xtrc lthe lgdp llex linm lp65 lp15 loda lgfc, vce(conventional) 
xtrc lghe lgdp llex linm lp65 lp15 loda lgfc, vce(conventional) 




/**Alternative Specification Without Trend**/ 
***************************** 
eststo m4: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc, cce robust 
res(ba12) 
test lgdp = 1 
 
eststo m5: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc, cce robust 
res(ba22) 
test lgdp = 1 
 
eststo m6: xtmg lope lgdp llex linm lp65 lp15 loda lgfc, cce robust 
res(ba32) 
test lgdp = 1 
 
esttab m4 m5 m6 using alternativeresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba12 ba22 ba32 
multipurt ba12 ba22 ba32, lags(1) 
 
***************************** 
/**Pooled Type Estimators**/ 
***************************** 
/**** POLS Method****/ 




predict ba13, residual 
estat ovtest   
di e(rmse) 
estat ic 
test lgdp = 1 
 
reg lghe lgdp llex linm lp65 lp15 loda lgfc cid#c.year, vce(robust) 
eststo m8 
predict ba23, residual 
estat ovtest   
di e(rmse) 
estat ic 
test lgdp = 1 
 
reg lope lgdp llex linm lp65 lp15 loda lgfc cid#c.year, vce(robust) 
eststo m9 
predict ba33, residual 
estat ovtest   
di e(rmse) 
estat ic 
test lgdp = 1 
 
esttab m7 m8 m9 using pooledestimatorresults.csv, star(* 0.10 ** 0.05 *** 
0.01)  
 
xtcd ba13 ba23 ba33 
multipurt ba13 ba23 ba33, lags(1) 
 
 
/****Fixed Effect Method****/ 
reg lthe lgdp llex linm lp65 lp15 loda lgfc cid##c.year, vce(cluster cid) 
eststo m10 
predict ba14, residual 
test lgdp = 1 





reg lghe lgdp llex linm lp65 lp15 loda lgfc cid##c.year, vce(cluster cid) 
eststo m11 
predict ba24, residual 
test lgdp = 1 





reg lope lgdp llex linm lp65 lp15 loda lgfc cid##c.year, vce(cluster cid) 
eststo m12 
predict ba34, residual 
test lgdp = 1 




esttab m10 m11 m12 using FEresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba14 ba24 ba34 







eststo m13: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc, aug trend robust 
res(ba15) 
di e(trend_sig) 
test lgdp = 1 
 
eststo m14: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc, aug trend robust 
res(ba25) 
di e(trend_sig) 
test lgdp = 1 
 
eststo m15: xtmg lope lgdp llex linm lp65 lp15 loda lgfc, aug trend robust 
res(ba35) 
di e(trend_sig) 
test lgdp = 1 
 
esttab m13 m14 m15 using AMGresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba15 ba25 ba35 








/****Low Middle Income****/ 
 
eststo m16: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc if income_group == 
"LMI", cce trend robust res(ba16) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m17: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc if income_group == 
"LMI", cce trend robust res(ba26) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m18: xtmg lope lgdp llex linm lp65 lp15 loda lgfc if income_group == 
"LMI", cce trend robust res(ba36) 
di e(trend_sig) 
test lgdp = 1 
 
esttab m16 m17 m18 using LMIresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba16 ba26  ba36  
multipurt ba16 ba26 ba36, lags(1) 
 
 
/****Upper Middle Income****/ 
 
eststo m19: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc if income_group == 
"UMI", cce trend robust res(ba17) 
di e(trend_sig) 





eststo m20: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc if income_group == 
"UMI", cce trend robust res(ba27) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m21: xtmg lope lgdp llex linm lp65 lp15 loda lgfc if income_group == 
"UMI", cce trend robust res(ba37) 
di e(trend_sig) 
test lgdp = 1 
 
esttab m19 m20 m21 using UMIresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba17 ba27  ba37  





eststo m22: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc if income_group == 
"LIN", cce trend robust res(ba18) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m23: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc if income_group == 
"LIN", cce trend robust res(ba28) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m24: xtmg lope lgdp llex linm lp65 lp15 loda lgfc if income_group == 
"LIN", cce trend robust res(ba38) 
di e(trend_sig) 
test lgdp = 1 
 
esttab m22 m23 m24 using LINresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba18 ba28  ba38  





reg lthe lgdp llex linm lp65 lp15 loda lgfc cid#c.year if income_group == 
"HIN", vce(robust) 
eststo m25 
predict ba19, residual 
test lgdp = 1 






reg lghe lgdp llex linm lp65 lp15 loda lgfc cid#c.year if income_group == 
"HIN", vce(robust) 
eststo m26 
predict ba29, residual 
test lgdp = 1 
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reg lope lgdp llex linm lp65 lp15 loda lgfc cid#c.year if income_group == 
"HIN", vce(robust) 
eststo m27 
predict ba39, residual 
test lgdp = 1 





esttab m25 m26 m27 using HINresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba19 ba29 ba39 









eststo m28: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc if region == 
"SSA", cce trend robust res(ba110) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m29: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc if region == 
"SSA", cce trend robust res(ba210) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m30: xtmg lope lgdp llex linm lp65 lp15 loda lgfc if region == 
"SSA", cce trend robust res(ba310) 
di e(trend_sig) 
test lgdp = 1 
 
esttab m28 m29 m30 using SSAresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba110 ba210 ba310  





eststo m31: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc if region == "NA", 
cce trend robust res(ba111) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m32: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc if region == "NA", 




test lgdp = 1 
 
 
eststo m33: xtmg lope lgdp llex linm lp65 lp15 loda lgfc if region == "NA", 
cce trend robust res(ba311) 
di e(trend_sig) 
test lgdp = 1 
 
esttab m31 m32 m33 using NAresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba111 ba211 ba311  
multipurt ba111 ba211 ba311, lags(1) 
 
***************************** 





eststo m34: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc if fragility == 
"FRA", cce trend robust res(ba112) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m35: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc if fragility == 
"FRA", cce trend robust res(ba212) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m36: xtmg lope lgdp llex linm lp65 lp15 loda lgfc if fragility == 
"FRA", cce trend robust res(ba312) 
di e(trend_sig) 
test lgdp = 1 
 
esttab m34 m35 m36 using FRAresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba112 ba212 ba312  






eststo m37: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc if fragility  == 
"NFR", cce trend robust res(ba113) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m38: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc if fragility == 
"NFR", cce trend robust res(ba213) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m39: xtmg lope lgdp llex linm lp65 lp15 loda lgfc if fragility == 




test lgdp = 1 
 
esttab m37 m38 m39 using NFRresults.csv, star(* 0.10 ** 0.05 *** 0.01) 
 
xtcd ba113 ba213 ba313  





/**Sensitivity to Exchange Rate Fluctuations**/ 
***************************** 
gen str ppp = "STABLE" 
 
label variable ppp "Stable & UnStable Exchange Rate Country" 
 
replace ppp = "UNSTABLE" if country == "Burundi" 
replace ppp = "UNSTABLE" if country == "Congo, Dem. Rep." 
replace ppp = "UNSTABLE" if country == "Guinea" 
replace ppp = "UNSTABLE" if country == "Madagascar" 
replace ppp = "UNSTABLE" if country == "Sierra Leone" 
replace ppp = "UNSTABLE" if country == "Tanzania" 
replace ppp = "UNSTABLE" if country == "Uganda" 
 
/****UNSTABLE Countries****/ 
eststo m40: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc if ppp  == 
"UNSTABLE", cce trend robust res(ba114) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m41: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc if ppp  == 
"UNSTABLE", cce trend robust res(ba214) 
di e(trend_sig) 
test lgdp = 1 
 
 
eststo m42: xtmg lope lgdp llex linm lp65 lp15 loda lgfc if ppp  == 
"UNSTABLE", cce trend robust res(ba314) 
di e(trend_sig) 
test lgdp = 1 
 
esttab m40 m41 m42 using unstableppresults.csv, star(* 0.10 ** 0.05 *** 
0.01) 
 
xtcd ba114 ba214 ba314  
multipurt ba114 ba214 ba314, lags(1) 
 
**Drop countries with trending PPP series 
drop if country == "Burundi" 
drop if country == "Congo, Dem. Rep." 
drop if country == "Guinea" 
drop if country == "Madagascar" 
drop if country == "Sierra Leone" 
drop if country == "Tanzania" 
drop if country == "Uganda" 
 
eststo m43: xtmg lthe lgdp llex linm lp65 lp15 loda lgfc, cce trend robust 
res(ba115) 
di e(trend_sig) 




eststo m44: xtmg lghe lgdp llex linm lp65 lp15 loda lgfc, cce trend robust 
res(ba215) 
di e(trend_sig) 
test lgdp = 1 
 
eststo m45: xtmg lope lgdp llex linm lp65 lp15 loda lgfc, cce trend robust 
res(ba315) 
di e(trend_sig) 
test lgdp = 1 
 
esttab m43 m44 m45 using stablepppresults.csv, star(* 0.10 ** 0.05 *** 
0.01)  
 
xtcd ba115 ba215 ba315 




//Change the .ado file directory to my P drive 
sysdir set OLDPLACE "P:\Desktop\ado" 
 
sysdir set PLUS "P:\Desktop\ado\plus" 
 




xtset cid year 
 
gen lrhex = log(rhex) 
 
 
//Somalia and South sudan have missing observations for all the variables 
excluding LEX, INM 
 
drop if country == "Somalia" 
 
drop if country == "South Sudan" 
 
//**********Exclude countries with over 10 observations for GFC ********// 
 
/**/ 
drop if country == "Cabo Verde" 
drop if country == "Ethiopia" 
drop if country == "Lesotho" 
drop if country == "Sao Tome and Principe" 





summarize ppp_con reer rhex 
 
correlate lrhex ppp_con 
 
xtline ppp_con if cid < 25, i(country) t(year) 
xtline ppp_con if cid > 24, i(country) t(year) 
  
xtline lrhex if cid < 25, i(country) t(year) 
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Appendix: Chapter 2 








Figure A2.3: Size of Baumol’s Effect in OECD using Random Coefficient Model 
 
 





Figure A2.5: Size of Baumol’s Effect in OECD using CCEMG Estimator 
 





DESCRIPTION OF CROSS-SECTIONAL DEPENDENCE TEST 
The cross-sectional dependence test is based on the following null and alternative 
hypotheses: 
 for  
 for some  
where  is the product-moment correlation coefficient of the disturbances and is given by 
       (A2.1) 
The number of possible pairing  can be derived from  and it rises with number 
of cross-section units ( ). 
I. Pesaran’s Cross-Section Dependence (CD) Test 
The null hypothesis of cross-sectional independence can be tested using the Pesaran 
(2004) CD test for unbalanced panels given by 
       (A2.2) 
where  i.e., the number of common time-series observations between cross-
section units and  
    (A2.3) 
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        (A2.4) 
II. Friedman’s Test 
A nonparametric test advanced by Friedman (1937) was based on Spearman’s rank 
correlation coefficient given by  
      (A2.5) 
where  is the ranks of , and is the average rank. From the 
expression (A2.5), Friedman’s statistic is based on the average correlation given as: 
        (A2.6) 
If the value of  is large, it suggests existence of nonzero cross-sectional correlation and 
Friedman showed that  is asymptotically distributed with  
degree of freedom, for fixed as gets large.  
 De Hoyos and Sarafidis (2006) noted that  and  involves the sum of the 
pairwise correlation coefficients of the residual matrix, and the tests are likely to miss cases of 
cross-sectional dependence where the sign of the correlations is alternating53. Although, if the 
                                                          
53 The alternating correlation coefficients is a case where the coefficient values cancels out during averaging as 




























































panel-data model is of single factor error structure (i.e. ) and the factor loadings 
mean are non-zero (i.e. ), then the  and  tests would be reliable and not 
undergo such alternating signs problem.  
III. Frees’ Test 
To avert the problem of factor loading being mean zero resulting from correlation 
coefficients of the error term alternate in signs (making  and  inappropriate and less 
reliable), Frees (1995); (2004) proposed a statistic based on the sum of the squared rank 
correlation coefficient and equals: 
        (A2.7) 
Frees indicated that the statistic follows a joint distribution of two independently drawn 
variables as follows: 
 (A2.8) 
where  and are the independent random variables with respective  and 
  degree of freedom. Also,  and 
.  
However, the null hypothesis is rejected when  and is the 
appropriate quantile of the distribution and a weighted sum of two -randomly distributed 
variables and depends on the size of . For tending from 20 to 30, the normal approximation 
to distribution performs well. 
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Table A2.1:  Brief Description and Set-up of Panel Data Estimators 









Model Static Static Static Static/Dynamic Static/Dynamic Static/Dynamic 
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(created by common 
factor structure (
))  
    -Augment with  




shock/factor ( ) 
-Augment with  
(common 
dynamic process) 
i.e. the estimated 
cross-section 





Where  is from 
 
and  is year 
dummies. 
Source: Banerjee, Eberhardt, & Reade, 2010; Beck & Katz, 2007; Bond & Eberhardt, 2009; Chudik & Pesaran, 2013; Eberhardt & Teal, 2010, 2011, 2014; 





































































and a solution 
for the rising 
































  Bar charts Prices in the service 
sector will continue to 
rise at a rate beyond 
control because of costs 
of service in terms of 
labour inputs and 
declining labour 
productivity. The cost 
disease implies that 
governments are faced 
with a daunting task of 
acquiring adequate 
revenues to prevent 
municipal services from 
collapsing. Then, these 
services constitutes a 
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caveats for a 
causal link 
Examines the 





















He explains the 
application of BCD in 
the health care industry 
based on the increasing 
long demand for the 
sector activities. He 
explains that there is 
unlimited demand for 
better health care 
services as long as 
people experience 
variation in their health 
status and spending in 
the sector as a share of 
national income increases 








The drivers of 
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is assumed to 
























The long-term care 
expenditure per 
dependent shifts upwards 
due to the “cost-disease” 
effect by an average of 
2.2% and expected to be 






























































































Health care expenditure 
per capita growth effect 
of Baumol variable was 
positive and ranges 
between 1.029 and 1.033. 
The study validated the 
Baumol hypothesis and 
concluded that Baumol 
effect on HCE growth is 



















































shifts into the 
health sector 
(as a service 
sector whose 
productivity is 



















the measure on 
the basis that 
the periods of 
strong 
increases in 
HCE are seen 







































All the lags of Baumol 
effect (i.e. lagged HCE 
growth) had negative and 
significant impact on 
GDP per capita growth 
rate. The Baumol effect 
coefficients ranges from -
0.074 to -0.179. This 
indicates that expenditure 
shifts into the health 
sector declines overall 
GDP growth. Thus 
supports the predictions 






















































price of health 


































Growth rate of relative 
medical care prices exert 
positive and significant 
effect on rising HCE. 
Thus supports the 
evidence of Baumol’s 
hypothesis. The Baumol 
effect coefficient ranges 













secular rise in 
HCE suffers 
from Baumol 
‘s cost disease 






























































The study supports that 
health care sector is 
trapped by Baumol’s cost 
disease between a positive 
and significant range of 
0.109 and 0.212 growth 
effect. But the effect is 
less than proportional as 
indicated by Hartwig 
(2008). They also provide 
supports that inflation in 
health care sector is 
overestimated due to 
difficulties in a reliable 
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They found a positive 
and significant Baumol 
effect ranging from 0.009 
to 0.037 for U.S states. 
Thus, they conclude that 
health care cost in the 
U.S suffers from Baumol 
cost-disease effect but in 
a lesser extent compared 




































This sub-section of the study presents the matrix notations and dimensions of the model set-up 
described in section 4.2. Notes are provided for some equations to give more details. The set-
up begins with: 
        (1) 
    (2) 
Note 1: 
For , , and  
; ; ; 
 
 
For and  
         (3) 
      (4) 
ititkiktiit uxdy  ,,
 
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For , , and  
;   
For and  
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For , , , and  




























































































































































































































itktmimktmimktikitk vfpgdx ,,,,,,,,,  




The observable common factor,  (i.e. deterministic trend or seasonal dummies) and the 
unobservable common factors ( ) are the same across group but vary over time.  
 
Random Slope Coefficients: 
For  and  
          (7) 




For  and  
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Factor loadings (Y-Equation): 
For and  
         (9) 








Factor loadings (X-Equation): 
For  
         (11) 
(12) 
         (13) 
 NN 
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For  and  
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Pesaran’s (2006: 972-973) CCE Estimator Assumption II 
This appendix is a supplementary note on the second assumption underlying the Pesaran’s 
(2006:972-973) CCE estimator. The assumption states that “individual specific errors in Y (
) and X ( ) are distributed independently for all and ”. 
For each ,  and  are  and  matrices respectively.  
 
For each cross-section unit, ,  and  follow linear  stationary processes with ABSOLUTE 
SUMMABLE AUTOCOVARIANCES-(i.e. the covariance structure is stable over time): 
         (15) 
         (16) 
 
 
Where 0, 1, 2, . . .  
 
is random variables called innovation process as it represents a part of  that is 
unexplained and unpredictable given the past values of  
 and  are IID (0, ) 
 
RESIDUALS IN Y 
(1) SUMMABLE AUTOCOVARIANCES 
For each cross-section unit, : 
Cov( ) =    (17) 
it
it tji ,, t 
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The absolute row-column difference ( ) of each of the elements in the matrix 
represents the AUTOCOVARIANCE at lag . It also indicates the existence of 
autocorrelation.  
 (2) VARIANCE 
Variance for each th cross-section unit is: 




Where 0, 1, 2, . . .  
 
For a single cross-section unit, the variance at time t across all considered periods is represented 
as the sum of the T x 1 vector: 
       (19) 
NOTE:  
 Pesaran (2006) indicated that the variance varies across each cross-section units (see 
Eq.(18)); 
 The sum of variances within each cross-section units is less than . It is a necessary 
condition for stationarity (see Wold (1938) decomposition theorem); 
Also, the variance for each specific cross-section unit is less than or equal to the average of 
variances for all cross-section units: 
































































































(3)  CONSTRUCTING VARIANCE-COVARIANCE MATRIX for each i 
Re-representing (19) as symmetric and identity matrix with variance at lag j as the 
diagonal elements: 
Combining (17) and (19) for each cross-section units gives: 
  (21)
 
NOTE: It is assumed that the variance of   is the same for all T i.e. Homoskedasticity. 
 
RESIDUALS IN X 
(1) SUMMABLE AUTOCOVARIANCES 
The errors in X regressors can be represented as matrix with each element as block of 
matrix for each cross-section: 
         (22) 
    
 
Alternatively, for each cross-section unit with  explanatory variables over time, the residual 
is a  matrix: 
       (23) 
 















































































































































        (24) 
Where N is a  matrix with one as elements. The diagonal elements are the variance for 
each explanatory variable and off-diagonal elements are the covariance and each represents a 
matrix of  matrix with ones along the diagonal as shown in (17).  
      (25) 
For each group specific, the auto-covariance is the sum of the off-diagonal elements
: 
         (26) 
 
(2) VARIANCE 
Variance for each th cross-section units is: 
The sum of the elements on the diagonal matrix given as: 
          (27) 
The average of variances for all cross-section units is less than  i.e.: 
         (28) 

















































































Derivation of Unobservable Common Factors Proxies when  and : 
For  and  
        (29) 
         (30) 
Random Slope Coefficients: 
         
 (31) 
Factor loadings (Y-Equation): 
         (32) 
Substitute (30), (31) and (32) into (29), give: 
      (33) 
Following the assumptions in Pesaran (2006, pp. 972-973) that the error disturbances have a 




Taking the cross-sectional average of Eq.(33) at each time period gives: 
        
 (34) 
        
 (35) 
OLS estimation of the above gives: 
        (36) 
Since the common factor loading vector ( ) is fixed across , then  and it is non-zero. 
        (37) 
According to Pesaran (2006), the unobservable common factor is a function of the observables 
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Table 5.3: Review of Selected Empirical Studies on Income Elasticity of Health Expenditures 
S/N Author(s)/ 
(Year) 
Title Scope Dependent 
variable 













 17 OECD 
countries (1975 
– 2003) 
 Real per 
capita health 
expenditure 
Real per capita GDP, 
proportion of population 
aged 65 years above, 
proportion of population 
under 15, share of public 
financing, and life 
expectancy as a measure of 





Necessity    














2000); 16 OECD 
countries (1960 - 
1997)  
 Per capita 
health 
expenditure 
For U.S & OECD: Per 
capita real gross state 
product, proportion of 
population aged 65. For 
Canada: Real   per capita 
provincial GDP, real per 
capita provincial revenue 
from federal cash transfers, 
proportion of population 
aged 65 and over 
 Fixed effect 
regression (OLS) 
 Necessity   












1965 – 1991 
Canada 
provinces (1965 
- 1991)  
 Per capita 
health 
expenditure 
 Real   per capita provincial 
GDP, real per capita 
provincial revenue from 
federal cash transfers, 
proportion of population 
aged 65 and over 







Title Scope Dependent 
variable 




















GDP per capita, proportion 
of the population over 65 
 Fixed effect 
regression (OLS) 



















US states (1980 






For U.S: Per real capita, real 
gross state product, 
proportion of population 
aged: 0-24, 25-44, 45-64, 
65-84, 65 and over, 85 and 
over. 
For Canada: real per capita 
provincial government total 
health expenditure, real   per 
capita provisional GDP, real 
per capita provincial 
revenue from federal cash 
transfers, proportion of 
population aged: 0-17, 18-
44, 45-64, 65-74, 75 and 
over. 

























Title Scope Dependent 
variable 






















Real per capita GDP, 
proportion of population 
aged 65 and over, individual 
income share of top and 
bottom quintile, real per 
capital federal health 
transfers, Canada health and 

























 30 African 
countries (1984) 
 Health care 
expenditure 
per capita 
Percentage of births 
attended by health staff, 
Gross national product per 
capita, proportion of 
populated aged under 15, 
proportion of urban 
population, crude birth rates, 








by health staff, 
and foreign aid 
received per 
capita 













countries (2001)  
 Real per 
capita health 
expenditure 
Real per capita GDP, real 
per capita foreign aid, 
proportion of population 
aged 65 and over, and 







 Necessity  POSITIVE & 
SIGNIFICANT:  






Title Scope Dependent 
variable 








 15 OECD 
countries (1990-
1998) 
 Real per 
capita health 
expenditure 
Real per capita GDP, 
Demand variables (infant 
mortality rates per 100,000 
population and proportion of 
population aged 65 years 
and above), and supply 
variables (average length of 
patient stay in hospital and 
number of physicians per 
1,000 of population) 












 POSITIVE & 
SIGNIFICANT:  
Average length 
of patient stay 













Is health care a 











 US states 
(1966-1998) 
 Health care 
expenditure 
























Title Scope Dependent 
variable 















 21 OECD 
countries (1975-
2001) 
 Real per 
capita health 
expenditure 
Real per capita GDP, life 
expectancy, infant mortality 
rate, and proportion of 
population aged 65-above 
 Fully Modified 
OLS and 
Dynamic OLS 
 Necessity  POSITIVE & 
SIGNIFICANT: 
Life expectancy 







12 Baltagi & 
Moscone 
(2010) 
 Health care 
expenditure 





 20 OECD 
(1971-2004) 
 Per capita 
total health 
expenditure 
 Public health expenditure as 
a share of total health 
expenditure, dependency 
rates for old and young 
people [ratio of population 
aged 65-over to population 
aged 15-64; ratio of 
population aged 0-14 to 











 Necessity  POSITIVE & 
SIGNIFICANT: 
Dependency 
rate of young 
people 
13 Hall & 
Jones 
(2007) 
The value of 








GDP, proportion of 
population in different aged 
groups, and life expectancy 













Title Scope Dependent 
variable 









and income in 
the United 
States 





Real per capita disposable 
income, proportion of 
population aged 65-over, 
number of beds, number of 
doctor, and proportion of 
public spending and total 





and Mean Group 
























GDP per capita, percentage 
of publicly funded health 
care spending, percentage of 
the population aged over 65 
years, ratio of health price 
index to the GDP deflator, 















ratio of health 
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an individual 






























Is health care 







Real GDP per capita, 
percentage of population 
aged 65 years and over, and 
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per capita as 
a function of 
income per 
capita 
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per capita as 
a function of 
income per 
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analysis of the 
Newhouse 
conjecture 




Per capita real disposable 
personal income and 
technological changes 
proxied by total R&D 
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variable 























GDP per capita, ratio of PPP 
for medical care to PPP for 
GDP, number of practicing 
physicians per capita 
multiplied by 1000, share of 
total health care expenditure 
used on inpatient health 
care, share of total health 
care expenditure used in 
public expenditure, dummy 
variables (fee-for-service in 
outpatient care, global 
budgeting in hospital care), 
female participation ratio 
(labour force as a ratio of 
population aged 15-64 
years), ratio of population 
65 years and over  to 
population aged 15-64, and 
share of population living in 




Luxury POSITIVE & 
SIGNIFICANT: 








and ratio of 
population 65 










1000, and share 
of total health 
care 
expenditure 






Title Scope Dependent 
variable 
















U.S (1960-2012) Real per 
capita health 
spending 
Per capita real income, 
population percent above 65 
years, and the level of health  
R&D (as a proxy for 
technology) 




65 years, and 
the level of 
health  R&D (as 
a proxy for 
technology) 


















GDP per capita, Percentage 
of population age 65, Voice 
and accountability, 
Government effectiveness, 















GDP per capita, 
Percentage of 
population age 
65, Voice and 
accountability, 
interactive term 

















GDP per capita Cross-section 
regression 







Title Scope Dependent 
variable 






The black box 












First year per capita health 
expenditure growth, GDP 
average growth rate, 
percentage change in 
population over 65, and 
dummy variables (time, 
types of health system 
[public reimbursement and 




Necessity NEGATIVE & 
SIGNIFICANT: 

























GDP per capita, total 
government expenditure as a 
share of GDP, proportion of 
population aged 60 years 
above, incidence of 
tuberculosis per 100,000 
people, out-of-pocket 
expenditure as a share of 
total health expenditure, 
external aids and time 
Fixed effect 
regression (OLS) 
















expenditure as a 
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variable 

























GDP per capita, total 
government expenditure as a 
share of GDP, proportion of 
population aged 60 years 
above, incidence of 
tuberculosis per 100,000 
people, out-of-pocket 
expenditure as a share of 
total health expenditure, 
external aids and time 
Fixed effect 
regression (OLS) 



































GDP per capita, total 
government expenditure as a 
share of GDP, proportion of 
population aged 60 years 
above, incidence of 
tuberculosis per 100,000 
people, out-of-pocket 
expenditure as a share of 
total health expenditure, 
external aids and time 
Fixed effect 
regression (OLS) 














expenditure as a 
share of GDP, 
proportion of 
population aged 





















Per capita GDP, GDP trend 
(computed using Hodrick-
Prescott filter ), negative 
and positive GDP gaps 
between GDP and GDP 
trend, and percentage of 
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variable 






















GDP per capita, proportion 
of population over age 60, 
proportion of government 









GDP, and Time 



















GDP per capita, proportion 
of population over age 60, 
proportion of government 









GDP, and old 
age. 



















GDP per capita, proportion 
of population over age 60, 
proportion of government 



























as a share of 
total health 
expenditure 
GDP per capita, proportion 
of population over age 60, 
proportion of government 
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income in the 










Real GDP per capita OLS regression 
(for individual 
country) 
Necessity   
41 Freeman 
(2012) 
Is health care a 
necessity or a 
luxury? New 
evidence from 
a panel of U.S. 
state-level data 


































Real GDP per capita, 
population aged over 65 
years, population aged under 
15 years, infant mortality 
rate, public health 
expenditure as a share of 
total health expenditure, 
private health expenditure as 

















expenditure as a 







Title Scope Dependent 
variable 



























Per capita GDP, labour 
force, literacy rate, and 
elderly population of age 65 
and above, life expectancy 
at birth 
Panel Dynamic 
OLS, and SUR 





























Real per capita GDP 
growth, growth in the 
relative price of health care, 
growth in doctor density per 
1000 population, rates of 
growth in the population 
segments over 65 years and 
under 15 years, growth of 
government spending for 


























Title Scope Dependent 
variable 




















Real per capita GDP, gini 
coefficient of income 
distribution, dependency 
ratio of population, 
percentage of population 
below aged 15 years, 
population per nurse, 
population per medical 
doctor, mortality rate, 
percentage of urbanized 
population, per capita 
official development 
assistance, percentage of 
births attended by trained 
health care personnel, 
corruption index, and intra-
country conflict (civil war) 
during the 1990s 
Cross-sectional 
regression (OLS) 






























Real per capita GDP, and 
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48  Lv and 
Zhu (2014)  
Health care 
expenditure 













GDP per capita, population 
age 65 and above, and infant 
mortality rate per 1,000 live 
birth 
FE OLS  Necessity POSITIVE & 
SIGNIFICANT: 
population age 










Table  A5.2: Test of Slope Homogeneity  
Dependent 
variables  
lnTHE lnGHE lnOPE 
Chi-square 35688.19*** 14757.10*** 69959.30*** 
















47,11,10 ...:  H   
Note: The models are estimated using the Random Coefficient Model (RCM). The reported statistic 
was suggested by Swamy (1970). It examines the difference between group-specific OLS estimate of 
the slope 1  while ignoring the panel data structure and the matrix-weighted average of the group-
specific OLS estimators (see Johnston & DiNardo, 1997 for details).  
*, **, and *** denote statistical significance at 10%, 5% and 1% level respectively 
 
 
 
